493434_Patient	hasGender	Female
493434_Patient	hasAgeCategory	Old
493434_Patient	hasStage	IV
493434_Patient	hasSmokingHabit	FormerSmoker
493434_Patient	hasBiomarker	EGFR_Positive
493434_Patient	hasRelapse_Progression	Progression
493434_Patient	patientDrug	Carboplatin
493434_Patient	patientDrug	Atezolizumab
493434_Patient	patientDrug	Paclitaxel
493434_Patient	patientDrug	Pemetrexed
493434_Patient	treatmentType	Intravenous_Chemotherapy
493434_Patient	treatmentType	Immunotherapy
493434_Patient	treatmentType	Radiotherapy_To_Bone
588015_Patient	hasGender	Female
588015_Patient	hasAgeCategory	Old
588015_Patient	hasStage	IV
588015_Patient	hasSmokingHabit	FormerSmoker
588015_Patient	hasBiomarker	EGFR_Positive
588015_Patient	hasBiomarker	ALK_Negative
588015_Patient	hasBiomarker	ROS1_Negative
588015_Patient	hasRelapse_Progression	Progression
588015_Patient	patientDrug	Carboplatin
588015_Patient	patientDrug	Atezolizumab
588015_Patient	patientDrug	Pemetrexed
588015_Patient	patientDrug	Cisplatin
588015_Patient	patientDrug	Vinorelbine
588015_Patient	treatmentType	Intravenous_Chemotherapy
588015_Patient	treatmentType	Immunotherapy
588015_Patient	treatmentType	Radiotherapy_To_Bone
588015_Patient	treatmentType	Surgery
751089_Patient	hasGender	Male
751089_Patient	hasAgeCategory	Old
751089_Patient	hasStage	IV
751089_Patient	hasSmokingHabit	FormerSmoker
751089_Patient	hasBiomarker	EGFR_Positive
751089_Patient	hasBiomarker	ALK_Negative
751089_Patient	hasRelapse_Progression	Progression
751089_Patient	patientDrug	Pemetrexed
751089_Patient	patientDrug	Cisplatin
751089_Patient	patientDrug	Docetaxel
751089_Patient	patientDrug	Daratumumab
751089_Patient	patientDrug	Nintedanib
751089_Patient	treatmentType	Intravenous_Chemotherapy
751089_Patient	treatmentType	Immunotherapy
2462990_Patient	hasGender	Female
2462990_Patient	hasAgeCategory	Old
2462990_Patient	hasStage	IV
2462990_Patient	hasSmokingHabit	CurrentSmoker
2462990_Patient	hasBiomarker	PDL1_Positive
2462990_Patient	hasBiomarker	ALK_Negative
2462990_Patient	hasBiomarker	BRAF_Negative
2462990_Patient	hasBiomarker	EGFR_Negative
2462990_Patient	hasRelapse_Progression	Progression
2462990_Patient	patientDrug	Carboplatin
2462990_Patient	patientDrug	Pemetrexed
2462990_Patient	patientDrug	Pembrolizumab
2462990_Patient	treatmentType	Intravenous_Chemotherapy
2462990_Patient	treatmentType	Immunotherapy
2462990_Patient	treatmentType	Radiotherapy_To_Bone
2462990_Patient	treatmentType	Thoracoscopy
2807165_Patient	hasGender	Female
2807165_Patient	hasAgeCategory	Young
2807165_Patient	hasStage	IV
2807165_Patient	hasSmokingHabit	FormerSmoker
2807165_Patient	hasBiomarker	EGFR_Negative
2807165_Patient	hasBiomarker	ROS1_Negative
2807165_Patient	hasRelapse_Progression	Progression
2807165_Patient	patientDrug	Pemetrexed
2807165_Patient	patientDrug	Cisplatin
2807165_Patient	patientDrug	Placebo%20Controlled%20Study
2807165_Patient	patientDrug	Pembrolizumab
2807165_Patient	patientDrug	Alectinib
2807165_Patient	patientDrug	Brigatinib
2807165_Patient	patientDrug	Lorlatinib
2807165_Patient	treatmentType	Molecular_Targeted_Therapy
2807165_Patient	treatmentType	Immunotherapy
2807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1258242_Patient	hasGender	Female
1258242_Patient	hasAgeCategory	Young
1258242_Patient	hasStage	IV
1258242_Patient	hasSmokingHabit	FormerSmoker
1258242_Patient	hasBiomarker	EGFR_Positive
1258242_Patient	hasRelapse_Progression	Progression
1258242_Patient	patientDrug	Erlotinib
1258242_Patient	patientDrug	Emibetuzumab
1258242_Patient	treatmentType	Molecular_Targeted_Therapy
1258242_Patient	treatmentType	Immunotherapy
1258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1258242_Patient	treatmentType	Radiotherapy_To_Bone
2603790_Patient	hasGender	Male
2603790_Patient	hasAgeCategory	Young
2603790_Patient	hasStage	IV
2603790_Patient	hasSmokingHabit	CurrentSmoker
2603790_Patient	hasBiomarker	EGFR_Positive
2603790_Patient	hasRelapse_Progression	Progression
2603790_Patient	patientDrug	Cisplatin
2603790_Patient	patientDrug	Gemcitabine
2603790_Patient	patientDrug	Durvalumab
2603790_Patient	treatmentType	Intravenous_Chemotherapy
2603790_Patient	treatmentType	Immunotherapy
2845808_Patient	hasGender	Male
2845808_Patient	hasAgeCategory	Old
2845808_Patient	hasStage	IV
2845808_Patient	hasSmokingHabit	CurrentSmoker
2845808_Patient	hasBiomarker	EGFR_Positive
2845808_Patient	hasRelapse_Progression	Progression
2845808_Patient	patientDrug	Carboplatin
2845808_Patient	patientDrug	Atezolizumab
2845808_Patient	patientDrug	Paclitaxel
2845808_Patient	patientDrug	Gemcitabine
2845808_Patient	treatmentType	Intravenous_Chemotherapy
2845808_Patient	treatmentType	Immunotherapy
2845808_Patient	treatmentType	Radiotherapy_To_Lung
1042707_Patient	hasGender	Male
1042707_Patient	hasAgeCategory	Old
1042707_Patient	hasStage	IIIA
1042707_Patient	hasSmokingHabit	CurrentSmoker
1042707_Patient	hasBiomarker	ALK_Negative
1042707_Patient	hasBiomarker	BRAF_Negative
1042707_Patient	hasBiomarker	EGFR_Negative
1042707_Patient	hasBiomarker	ROS1_Negative
1042707_Patient	hasRelapse_Progression	No_Progression
1042707_Patient	patientDrug	Carboplatin
1042707_Patient	patientDrug	Paclitaxel
1042707_Patient	patientDrug	Vinorelbine
1042707_Patient	patientDrug	Durvalumab
1042707_Patient	treatmentType	Intravenous_Chemotherapy
1042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
1042707_Patient	treatmentType	Immunotherapy
1042707_Patient	treatmentType	Radiotherapy_To_Lung
1267046_Patient	hasGender	Female
1267046_Patient	hasAgeCategory	Old
1267046_Patient	hasStage	IVB
1267046_Patient	hasSmokingHabit	CurrentSmoker
1267046_Patient	hasBiomarker	PDL1_Positive
1267046_Patient	hasBiomarker	ALK_Negative
1267046_Patient	hasBiomarker	EGFR_Negative
1267046_Patient	hasBiomarker	ROS1_Negative
1267046_Patient	hasRelapse_Progression	Progression
1267046_Patient	patientDrug	Carboplatin
1267046_Patient	patientDrug	Pemetrexed
1267046_Patient	patientDrug	Other
1267046_Patient	patientDrug	Pembrolizumab
1267046_Patient	treatmentType	Intravenous_Chemotherapy
1267046_Patient	treatmentType	Immunotherapy
1267046_Patient	treatmentType	Radiotherapy_To_Bone
2325330_Patient	hasGender	Male
2325330_Patient	hasAgeCategory	Young
2325330_Patient	hasStage	IVA
2325330_Patient	hasSmokingHabit	CurrentSmoker
2325330_Patient	hasBiomarker	PDL1_Positive
2325330_Patient	hasBiomarker	ALK_Negative
2325330_Patient	hasBiomarker	BRAF_Negative
2325330_Patient	hasBiomarker	EGFR_Negative
2325330_Patient	hasBiomarker	ROS1_Negative
2325330_Patient	hasRelapse_Progression	Progression
2325330_Patient	patientDrug	Carboplatin
2325330_Patient	patientDrug	Paclitaxel
2325330_Patient	patientDrug	Pembrolizumab
2325330_Patient	treatmentType	Intravenous_Chemotherapy
2325330_Patient	treatmentType	Immunotherapy
2325330_Patient	treatmentType	Radiotherapy_To_Bone
2369878_Patient	hasGender	Male
2369878_Patient	hasAgeCategory	Young
2369878_Patient	hasStage	IIIB
2369878_Patient	hasSmokingHabit	NonSmoker
2369878_Patient	hasBiomarker	ALK_Positive
2369878_Patient	hasBiomarker	EGFR_Negative
2369878_Patient	hasRelapse_Progression	Progression
2369878_Patient	patientDrug	Cisplatin
2369878_Patient	patientDrug	Vinorelbine
2369878_Patient	patientDrug	Pembrolizumab
2369878_Patient	patientDrug	Crizotinib
2369878_Patient	treatmentType	Intravenous_Chemotherapy
2369878_Patient	treatmentType	Molecular_Targeted_Therapy
2369878_Patient	treatmentType	Immunotherapy
2670938_Patient	hasGender	Male
2670938_Patient	hasAgeCategory	Old
2670938_Patient	hasStage	IIA
2670938_Patient	hasSmokingHabit	CurrentSmoker
2670938_Patient	hasBiomarker	ALK_Negative
2670938_Patient	hasBiomarker	EGFR_Negative
2670938_Patient	hasRelapse_Progression	Progression
2670938_Patient	patientDrug	Carboplatin
2670938_Patient	patientDrug	Paclitaxel
2670938_Patient	patientDrug	Cisplatin
2670938_Patient	patientDrug	Vinorelbine
2670938_Patient	patientDrug	Pembrolizumab
2670938_Patient	patientDrug	Docetaxel
2670938_Patient	treatmentType	Intravenous_Chemotherapy
2670938_Patient	treatmentType	Immunotherapy
2670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
2670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2670938_Patient	treatmentType	Thoracoscopy
2777040_Patient	hasGender	Female
2777040_Patient	hasAgeCategory	Young
2777040_Patient	hasStage	IVB
2777040_Patient	hasSmokingHabit	CurrentSmoker
2777040_Patient	hasBiomarker	PDL1_Positive
2777040_Patient	hasBiomarker	ALK_Negative
2777040_Patient	hasBiomarker	EGFR_Negative
2777040_Patient	hasBiomarker	ROS1_Negative
2777040_Patient	hasRelapse_Progression	Progression
2777040_Patient	patientDrug	Carboplatin
2777040_Patient	patientDrug	Pemetrexed
2777040_Patient	patientDrug	Pembrolizumab
2777040_Patient	treatmentType	Intravenous_Chemotherapy
2777040_Patient	treatmentType	Immunotherapy
2777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2803612_Patient	hasGender	Male
2803612_Patient	hasAgeCategory	Old
2803612_Patient	hasStage	IVA
2803612_Patient	hasSmokingHabit	CurrentSmoker
2803612_Patient	hasBiomarker	PDL1_Positive
2803612_Patient	hasBiomarker	ALK_Negative
2803612_Patient	hasBiomarker	EGFR_Negative
2803612_Patient	hasBiomarker	ROS1_Negative
2803612_Patient	hasRelapse_Progression	Progression
2803612_Patient	hasRelapse_Progression	Relapse
2803612_Patient	patientDrug	Paclitaxel
2803612_Patient	patientDrug	Pemetrexed
2803612_Patient	patientDrug	Cisplatin
2803612_Patient	patientDrug	Pembrolizumab
2803612_Patient	treatmentType	Intravenous_Chemotherapy
2803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
2803612_Patient	treatmentType	Immunotherapy
2803612_Patient	treatmentType	Radiotherapy_To_Lung
2825213_Patient	hasGender	Female
2825213_Patient	hasAgeCategory	Young
2825213_Patient	hasStage	IVB
2825213_Patient	hasSmokingHabit	FormerSmoker
2825213_Patient	hasBiomarker	PDL1_Positive
2825213_Patient	hasBiomarker	ALK_Negative
2825213_Patient	hasBiomarker	EGFR_Negative
2825213_Patient	hasBiomarker	ROS1_Negative
2825213_Patient	hasRelapse_Progression	Progression
2825213_Patient	patientDrug	Carboplatin
2825213_Patient	patientDrug	Paclitaxel
2825213_Patient	patientDrug	Other
2825213_Patient	patientDrug	Pembrolizumab
2825213_Patient	patientDrug	Docetaxel
2825213_Patient	treatmentType	Intravenous_Chemotherapy
2825213_Patient	treatmentType	Immunotherapy
2825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2825213_Patient	treatmentType	Open_Surgical_Procedure
2834441_Patient	hasGender	Male
2834441_Patient	hasAgeCategory	Young
2834441_Patient	hasStage	IVB
2834441_Patient	hasSmokingHabit	CurrentSmoker
2834441_Patient	hasBiomarker	PDL1_Positive
2834441_Patient	hasBiomarker	ALK_Negative
2834441_Patient	hasBiomarker	EGFR_Negative
2834441_Patient	hasBiomarker	KRAS_Negative
2834441_Patient	hasBiomarker	MET_Negative
2834441_Patient	hasBiomarker	RET_Negative
2834441_Patient	hasBiomarker	ROS1_Negative
2834441_Patient	hasRelapse_Progression	Progression
2834441_Patient	patientDrug	Atezolizumab
2834441_Patient	patientDrug	Pemetrexed
2834441_Patient	patientDrug	Cisplatin
2834441_Patient	patientDrug	Gemcitabine
2834441_Patient	patientDrug	Other
2834441_Patient	patientDrug	Docetaxel
2834441_Patient	patientDrug	Nintedanib
2834441_Patient	treatmentType	Intravenous_Chemotherapy
2834441_Patient	treatmentType	Immunotherapy
2834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
438540_Patient	hasGender	Male
438540_Patient	hasAgeCategory	Old
438540_Patient	hasStage	IVA
438540_Patient	hasSmokingHabit	FormerSmoker
438540_Patient	hasBiomarker	EGFR_Positive
438540_Patient	hasBiomarker	ALK_Negative
438540_Patient	hasBiomarker	PDL1_Negative
438540_Patient	hasBiomarker	ROS1_Negative
438540_Patient	hasRelapse_Progression	Progression
438540_Patient	patientDrug	Carboplatin
438540_Patient	patientDrug	Atezolizumab
438540_Patient	patientDrug	Pemetrexed
438540_Patient	treatmentType	Intravenous_Chemotherapy
438540_Patient	treatmentType	Immunotherapy
438540_Patient	treatmentType	Thoracoscopy
576411_Patient	hasGender	Female
576411_Patient	hasAgeCategory	Young
576411_Patient	hasStage	IIIB
576411_Patient	hasSmokingHabit	FormerSmoker
576411_Patient	hasBiomarker	EGFR_Positive
576411_Patient	hasRelapse_Progression	Progression
576411_Patient	patientDrug	Paclitaxel
576411_Patient	patientDrug	Pemetrexed
576411_Patient	patientDrug	Cisplatin
576411_Patient	patientDrug	Pembrolizumab
576411_Patient	treatmentType	Intravenous_Chemotherapy
576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
576411_Patient	treatmentType	Immunotherapy
576411_Patient	treatmentType	Radiotherapy_To_Lung
583611_Patient	hasGender	Female
583611_Patient	hasAgeCategory	Old
583611_Patient	hasStage	IIIC
583611_Patient	hasSmokingHabit	CurrentSmoker
583611_Patient	hasBiomarker	EGFR_Positive
583611_Patient	hasBiomarker	PDL1_Positive
583611_Patient	hasBiomarker	ALK_Negative
583611_Patient	hasBiomarker	ROS1_Negative
583611_Patient	hasRelapse_Progression	No_Progression
583611_Patient	patientDrug	Carboplatin
583611_Patient	patientDrug	Vinorelbine
583611_Patient	patientDrug	Durvalumab
583611_Patient	treatmentType	Intravenous_Chemotherapy
583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
583611_Patient	treatmentType	Immunotherapy
583611_Patient	treatmentType	Radiotherapy_To_Lung
619371_Patient	hasGender	Female
619371_Patient	hasAgeCategory	Young
619371_Patient	hasStage	IVB
619371_Patient	hasSmokingHabit	CurrentSmoker
619371_Patient	hasBiomarker	EGFR_Positive
619371_Patient	hasBiomarker	PDL1_Positive
619371_Patient	hasBiomarker	ALK_Negative
619371_Patient	hasBiomarker	ROS1_Negative
619371_Patient	hasRelapse_Progression	Progression
619371_Patient	patientDrug	Carboplatin
619371_Patient	patientDrug	Pemetrexed
619371_Patient	patientDrug	Pembrolizumab
619371_Patient	patientDrug	Docetaxel
619371_Patient	treatmentType	Intravenous_Chemotherapy
619371_Patient	treatmentType	Immunotherapy
619371_Patient	treatmentType	Radiotherapy_To_Lung
619371_Patient	treatmentType	Radiotherapy_To_Bone
623804_Patient	hasGender	Female
623804_Patient	hasAgeCategory	Young
623804_Patient	hasStage	IVB
623804_Patient	hasSmokingHabit	CurrentSmoker
623804_Patient	hasBiomarker	PDL1_Positive
623804_Patient	hasBiomarker	ALK_Negative
623804_Patient	hasBiomarker	EGFR_Negative
623804_Patient	hasBiomarker	ROS1_Negative
623804_Patient	hasRelapse_Progression	Progression
623804_Patient	patientDrug	Atezolizumab
623804_Patient	patientDrug	Pemetrexed
623804_Patient	patientDrug	Cisplatin
623804_Patient	patientDrug	Vinorelbine
623804_Patient	patientDrug	Docetaxel
623804_Patient	treatmentType	Intravenous_Chemotherapy
623804_Patient	treatmentType	Immunotherapy
623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
623804_Patient	treatmentType	Radiotherapy_To_Bone
810098_Patient	hasGender	Female
810098_Patient	hasAgeCategory	Young
810098_Patient	hasStage	IIIA
810098_Patient	hasSmokingHabit	FormerSmoker
810098_Patient	hasBiomarker	EGFR_Positive
810098_Patient	hasRelapse_Progression	Progression
810098_Patient	patientDrug	Carboplatin
810098_Patient	patientDrug	Atezolizumab
810098_Patient	patientDrug	Pemetrexed
810098_Patient	patientDrug	Vinorelbine
810098_Patient	patientDrug	Other
810098_Patient	patientDrug	Docetaxel
810098_Patient	treatmentType	Intravenous_Chemotherapy
810098_Patient	treatmentType	Chemotherapy_Adjuvant
810098_Patient	treatmentType	Molecular_Targeted_Therapy
810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
810098_Patient	treatmentType	Immunotherapy
810098_Patient	treatmentType	Radiotherapy_To_Lung
810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
810098_Patient	treatmentType	Open_Surgical_Procedure
829640_Patient	hasGender	Female
829640_Patient	hasAgeCategory	Young
829640_Patient	hasStage	IVA
829640_Patient	hasSmokingHabit	CurrentSmoker
829640_Patient	hasBiomarker	EGFR_Positive
829640_Patient	hasBiomarker	PDL1_Positive
829640_Patient	hasBiomarker	ALK_Negative
829640_Patient	hasBiomarker	ROS1_Negative
829640_Patient	hasRelapse_Progression	Progression
829640_Patient	patientDrug	Carboplatin
829640_Patient	patientDrug	Pemetrexed
829640_Patient	patientDrug	Pembrolizumab
829640_Patient	patientDrug	Docetaxel
829640_Patient	treatmentType	Intravenous_Chemotherapy
829640_Patient	treatmentType	Immunotherapy
829640_Patient	treatmentType	Radiotherapy_To_Lung
790159_Patient	hasGender	Male
790159_Patient	hasAgeCategory	Old
790159_Patient	hasStage	IVA
790159_Patient	hasSmokingHabit	FormerSmoker
790159_Patient	hasBiomarker	PDL1_Positive
790159_Patient	hasRelapse_Progression	Progression
790159_Patient	patientDrug	Pembrolizumab
790159_Patient	patientDrug	Afatinib
790159_Patient	treatmentType	Immunotherapy
790159_Patient	treatmentType	Radiotherapy_To_Lung
1110078_Patient	hasGender	Male
1110078_Patient	hasAgeCategory	Young
1110078_Patient	hasStage	IVB
1110078_Patient	hasSmokingHabit	CurrentSmoker
1110078_Patient	hasBiomarker	EGFR_Positive
1110078_Patient	hasBiomarker	ALK_Negative
1110078_Patient	hasRelapse_Progression	Progression
1110078_Patient	patientDrug	Carboplatin
1110078_Patient	patientDrug	Paclitaxel
1110078_Patient	patientDrug	Pemetrexed
1110078_Patient	patientDrug	Cisplatin
1110078_Patient	patientDrug	Afatinib
1110078_Patient	patientDrug	Osimertinib
1110078_Patient	treatmentType	Intravenous_Chemotherapy
1110078_Patient	treatmentType	Molecular_Targeted_Therapy
1110078_Patient	treatmentType	Radiotherapy_To_Bone
2831180_Patient	hasGender	Female
2831180_Patient	hasAgeCategory	Young
2831180_Patient	hasStage	IVB
2831180_Patient	hasSmokingHabit	NonSmoker
2831180_Patient	hasBiomarker	EGFR_Positive
2831180_Patient	hasBiomarker	PDL1_Positive
2831180_Patient	hasBiomarker	ALK_Negative
2831180_Patient	hasBiomarker	ROS1_Negative
2831180_Patient	patientDrug	Afatinib
2831180_Patient	patientDrug	Osimertinib
2831180_Patient	treatmentType	Molecular_Targeted_Therapy
2831180_Patient	treatmentType	Radiotherapy_To_Bone
583557_Patient	hasGender	Male
583557_Patient	hasAgeCategory	Old
583557_Patient	hasStage	IVB
583557_Patient	hasSmokingHabit	NonSmoker
583557_Patient	hasBiomarker	EGFR_Positive
583557_Patient	hasBiomarker	ALK_Negative
583557_Patient	hasBiomarker	ROS1_Negative
583557_Patient	hasRelapse_Progression	Progression
583557_Patient	patientDrug	Carboplatin
583557_Patient	patientDrug	Pemetrexed
583557_Patient	patientDrug	Vinorelbine
583557_Patient	patientDrug	Erlotinib
583557_Patient	patientDrug	Gefitinib
583557_Patient	treatmentType	Molecular_Targeted_Therapy
583557_Patient	treatmentType	Immunotherapy
583557_Patient	treatmentType	Radiotherapy_To_Bone
1077426_Patient	hasGender	Female
1077426_Patient	hasAgeCategory	Young
1077426_Patient	hasStage	IVA
1077426_Patient	hasSmokingHabit	FormerSmoker
1077426_Patient	hasBiomarker	EGFR_Positive
1077426_Patient	hasBiomarker	PDL1_Positive
1077426_Patient	hasBiomarker	ALK_Negative
1077426_Patient	hasBiomarker	BRAF_Negative
1077426_Patient	hasBiomarker	ROS1_Negative
1077426_Patient	patientDrug	Osimertinib
1077426_Patient	treatmentType	Molecular_Targeted_Therapy
1077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1077426_Patient	treatmentType	Radiotherapy_To_Bone
751089_Patient	patientDrug	Nivolumab
2462990_Patient	patientDrug	Nivolumab
2803612_Patient	patientDrug	Nivolumab
1267046_Patient	patientDrug	Nivolumab
2807165_Patient	patientDrug	Nivolumab
2670938_Patient	patientDrug	Nivolumab
493434_Patient	patientDrug	Nivolumab
1077426_Patient	hasBiomarker	EGFR_Negative
2825213_Patient	patientDrug	Nivolumab
2325330_Patient	patientDrug	Nivolumab
2777040_Patient	patientDrug	Nivolumab
1042707_Patient	patientDrug	Nivolumab
2369878_Patient	patientDrug	Nivolumab
2834441_Patient	patientDrug	Nivolumab
583557_Patient	hasBiomarker	EGFR_Negative
0493434_Patient	hasGender	Female
0493434_Patient	hasAgeCategory	Old
0493434_Patient	hasStage	IV
0493434_Patient	hasSmokingHabit	FormerSmoker
0493434_Patient	hasBiomarker	EGFR_Positive
0493434_Patient	hasRelapse_Progression	Progression
0493434_Patient	patientDrug	Carboplatin
0493434_Patient	patientDrug	Atezolizumab
0493434_Patient	patientDrug	Paclitaxel
0493434_Patient	patientDrug	Pemetrexed
0493434_Patient	treatmentType	Intravenous_Chemotherapy
0493434_Patient	treatmentType	Immunotherapy
0493434_Patient	treatmentType	Radiotherapy_To_Bone
0493434_Patient	patientDrug	Nivolumab
1493434_Patient	hasGender	Female
1493434_Patient	hasAgeCategory	Old
1493434_Patient	hasStage	IV
1493434_Patient	hasSmokingHabit	FormerSmoker
1493434_Patient	hasBiomarker	EGFR_Positive
1493434_Patient	hasRelapse_Progression	Progression
1493434_Patient	patientDrug	Carboplatin
1493434_Patient	patientDrug	Atezolizumab
1493434_Patient	patientDrug	Paclitaxel
1493434_Patient	patientDrug	Pemetrexed
1493434_Patient	treatmentType	Intravenous_Chemotherapy
1493434_Patient	treatmentType	Immunotherapy
1493434_Patient	treatmentType	Radiotherapy_To_Bone
1493434_Patient	patientDrug	Nivolumab
2493434_Patient	hasGender	Female
2493434_Patient	hasAgeCategory	Old
2493434_Patient	hasStage	IV
2493434_Patient	hasSmokingHabit	FormerSmoker
2493434_Patient	hasBiomarker	EGFR_Positive
2493434_Patient	hasRelapse_Progression	Progression
2493434_Patient	patientDrug	Carboplatin
2493434_Patient	patientDrug	Atezolizumab
2493434_Patient	patientDrug	Paclitaxel
2493434_Patient	patientDrug	Pemetrexed
2493434_Patient	treatmentType	Intravenous_Chemotherapy
2493434_Patient	treatmentType	Immunotherapy
2493434_Patient	treatmentType	Radiotherapy_To_Bone
2493434_Patient	patientDrug	Nivolumab
3493434_Patient	hasGender	Female
3493434_Patient	hasAgeCategory	Old
3493434_Patient	hasStage	IV
3493434_Patient	hasSmokingHabit	FormerSmoker
3493434_Patient	hasBiomarker	EGFR_Positive
3493434_Patient	hasRelapse_Progression	Progression
3493434_Patient	patientDrug	Carboplatin
3493434_Patient	patientDrug	Atezolizumab
3493434_Patient	patientDrug	Paclitaxel
3493434_Patient	patientDrug	Pemetrexed
3493434_Patient	treatmentType	Intravenous_Chemotherapy
3493434_Patient	treatmentType	Immunotherapy
3493434_Patient	treatmentType	Radiotherapy_To_Bone
3493434_Patient	patientDrug	Nivolumab
4493434_Patient	hasGender	Female
4493434_Patient	hasAgeCategory	Old
4493434_Patient	hasStage	IV
4493434_Patient	hasSmokingHabit	FormerSmoker
4493434_Patient	hasBiomarker	EGFR_Positive
4493434_Patient	hasRelapse_Progression	Progression
4493434_Patient	patientDrug	Carboplatin
4493434_Patient	patientDrug	Atezolizumab
4493434_Patient	patientDrug	Paclitaxel
4493434_Patient	patientDrug	Pemetrexed
4493434_Patient	treatmentType	Intravenous_Chemotherapy
4493434_Patient	treatmentType	Immunotherapy
4493434_Patient	treatmentType	Radiotherapy_To_Bone
4493434_Patient	patientDrug	Nivolumab
5493434_Patient	hasGender	Female
5493434_Patient	hasAgeCategory	Old
5493434_Patient	hasStage	IV
5493434_Patient	hasSmokingHabit	FormerSmoker
5493434_Patient	hasBiomarker	EGFR_Positive
5493434_Patient	hasRelapse_Progression	Progression
5493434_Patient	patientDrug	Carboplatin
5493434_Patient	patientDrug	Atezolizumab
5493434_Patient	patientDrug	Paclitaxel
5493434_Patient	patientDrug	Pemetrexed
5493434_Patient	treatmentType	Intravenous_Chemotherapy
5493434_Patient	treatmentType	Immunotherapy
5493434_Patient	treatmentType	Radiotherapy_To_Bone
5493434_Patient	patientDrug	Nivolumab
6493434_Patient	hasGender	Female
6493434_Patient	hasAgeCategory	Old
6493434_Patient	hasStage	IV
6493434_Patient	hasSmokingHabit	FormerSmoker
6493434_Patient	hasBiomarker	EGFR_Positive
6493434_Patient	hasRelapse_Progression	Progression
6493434_Patient	patientDrug	Carboplatin
6493434_Patient	patientDrug	Atezolizumab
6493434_Patient	patientDrug	Paclitaxel
6493434_Patient	patientDrug	Pemetrexed
6493434_Patient	treatmentType	Intravenous_Chemotherapy
6493434_Patient	treatmentType	Immunotherapy
6493434_Patient	treatmentType	Radiotherapy_To_Bone
6493434_Patient	patientDrug	Nivolumab
7493434_Patient	hasGender	Female
7493434_Patient	hasAgeCategory	Old
7493434_Patient	hasStage	IV
7493434_Patient	hasSmokingHabit	FormerSmoker
7493434_Patient	hasBiomarker	EGFR_Positive
7493434_Patient	hasRelapse_Progression	Progression
7493434_Patient	patientDrug	Carboplatin
7493434_Patient	patientDrug	Atezolizumab
7493434_Patient	patientDrug	Paclitaxel
7493434_Patient	patientDrug	Pemetrexed
7493434_Patient	treatmentType	Intravenous_Chemotherapy
7493434_Patient	treatmentType	Immunotherapy
7493434_Patient	treatmentType	Radiotherapy_To_Bone
7493434_Patient	patientDrug	Nivolumab
8493434_Patient	hasGender	Female
8493434_Patient	hasAgeCategory	Old
8493434_Patient	hasStage	IV
8493434_Patient	hasSmokingHabit	FormerSmoker
8493434_Patient	hasBiomarker	EGFR_Positive
8493434_Patient	hasRelapse_Progression	Progression
8493434_Patient	patientDrug	Carboplatin
8493434_Patient	patientDrug	Atezolizumab
8493434_Patient	patientDrug	Paclitaxel
8493434_Patient	patientDrug	Pemetrexed
8493434_Patient	treatmentType	Intravenous_Chemotherapy
8493434_Patient	treatmentType	Immunotherapy
8493434_Patient	treatmentType	Radiotherapy_To_Bone
8493434_Patient	patientDrug	Nivolumab
9493434_Patient	hasGender	Female
9493434_Patient	hasAgeCategory	Old
9493434_Patient	hasStage	IV
9493434_Patient	hasSmokingHabit	FormerSmoker
9493434_Patient	hasBiomarker	EGFR_Positive
9493434_Patient	hasRelapse_Progression	Progression
9493434_Patient	patientDrug	Carboplatin
9493434_Patient	patientDrug	Atezolizumab
9493434_Patient	patientDrug	Paclitaxel
9493434_Patient	patientDrug	Pemetrexed
9493434_Patient	treatmentType	Intravenous_Chemotherapy
9493434_Patient	treatmentType	Immunotherapy
9493434_Patient	treatmentType	Radiotherapy_To_Bone
9493434_Patient	patientDrug	Nivolumab
0588015_Patient	hasGender	Female
0588015_Patient	hasAgeCategory	Old
0588015_Patient	hasStage	IV
0588015_Patient	hasSmokingHabit	FormerSmoker
0588015_Patient	hasBiomarker	EGFR_Positive
0588015_Patient	hasBiomarker	ALK_Negative
0588015_Patient	hasBiomarker	ROS1_Negative
0588015_Patient	hasRelapse_Progression	Progression
0588015_Patient	patientDrug	Carboplatin
0588015_Patient	patientDrug	Atezolizumab
0588015_Patient	patientDrug	Pemetrexed
0588015_Patient	patientDrug	Cisplatin
0588015_Patient	patientDrug	Vinorelbine
0588015_Patient	treatmentType	Intravenous_Chemotherapy
0588015_Patient	treatmentType	Immunotherapy
0588015_Patient	treatmentType	Radiotherapy_To_Bone
0588015_Patient	treatmentType	Surgery
1588015_Patient	hasGender	Female
1588015_Patient	hasAgeCategory	Old
1588015_Patient	hasStage	IV
1588015_Patient	hasSmokingHabit	FormerSmoker
1588015_Patient	hasBiomarker	EGFR_Positive
1588015_Patient	hasBiomarker	ALK_Negative
1588015_Patient	hasBiomarker	ROS1_Negative
1588015_Patient	hasRelapse_Progression	Progression
1588015_Patient	patientDrug	Carboplatin
1588015_Patient	patientDrug	Atezolizumab
1588015_Patient	patientDrug	Pemetrexed
1588015_Patient	patientDrug	Cisplatin
1588015_Patient	patientDrug	Vinorelbine
1588015_Patient	treatmentType	Intravenous_Chemotherapy
1588015_Patient	treatmentType	Immunotherapy
1588015_Patient	treatmentType	Radiotherapy_To_Bone
1588015_Patient	treatmentType	Surgery
2588015_Patient	hasGender	Female
2588015_Patient	hasAgeCategory	Old
2588015_Patient	hasStage	IV
2588015_Patient	hasSmokingHabit	FormerSmoker
2588015_Patient	hasBiomarker	EGFR_Positive
2588015_Patient	hasBiomarker	ALK_Negative
2588015_Patient	hasBiomarker	ROS1_Negative
2588015_Patient	hasRelapse_Progression	Progression
2588015_Patient	patientDrug	Carboplatin
2588015_Patient	patientDrug	Atezolizumab
2588015_Patient	patientDrug	Pemetrexed
2588015_Patient	patientDrug	Cisplatin
2588015_Patient	patientDrug	Vinorelbine
2588015_Patient	treatmentType	Intravenous_Chemotherapy
2588015_Patient	treatmentType	Immunotherapy
2588015_Patient	treatmentType	Radiotherapy_To_Bone
2588015_Patient	treatmentType	Surgery
3588015_Patient	hasGender	Female
3588015_Patient	hasAgeCategory	Old
3588015_Patient	hasStage	IV
3588015_Patient	hasSmokingHabit	FormerSmoker
3588015_Patient	hasBiomarker	EGFR_Positive
3588015_Patient	hasBiomarker	ALK_Negative
3588015_Patient	hasBiomarker	ROS1_Negative
3588015_Patient	hasRelapse_Progression	Progression
3588015_Patient	patientDrug	Carboplatin
3588015_Patient	patientDrug	Atezolizumab
3588015_Patient	patientDrug	Pemetrexed
3588015_Patient	patientDrug	Cisplatin
3588015_Patient	patientDrug	Vinorelbine
3588015_Patient	treatmentType	Intravenous_Chemotherapy
3588015_Patient	treatmentType	Immunotherapy
3588015_Patient	treatmentType	Radiotherapy_To_Bone
3588015_Patient	treatmentType	Surgery
4588015_Patient	hasGender	Female
4588015_Patient	hasAgeCategory	Old
4588015_Patient	hasStage	IV
4588015_Patient	hasSmokingHabit	FormerSmoker
4588015_Patient	hasBiomarker	EGFR_Positive
4588015_Patient	hasBiomarker	ALK_Negative
4588015_Patient	hasBiomarker	ROS1_Negative
4588015_Patient	hasRelapse_Progression	Progression
4588015_Patient	patientDrug	Carboplatin
4588015_Patient	patientDrug	Atezolizumab
4588015_Patient	patientDrug	Pemetrexed
4588015_Patient	patientDrug	Cisplatin
4588015_Patient	patientDrug	Vinorelbine
4588015_Patient	treatmentType	Intravenous_Chemotherapy
4588015_Patient	treatmentType	Immunotherapy
4588015_Patient	treatmentType	Radiotherapy_To_Bone
4588015_Patient	treatmentType	Surgery
5588015_Patient	hasGender	Female
5588015_Patient	hasAgeCategory	Old
5588015_Patient	hasStage	IV
5588015_Patient	hasSmokingHabit	FormerSmoker
5588015_Patient	hasBiomarker	EGFR_Positive
5588015_Patient	hasBiomarker	ALK_Negative
5588015_Patient	hasBiomarker	ROS1_Negative
5588015_Patient	hasRelapse_Progression	Progression
5588015_Patient	patientDrug	Carboplatin
5588015_Patient	patientDrug	Atezolizumab
5588015_Patient	patientDrug	Pemetrexed
5588015_Patient	patientDrug	Cisplatin
5588015_Patient	patientDrug	Vinorelbine
5588015_Patient	treatmentType	Intravenous_Chemotherapy
5588015_Patient	treatmentType	Immunotherapy
5588015_Patient	treatmentType	Radiotherapy_To_Bone
5588015_Patient	treatmentType	Surgery
6588015_Patient	hasGender	Female
6588015_Patient	hasAgeCategory	Old
6588015_Patient	hasStage	IV
6588015_Patient	hasSmokingHabit	FormerSmoker
6588015_Patient	hasBiomarker	EGFR_Positive
6588015_Patient	hasBiomarker	ALK_Negative
6588015_Patient	hasBiomarker	ROS1_Negative
6588015_Patient	hasRelapse_Progression	Progression
6588015_Patient	patientDrug	Carboplatin
6588015_Patient	patientDrug	Atezolizumab
6588015_Patient	patientDrug	Pemetrexed
6588015_Patient	patientDrug	Cisplatin
6588015_Patient	patientDrug	Vinorelbine
6588015_Patient	treatmentType	Intravenous_Chemotherapy
6588015_Patient	treatmentType	Immunotherapy
6588015_Patient	treatmentType	Radiotherapy_To_Bone
6588015_Patient	treatmentType	Surgery
7588015_Patient	hasGender	Female
7588015_Patient	hasAgeCategory	Old
7588015_Patient	hasStage	IV
7588015_Patient	hasSmokingHabit	FormerSmoker
7588015_Patient	hasBiomarker	EGFR_Positive
7588015_Patient	hasBiomarker	ALK_Negative
7588015_Patient	hasBiomarker	ROS1_Negative
7588015_Patient	hasRelapse_Progression	Progression
7588015_Patient	patientDrug	Carboplatin
7588015_Patient	patientDrug	Atezolizumab
7588015_Patient	patientDrug	Pemetrexed
7588015_Patient	patientDrug	Cisplatin
7588015_Patient	patientDrug	Vinorelbine
7588015_Patient	treatmentType	Intravenous_Chemotherapy
7588015_Patient	treatmentType	Immunotherapy
7588015_Patient	treatmentType	Radiotherapy_To_Bone
7588015_Patient	treatmentType	Surgery
8588015_Patient	hasGender	Female
8588015_Patient	hasAgeCategory	Old
8588015_Patient	hasStage	IV
8588015_Patient	hasSmokingHabit	FormerSmoker
8588015_Patient	hasBiomarker	EGFR_Positive
8588015_Patient	hasBiomarker	ALK_Negative
8588015_Patient	hasBiomarker	ROS1_Negative
8588015_Patient	hasRelapse_Progression	Progression
8588015_Patient	patientDrug	Carboplatin
8588015_Patient	patientDrug	Atezolizumab
8588015_Patient	patientDrug	Pemetrexed
8588015_Patient	patientDrug	Cisplatin
8588015_Patient	patientDrug	Vinorelbine
8588015_Patient	treatmentType	Intravenous_Chemotherapy
8588015_Patient	treatmentType	Immunotherapy
8588015_Patient	treatmentType	Radiotherapy_To_Bone
8588015_Patient	treatmentType	Surgery
9588015_Patient	hasGender	Female
9588015_Patient	hasAgeCategory	Old
9588015_Patient	hasStage	IV
9588015_Patient	hasSmokingHabit	FormerSmoker
9588015_Patient	hasBiomarker	EGFR_Positive
9588015_Patient	hasBiomarker	ALK_Negative
9588015_Patient	hasBiomarker	ROS1_Negative
9588015_Patient	hasRelapse_Progression	Progression
9588015_Patient	patientDrug	Carboplatin
9588015_Patient	patientDrug	Atezolizumab
9588015_Patient	patientDrug	Pemetrexed
9588015_Patient	patientDrug	Cisplatin
9588015_Patient	patientDrug	Vinorelbine
9588015_Patient	treatmentType	Intravenous_Chemotherapy
9588015_Patient	treatmentType	Immunotherapy
9588015_Patient	treatmentType	Radiotherapy_To_Bone
9588015_Patient	treatmentType	Surgery
0751089_Patient	hasGender	Male
0751089_Patient	hasAgeCategory	Old
0751089_Patient	hasStage	IV
0751089_Patient	hasSmokingHabit	FormerSmoker
0751089_Patient	hasBiomarker	EGFR_Positive
0751089_Patient	hasBiomarker	ALK_Negative
0751089_Patient	hasRelapse_Progression	Progression
0751089_Patient	patientDrug	Pemetrexed
0751089_Patient	patientDrug	Cisplatin
0751089_Patient	patientDrug	Docetaxel
0751089_Patient	patientDrug	Daratumumab
0751089_Patient	patientDrug	Nintedanib
0751089_Patient	treatmentType	Intravenous_Chemotherapy
0751089_Patient	treatmentType	Immunotherapy
0751089_Patient	patientDrug	Nivolumab
1751089_Patient	hasGender	Male
1751089_Patient	hasAgeCategory	Old
1751089_Patient	hasStage	IV
1751089_Patient	hasSmokingHabit	FormerSmoker
1751089_Patient	hasBiomarker	EGFR_Positive
1751089_Patient	hasBiomarker	ALK_Negative
1751089_Patient	hasRelapse_Progression	Progression
1751089_Patient	patientDrug	Pemetrexed
1751089_Patient	patientDrug	Cisplatin
1751089_Patient	patientDrug	Docetaxel
1751089_Patient	patientDrug	Daratumumab
1751089_Patient	patientDrug	Nintedanib
1751089_Patient	treatmentType	Intravenous_Chemotherapy
1751089_Patient	treatmentType	Immunotherapy
1751089_Patient	patientDrug	Nivolumab
2751089_Patient	hasGender	Male
2751089_Patient	hasAgeCategory	Old
2751089_Patient	hasStage	IV
2751089_Patient	hasSmokingHabit	FormerSmoker
2751089_Patient	hasBiomarker	EGFR_Positive
2751089_Patient	hasBiomarker	ALK_Negative
2751089_Patient	hasRelapse_Progression	Progression
2751089_Patient	patientDrug	Pemetrexed
2751089_Patient	patientDrug	Cisplatin
2751089_Patient	patientDrug	Docetaxel
2751089_Patient	patientDrug	Daratumumab
2751089_Patient	patientDrug	Nintedanib
2751089_Patient	treatmentType	Intravenous_Chemotherapy
2751089_Patient	treatmentType	Immunotherapy
2751089_Patient	patientDrug	Nivolumab
3751089_Patient	hasGender	Male
3751089_Patient	hasAgeCategory	Old
3751089_Patient	hasStage	IV
3751089_Patient	hasSmokingHabit	FormerSmoker
3751089_Patient	hasBiomarker	EGFR_Positive
3751089_Patient	hasBiomarker	ALK_Negative
3751089_Patient	hasRelapse_Progression	Progression
3751089_Patient	patientDrug	Pemetrexed
3751089_Patient	patientDrug	Cisplatin
3751089_Patient	patientDrug	Docetaxel
3751089_Patient	patientDrug	Daratumumab
3751089_Patient	patientDrug	Nintedanib
3751089_Patient	treatmentType	Intravenous_Chemotherapy
3751089_Patient	treatmentType	Immunotherapy
3751089_Patient	patientDrug	Nivolumab
4751089_Patient	hasGender	Male
4751089_Patient	hasAgeCategory	Old
4751089_Patient	hasStage	IV
4751089_Patient	hasSmokingHabit	FormerSmoker
4751089_Patient	hasBiomarker	EGFR_Positive
4751089_Patient	hasBiomarker	ALK_Negative
4751089_Patient	hasRelapse_Progression	Progression
4751089_Patient	patientDrug	Pemetrexed
4751089_Patient	patientDrug	Cisplatin
4751089_Patient	patientDrug	Docetaxel
4751089_Patient	patientDrug	Daratumumab
4751089_Patient	patientDrug	Nintedanib
4751089_Patient	treatmentType	Intravenous_Chemotherapy
4751089_Patient	treatmentType	Immunotherapy
4751089_Patient	patientDrug	Nivolumab
5751089_Patient	hasGender	Male
5751089_Patient	hasAgeCategory	Old
5751089_Patient	hasStage	IV
5751089_Patient	hasSmokingHabit	FormerSmoker
5751089_Patient	hasBiomarker	EGFR_Positive
5751089_Patient	hasBiomarker	ALK_Negative
5751089_Patient	hasRelapse_Progression	Progression
5751089_Patient	patientDrug	Pemetrexed
5751089_Patient	patientDrug	Cisplatin
5751089_Patient	patientDrug	Docetaxel
5751089_Patient	patientDrug	Daratumumab
5751089_Patient	patientDrug	Nintedanib
5751089_Patient	treatmentType	Intravenous_Chemotherapy
5751089_Patient	treatmentType	Immunotherapy
5751089_Patient	patientDrug	Nivolumab
6751089_Patient	hasGender	Male
6751089_Patient	hasAgeCategory	Old
6751089_Patient	hasStage	IV
6751089_Patient	hasSmokingHabit	FormerSmoker
6751089_Patient	hasBiomarker	EGFR_Positive
6751089_Patient	hasBiomarker	ALK_Negative
6751089_Patient	hasRelapse_Progression	Progression
6751089_Patient	patientDrug	Pemetrexed
6751089_Patient	patientDrug	Cisplatin
6751089_Patient	patientDrug	Docetaxel
6751089_Patient	patientDrug	Daratumumab
6751089_Patient	patientDrug	Nintedanib
6751089_Patient	treatmentType	Intravenous_Chemotherapy
6751089_Patient	treatmentType	Immunotherapy
6751089_Patient	patientDrug	Nivolumab
7751089_Patient	hasGender	Male
7751089_Patient	hasAgeCategory	Old
7751089_Patient	hasStage	IV
7751089_Patient	hasSmokingHabit	FormerSmoker
7751089_Patient	hasBiomarker	EGFR_Positive
7751089_Patient	hasBiomarker	ALK_Negative
7751089_Patient	hasRelapse_Progression	Progression
7751089_Patient	patientDrug	Pemetrexed
7751089_Patient	patientDrug	Cisplatin
7751089_Patient	patientDrug	Docetaxel
7751089_Patient	patientDrug	Daratumumab
7751089_Patient	patientDrug	Nintedanib
7751089_Patient	treatmentType	Intravenous_Chemotherapy
7751089_Patient	treatmentType	Immunotherapy
7751089_Patient	patientDrug	Nivolumab
8751089_Patient	hasGender	Male
8751089_Patient	hasAgeCategory	Old
8751089_Patient	hasStage	IV
8751089_Patient	hasSmokingHabit	FormerSmoker
8751089_Patient	hasBiomarker	EGFR_Positive
8751089_Patient	hasBiomarker	ALK_Negative
8751089_Patient	hasRelapse_Progression	Progression
8751089_Patient	patientDrug	Pemetrexed
8751089_Patient	patientDrug	Cisplatin
8751089_Patient	patientDrug	Docetaxel
8751089_Patient	patientDrug	Daratumumab
8751089_Patient	patientDrug	Nintedanib
8751089_Patient	treatmentType	Intravenous_Chemotherapy
8751089_Patient	treatmentType	Immunotherapy
8751089_Patient	patientDrug	Nivolumab
9751089_Patient	hasGender	Male
9751089_Patient	hasAgeCategory	Old
9751089_Patient	hasStage	IV
9751089_Patient	hasSmokingHabit	FormerSmoker
9751089_Patient	hasBiomarker	EGFR_Positive
9751089_Patient	hasBiomarker	ALK_Negative
9751089_Patient	hasRelapse_Progression	Progression
9751089_Patient	patientDrug	Pemetrexed
9751089_Patient	patientDrug	Cisplatin
9751089_Patient	patientDrug	Docetaxel
9751089_Patient	patientDrug	Daratumumab
9751089_Patient	patientDrug	Nintedanib
9751089_Patient	treatmentType	Intravenous_Chemotherapy
9751089_Patient	treatmentType	Immunotherapy
9751089_Patient	patientDrug	Nivolumab
02462990_Patient	hasGender	Female
02462990_Patient	hasAgeCategory	Old
02462990_Patient	hasStage	IV
02462990_Patient	hasSmokingHabit	CurrentSmoker
02462990_Patient	hasBiomarker	PDL1_Positive
02462990_Patient	hasBiomarker	ALK_Negative
02462990_Patient	hasBiomarker	BRAF_Negative
02462990_Patient	hasBiomarker	EGFR_Negative
02462990_Patient	hasRelapse_Progression	Progression
02462990_Patient	patientDrug	Carboplatin
02462990_Patient	patientDrug	Pemetrexed
02462990_Patient	patientDrug	Pembrolizumab
02462990_Patient	treatmentType	Intravenous_Chemotherapy
02462990_Patient	treatmentType	Immunotherapy
02462990_Patient	treatmentType	Radiotherapy_To_Bone
02462990_Patient	treatmentType	Thoracoscopy
02462990_Patient	patientDrug	Nivolumab
12462990_Patient	hasGender	Female
12462990_Patient	hasAgeCategory	Old
12462990_Patient	hasStage	IV
12462990_Patient	hasSmokingHabit	CurrentSmoker
12462990_Patient	hasBiomarker	PDL1_Positive
12462990_Patient	hasBiomarker	ALK_Negative
12462990_Patient	hasBiomarker	BRAF_Negative
12462990_Patient	hasBiomarker	EGFR_Negative
12462990_Patient	hasRelapse_Progression	Progression
12462990_Patient	patientDrug	Carboplatin
12462990_Patient	patientDrug	Pemetrexed
12462990_Patient	patientDrug	Pembrolizumab
12462990_Patient	treatmentType	Intravenous_Chemotherapy
12462990_Patient	treatmentType	Immunotherapy
12462990_Patient	treatmentType	Radiotherapy_To_Bone
12462990_Patient	treatmentType	Thoracoscopy
12462990_Patient	patientDrug	Nivolumab
22462990_Patient	hasGender	Female
22462990_Patient	hasAgeCategory	Old
22462990_Patient	hasStage	IV
22462990_Patient	hasSmokingHabit	CurrentSmoker
22462990_Patient	hasBiomarker	PDL1_Positive
22462990_Patient	hasBiomarker	ALK_Negative
22462990_Patient	hasBiomarker	BRAF_Negative
22462990_Patient	hasBiomarker	EGFR_Negative
22462990_Patient	hasRelapse_Progression	Progression
22462990_Patient	patientDrug	Carboplatin
22462990_Patient	patientDrug	Pemetrexed
22462990_Patient	patientDrug	Pembrolizumab
22462990_Patient	treatmentType	Intravenous_Chemotherapy
22462990_Patient	treatmentType	Immunotherapy
22462990_Patient	treatmentType	Radiotherapy_To_Bone
22462990_Patient	treatmentType	Thoracoscopy
22462990_Patient	patientDrug	Nivolumab
32462990_Patient	hasGender	Female
32462990_Patient	hasAgeCategory	Old
32462990_Patient	hasStage	IV
32462990_Patient	hasSmokingHabit	CurrentSmoker
32462990_Patient	hasBiomarker	PDL1_Positive
32462990_Patient	hasBiomarker	ALK_Negative
32462990_Patient	hasBiomarker	BRAF_Negative
32462990_Patient	hasBiomarker	EGFR_Negative
32462990_Patient	hasRelapse_Progression	Progression
32462990_Patient	patientDrug	Carboplatin
32462990_Patient	patientDrug	Pemetrexed
32462990_Patient	patientDrug	Pembrolizumab
32462990_Patient	treatmentType	Intravenous_Chemotherapy
32462990_Patient	treatmentType	Immunotherapy
32462990_Patient	treatmentType	Radiotherapy_To_Bone
32462990_Patient	treatmentType	Thoracoscopy
32462990_Patient	patientDrug	Nivolumab
42462990_Patient	hasGender	Female
42462990_Patient	hasAgeCategory	Old
42462990_Patient	hasStage	IV
42462990_Patient	hasSmokingHabit	CurrentSmoker
42462990_Patient	hasBiomarker	PDL1_Positive
42462990_Patient	hasBiomarker	ALK_Negative
42462990_Patient	hasBiomarker	BRAF_Negative
42462990_Patient	hasBiomarker	EGFR_Negative
42462990_Patient	hasRelapse_Progression	Progression
42462990_Patient	patientDrug	Carboplatin
42462990_Patient	patientDrug	Pemetrexed
42462990_Patient	patientDrug	Pembrolizumab
42462990_Patient	treatmentType	Intravenous_Chemotherapy
42462990_Patient	treatmentType	Immunotherapy
42462990_Patient	treatmentType	Radiotherapy_To_Bone
42462990_Patient	treatmentType	Thoracoscopy
42462990_Patient	patientDrug	Nivolumab
52462990_Patient	hasGender	Female
52462990_Patient	hasAgeCategory	Old
52462990_Patient	hasStage	IV
52462990_Patient	hasSmokingHabit	CurrentSmoker
52462990_Patient	hasBiomarker	PDL1_Positive
52462990_Patient	hasBiomarker	ALK_Negative
52462990_Patient	hasBiomarker	BRAF_Negative
52462990_Patient	hasBiomarker	EGFR_Negative
52462990_Patient	hasRelapse_Progression	Progression
52462990_Patient	patientDrug	Carboplatin
52462990_Patient	patientDrug	Pemetrexed
52462990_Patient	patientDrug	Pembrolizumab
52462990_Patient	treatmentType	Intravenous_Chemotherapy
52462990_Patient	treatmentType	Immunotherapy
52462990_Patient	treatmentType	Radiotherapy_To_Bone
52462990_Patient	treatmentType	Thoracoscopy
52462990_Patient	patientDrug	Nivolumab
62462990_Patient	hasGender	Female
62462990_Patient	hasAgeCategory	Old
62462990_Patient	hasStage	IV
62462990_Patient	hasSmokingHabit	CurrentSmoker
62462990_Patient	hasBiomarker	PDL1_Positive
62462990_Patient	hasBiomarker	ALK_Negative
62462990_Patient	hasBiomarker	BRAF_Negative
62462990_Patient	hasBiomarker	EGFR_Negative
62462990_Patient	hasRelapse_Progression	Progression
62462990_Patient	patientDrug	Carboplatin
62462990_Patient	patientDrug	Pemetrexed
62462990_Patient	patientDrug	Pembrolizumab
62462990_Patient	treatmentType	Intravenous_Chemotherapy
62462990_Patient	treatmentType	Immunotherapy
62462990_Patient	treatmentType	Radiotherapy_To_Bone
62462990_Patient	treatmentType	Thoracoscopy
62462990_Patient	patientDrug	Nivolumab
72462990_Patient	hasGender	Female
72462990_Patient	hasAgeCategory	Old
72462990_Patient	hasStage	IV
72462990_Patient	hasSmokingHabit	CurrentSmoker
72462990_Patient	hasBiomarker	PDL1_Positive
72462990_Patient	hasBiomarker	ALK_Negative
72462990_Patient	hasBiomarker	BRAF_Negative
72462990_Patient	hasBiomarker	EGFR_Negative
72462990_Patient	hasRelapse_Progression	Progression
72462990_Patient	patientDrug	Carboplatin
72462990_Patient	patientDrug	Pemetrexed
72462990_Patient	patientDrug	Pembrolizumab
72462990_Patient	treatmentType	Intravenous_Chemotherapy
72462990_Patient	treatmentType	Immunotherapy
72462990_Patient	treatmentType	Radiotherapy_To_Bone
72462990_Patient	treatmentType	Thoracoscopy
72462990_Patient	patientDrug	Nivolumab
82462990_Patient	hasGender	Female
82462990_Patient	hasAgeCategory	Old
82462990_Patient	hasStage	IV
82462990_Patient	hasSmokingHabit	CurrentSmoker
82462990_Patient	hasBiomarker	PDL1_Positive
82462990_Patient	hasBiomarker	ALK_Negative
82462990_Patient	hasBiomarker	BRAF_Negative
82462990_Patient	hasBiomarker	EGFR_Negative
82462990_Patient	hasRelapse_Progression	Progression
82462990_Patient	patientDrug	Carboplatin
82462990_Patient	patientDrug	Pemetrexed
82462990_Patient	patientDrug	Pembrolizumab
82462990_Patient	treatmentType	Intravenous_Chemotherapy
82462990_Patient	treatmentType	Immunotherapy
82462990_Patient	treatmentType	Radiotherapy_To_Bone
82462990_Patient	treatmentType	Thoracoscopy
82462990_Patient	patientDrug	Nivolumab
92462990_Patient	hasGender	Female
92462990_Patient	hasAgeCategory	Old
92462990_Patient	hasStage	IV
92462990_Patient	hasSmokingHabit	CurrentSmoker
92462990_Patient	hasBiomarker	PDL1_Positive
92462990_Patient	hasBiomarker	ALK_Negative
92462990_Patient	hasBiomarker	BRAF_Negative
92462990_Patient	hasBiomarker	EGFR_Negative
92462990_Patient	hasRelapse_Progression	Progression
92462990_Patient	patientDrug	Carboplatin
92462990_Patient	patientDrug	Pemetrexed
92462990_Patient	patientDrug	Pembrolizumab
92462990_Patient	treatmentType	Intravenous_Chemotherapy
92462990_Patient	treatmentType	Immunotherapy
92462990_Patient	treatmentType	Radiotherapy_To_Bone
92462990_Patient	treatmentType	Thoracoscopy
92462990_Patient	patientDrug	Nivolumab
02807165_Patient	hasGender	Female
02807165_Patient	hasAgeCategory	Young
02807165_Patient	hasStage	IV
02807165_Patient	hasSmokingHabit	FormerSmoker
02807165_Patient	hasBiomarker	EGFR_Negative
02807165_Patient	hasBiomarker	ROS1_Negative
02807165_Patient	hasRelapse_Progression	Progression
02807165_Patient	patientDrug	Pemetrexed
02807165_Patient	patientDrug	Cisplatin
02807165_Patient	patientDrug	Placebo%20Controlled%20Study
02807165_Patient	patientDrug	Pembrolizumab
02807165_Patient	patientDrug	Alectinib
02807165_Patient	patientDrug	Brigatinib
02807165_Patient	patientDrug	Lorlatinib
02807165_Patient	treatmentType	Molecular_Targeted_Therapy
02807165_Patient	treatmentType	Immunotherapy
02807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02807165_Patient	patientDrug	Nivolumab
12807165_Patient	hasGender	Female
12807165_Patient	hasAgeCategory	Young
12807165_Patient	hasStage	IV
12807165_Patient	hasSmokingHabit	FormerSmoker
12807165_Patient	hasBiomarker	EGFR_Negative
12807165_Patient	hasBiomarker	ROS1_Negative
12807165_Patient	hasRelapse_Progression	Progression
12807165_Patient	patientDrug	Pemetrexed
12807165_Patient	patientDrug	Cisplatin
12807165_Patient	patientDrug	Placebo%20Controlled%20Study
12807165_Patient	patientDrug	Pembrolizumab
12807165_Patient	patientDrug	Alectinib
12807165_Patient	patientDrug	Brigatinib
12807165_Patient	patientDrug	Lorlatinib
12807165_Patient	treatmentType	Molecular_Targeted_Therapy
12807165_Patient	treatmentType	Immunotherapy
12807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12807165_Patient	patientDrug	Nivolumab
22807165_Patient	hasGender	Female
22807165_Patient	hasAgeCategory	Young
22807165_Patient	hasStage	IV
22807165_Patient	hasSmokingHabit	FormerSmoker
22807165_Patient	hasBiomarker	EGFR_Negative
22807165_Patient	hasBiomarker	ROS1_Negative
22807165_Patient	hasRelapse_Progression	Progression
22807165_Patient	patientDrug	Pemetrexed
22807165_Patient	patientDrug	Cisplatin
22807165_Patient	patientDrug	Placebo%20Controlled%20Study
22807165_Patient	patientDrug	Pembrolizumab
22807165_Patient	patientDrug	Alectinib
22807165_Patient	patientDrug	Brigatinib
22807165_Patient	patientDrug	Lorlatinib
22807165_Patient	treatmentType	Molecular_Targeted_Therapy
22807165_Patient	treatmentType	Immunotherapy
22807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22807165_Patient	patientDrug	Nivolumab
32807165_Patient	hasGender	Female
32807165_Patient	hasAgeCategory	Young
32807165_Patient	hasStage	IV
32807165_Patient	hasSmokingHabit	FormerSmoker
32807165_Patient	hasBiomarker	EGFR_Negative
32807165_Patient	hasBiomarker	ROS1_Negative
32807165_Patient	hasRelapse_Progression	Progression
32807165_Patient	patientDrug	Pemetrexed
32807165_Patient	patientDrug	Cisplatin
32807165_Patient	patientDrug	Placebo%20Controlled%20Study
32807165_Patient	patientDrug	Pembrolizumab
32807165_Patient	patientDrug	Alectinib
32807165_Patient	patientDrug	Brigatinib
32807165_Patient	patientDrug	Lorlatinib
32807165_Patient	treatmentType	Molecular_Targeted_Therapy
32807165_Patient	treatmentType	Immunotherapy
32807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32807165_Patient	patientDrug	Nivolumab
42807165_Patient	hasGender	Female
42807165_Patient	hasAgeCategory	Young
42807165_Patient	hasStage	IV
42807165_Patient	hasSmokingHabit	FormerSmoker
42807165_Patient	hasBiomarker	EGFR_Negative
42807165_Patient	hasBiomarker	ROS1_Negative
42807165_Patient	hasRelapse_Progression	Progression
42807165_Patient	patientDrug	Pemetrexed
42807165_Patient	patientDrug	Cisplatin
42807165_Patient	patientDrug	Placebo%20Controlled%20Study
42807165_Patient	patientDrug	Pembrolizumab
42807165_Patient	patientDrug	Alectinib
42807165_Patient	patientDrug	Brigatinib
42807165_Patient	patientDrug	Lorlatinib
42807165_Patient	treatmentType	Molecular_Targeted_Therapy
42807165_Patient	treatmentType	Immunotherapy
42807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42807165_Patient	patientDrug	Nivolumab
52807165_Patient	hasGender	Female
52807165_Patient	hasAgeCategory	Young
52807165_Patient	hasStage	IV
52807165_Patient	hasSmokingHabit	FormerSmoker
52807165_Patient	hasBiomarker	EGFR_Negative
52807165_Patient	hasBiomarker	ROS1_Negative
52807165_Patient	hasRelapse_Progression	Progression
52807165_Patient	patientDrug	Pemetrexed
52807165_Patient	patientDrug	Cisplatin
52807165_Patient	patientDrug	Placebo%20Controlled%20Study
52807165_Patient	patientDrug	Pembrolizumab
52807165_Patient	patientDrug	Alectinib
52807165_Patient	patientDrug	Brigatinib
52807165_Patient	patientDrug	Lorlatinib
52807165_Patient	treatmentType	Molecular_Targeted_Therapy
52807165_Patient	treatmentType	Immunotherapy
52807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52807165_Patient	patientDrug	Nivolumab
62807165_Patient	hasGender	Female
62807165_Patient	hasAgeCategory	Young
62807165_Patient	hasStage	IV
62807165_Patient	hasSmokingHabit	FormerSmoker
62807165_Patient	hasBiomarker	EGFR_Negative
62807165_Patient	hasBiomarker	ROS1_Negative
62807165_Patient	hasRelapse_Progression	Progression
62807165_Patient	patientDrug	Pemetrexed
62807165_Patient	patientDrug	Cisplatin
62807165_Patient	patientDrug	Placebo%20Controlled%20Study
62807165_Patient	patientDrug	Pembrolizumab
62807165_Patient	patientDrug	Alectinib
62807165_Patient	patientDrug	Brigatinib
62807165_Patient	patientDrug	Lorlatinib
62807165_Patient	treatmentType	Molecular_Targeted_Therapy
62807165_Patient	treatmentType	Immunotherapy
62807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
62807165_Patient	patientDrug	Nivolumab
72807165_Patient	hasGender	Female
72807165_Patient	hasAgeCategory	Young
72807165_Patient	hasStage	IV
72807165_Patient	hasSmokingHabit	FormerSmoker
72807165_Patient	hasBiomarker	EGFR_Negative
72807165_Patient	hasBiomarker	ROS1_Negative
72807165_Patient	hasRelapse_Progression	Progression
72807165_Patient	patientDrug	Pemetrexed
72807165_Patient	patientDrug	Cisplatin
72807165_Patient	patientDrug	Placebo%20Controlled%20Study
72807165_Patient	patientDrug	Pembrolizumab
72807165_Patient	patientDrug	Alectinib
72807165_Patient	patientDrug	Brigatinib
72807165_Patient	patientDrug	Lorlatinib
72807165_Patient	treatmentType	Molecular_Targeted_Therapy
72807165_Patient	treatmentType	Immunotherapy
72807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
72807165_Patient	patientDrug	Nivolumab
82807165_Patient	hasGender	Female
82807165_Patient	hasAgeCategory	Young
82807165_Patient	hasStage	IV
82807165_Patient	hasSmokingHabit	FormerSmoker
82807165_Patient	hasBiomarker	EGFR_Negative
82807165_Patient	hasBiomarker	ROS1_Negative
82807165_Patient	hasRelapse_Progression	Progression
82807165_Patient	patientDrug	Pemetrexed
82807165_Patient	patientDrug	Cisplatin
82807165_Patient	patientDrug	Placebo%20Controlled%20Study
82807165_Patient	patientDrug	Pembrolizumab
82807165_Patient	patientDrug	Alectinib
82807165_Patient	patientDrug	Brigatinib
82807165_Patient	patientDrug	Lorlatinib
82807165_Patient	treatmentType	Molecular_Targeted_Therapy
82807165_Patient	treatmentType	Immunotherapy
82807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
82807165_Patient	patientDrug	Nivolumab
92807165_Patient	hasGender	Female
92807165_Patient	hasAgeCategory	Young
92807165_Patient	hasStage	IV
92807165_Patient	hasSmokingHabit	FormerSmoker
92807165_Patient	hasBiomarker	EGFR_Negative
92807165_Patient	hasBiomarker	ROS1_Negative
92807165_Patient	hasRelapse_Progression	Progression
92807165_Patient	patientDrug	Pemetrexed
92807165_Patient	patientDrug	Cisplatin
92807165_Patient	patientDrug	Placebo%20Controlled%20Study
92807165_Patient	patientDrug	Pembrolizumab
92807165_Patient	patientDrug	Alectinib
92807165_Patient	patientDrug	Brigatinib
92807165_Patient	patientDrug	Lorlatinib
92807165_Patient	treatmentType	Molecular_Targeted_Therapy
92807165_Patient	treatmentType	Immunotherapy
92807165_Patient	treatmentType	Whole_Brain_Radiation_Therapy
92807165_Patient	patientDrug	Nivolumab
01258242_Patient	hasGender	Female
01258242_Patient	hasAgeCategory	Young
01258242_Patient	hasStage	IV
01258242_Patient	hasSmokingHabit	FormerSmoker
01258242_Patient	hasBiomarker	EGFR_Positive
01258242_Patient	hasRelapse_Progression	Progression
01258242_Patient	patientDrug	Erlotinib
01258242_Patient	patientDrug	Emibetuzumab
01258242_Patient	treatmentType	Molecular_Targeted_Therapy
01258242_Patient	treatmentType	Immunotherapy
01258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
01258242_Patient	treatmentType	Radiotherapy_To_Bone
11258242_Patient	hasGender	Female
11258242_Patient	hasAgeCategory	Young
11258242_Patient	hasStage	IV
11258242_Patient	hasSmokingHabit	FormerSmoker
11258242_Patient	hasBiomarker	EGFR_Positive
11258242_Patient	hasRelapse_Progression	Progression
11258242_Patient	patientDrug	Erlotinib
11258242_Patient	patientDrug	Emibetuzumab
11258242_Patient	treatmentType	Molecular_Targeted_Therapy
11258242_Patient	treatmentType	Immunotherapy
11258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
11258242_Patient	treatmentType	Radiotherapy_To_Bone
21258242_Patient	hasGender	Female
21258242_Patient	hasAgeCategory	Young
21258242_Patient	hasStage	IV
21258242_Patient	hasSmokingHabit	FormerSmoker
21258242_Patient	hasBiomarker	EGFR_Positive
21258242_Patient	hasRelapse_Progression	Progression
21258242_Patient	patientDrug	Erlotinib
21258242_Patient	patientDrug	Emibetuzumab
21258242_Patient	treatmentType	Molecular_Targeted_Therapy
21258242_Patient	treatmentType	Immunotherapy
21258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
21258242_Patient	treatmentType	Radiotherapy_To_Bone
31258242_Patient	hasGender	Female
31258242_Patient	hasAgeCategory	Young
31258242_Patient	hasStage	IV
31258242_Patient	hasSmokingHabit	FormerSmoker
31258242_Patient	hasBiomarker	EGFR_Positive
31258242_Patient	hasRelapse_Progression	Progression
31258242_Patient	patientDrug	Erlotinib
31258242_Patient	patientDrug	Emibetuzumab
31258242_Patient	treatmentType	Molecular_Targeted_Therapy
31258242_Patient	treatmentType	Immunotherapy
31258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
31258242_Patient	treatmentType	Radiotherapy_To_Bone
41258242_Patient	hasGender	Female
41258242_Patient	hasAgeCategory	Young
41258242_Patient	hasStage	IV
41258242_Patient	hasSmokingHabit	FormerSmoker
41258242_Patient	hasBiomarker	EGFR_Positive
41258242_Patient	hasRelapse_Progression	Progression
41258242_Patient	patientDrug	Erlotinib
41258242_Patient	patientDrug	Emibetuzumab
41258242_Patient	treatmentType	Molecular_Targeted_Therapy
41258242_Patient	treatmentType	Immunotherapy
41258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
41258242_Patient	treatmentType	Radiotherapy_To_Bone
51258242_Patient	hasGender	Female
51258242_Patient	hasAgeCategory	Young
51258242_Patient	hasStage	IV
51258242_Patient	hasSmokingHabit	FormerSmoker
51258242_Patient	hasBiomarker	EGFR_Positive
51258242_Patient	hasRelapse_Progression	Progression
51258242_Patient	patientDrug	Erlotinib
51258242_Patient	patientDrug	Emibetuzumab
51258242_Patient	treatmentType	Molecular_Targeted_Therapy
51258242_Patient	treatmentType	Immunotherapy
51258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
51258242_Patient	treatmentType	Radiotherapy_To_Bone
61258242_Patient	hasGender	Female
61258242_Patient	hasAgeCategory	Young
61258242_Patient	hasStage	IV
61258242_Patient	hasSmokingHabit	FormerSmoker
61258242_Patient	hasBiomarker	EGFR_Positive
61258242_Patient	hasRelapse_Progression	Progression
61258242_Patient	patientDrug	Erlotinib
61258242_Patient	patientDrug	Emibetuzumab
61258242_Patient	treatmentType	Molecular_Targeted_Therapy
61258242_Patient	treatmentType	Immunotherapy
61258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
61258242_Patient	treatmentType	Radiotherapy_To_Bone
71258242_Patient	hasGender	Female
71258242_Patient	hasAgeCategory	Young
71258242_Patient	hasStage	IV
71258242_Patient	hasSmokingHabit	FormerSmoker
71258242_Patient	hasBiomarker	EGFR_Positive
71258242_Patient	hasRelapse_Progression	Progression
71258242_Patient	patientDrug	Erlotinib
71258242_Patient	patientDrug	Emibetuzumab
71258242_Patient	treatmentType	Molecular_Targeted_Therapy
71258242_Patient	treatmentType	Immunotherapy
71258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
71258242_Patient	treatmentType	Radiotherapy_To_Bone
81258242_Patient	hasGender	Female
81258242_Patient	hasAgeCategory	Young
81258242_Patient	hasStage	IV
81258242_Patient	hasSmokingHabit	FormerSmoker
81258242_Patient	hasBiomarker	EGFR_Positive
81258242_Patient	hasRelapse_Progression	Progression
81258242_Patient	patientDrug	Erlotinib
81258242_Patient	patientDrug	Emibetuzumab
81258242_Patient	treatmentType	Molecular_Targeted_Therapy
81258242_Patient	treatmentType	Immunotherapy
81258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
81258242_Patient	treatmentType	Radiotherapy_To_Bone
91258242_Patient	hasGender	Female
91258242_Patient	hasAgeCategory	Young
91258242_Patient	hasStage	IV
91258242_Patient	hasSmokingHabit	FormerSmoker
91258242_Patient	hasBiomarker	EGFR_Positive
91258242_Patient	hasRelapse_Progression	Progression
91258242_Patient	patientDrug	Erlotinib
91258242_Patient	patientDrug	Emibetuzumab
91258242_Patient	treatmentType	Molecular_Targeted_Therapy
91258242_Patient	treatmentType	Immunotherapy
91258242_Patient	treatmentType	Whole_Brain_Radiation_Therapy
91258242_Patient	treatmentType	Radiotherapy_To_Bone
02603790_Patient	hasGender	Male
02603790_Patient	hasAgeCategory	Young
02603790_Patient	hasStage	IV
02603790_Patient	hasSmokingHabit	CurrentSmoker
02603790_Patient	hasBiomarker	EGFR_Positive
02603790_Patient	hasRelapse_Progression	Progression
02603790_Patient	patientDrug	Cisplatin
02603790_Patient	patientDrug	Gemcitabine
02603790_Patient	patientDrug	Durvalumab
02603790_Patient	treatmentType	Intravenous_Chemotherapy
02603790_Patient	treatmentType	Immunotherapy
12603790_Patient	hasGender	Male
12603790_Patient	hasAgeCategory	Young
12603790_Patient	hasStage	IV
12603790_Patient	hasSmokingHabit	CurrentSmoker
12603790_Patient	hasBiomarker	EGFR_Positive
12603790_Patient	hasRelapse_Progression	Progression
12603790_Patient	patientDrug	Cisplatin
12603790_Patient	patientDrug	Gemcitabine
12603790_Patient	patientDrug	Durvalumab
12603790_Patient	treatmentType	Intravenous_Chemotherapy
12603790_Patient	treatmentType	Immunotherapy
22603790_Patient	hasGender	Male
22603790_Patient	hasAgeCategory	Young
22603790_Patient	hasStage	IV
22603790_Patient	hasSmokingHabit	CurrentSmoker
22603790_Patient	hasBiomarker	EGFR_Positive
22603790_Patient	hasRelapse_Progression	Progression
22603790_Patient	patientDrug	Cisplatin
22603790_Patient	patientDrug	Gemcitabine
22603790_Patient	patientDrug	Durvalumab
22603790_Patient	treatmentType	Intravenous_Chemotherapy
22603790_Patient	treatmentType	Immunotherapy
32603790_Patient	hasGender	Male
32603790_Patient	hasAgeCategory	Young
32603790_Patient	hasStage	IV
32603790_Patient	hasSmokingHabit	CurrentSmoker
32603790_Patient	hasBiomarker	EGFR_Positive
32603790_Patient	hasRelapse_Progression	Progression
32603790_Patient	patientDrug	Cisplatin
32603790_Patient	patientDrug	Gemcitabine
32603790_Patient	patientDrug	Durvalumab
32603790_Patient	treatmentType	Intravenous_Chemotherapy
32603790_Patient	treatmentType	Immunotherapy
42603790_Patient	hasGender	Male
42603790_Patient	hasAgeCategory	Young
42603790_Patient	hasStage	IV
42603790_Patient	hasSmokingHabit	CurrentSmoker
42603790_Patient	hasBiomarker	EGFR_Positive
42603790_Patient	hasRelapse_Progression	Progression
42603790_Patient	patientDrug	Cisplatin
42603790_Patient	patientDrug	Gemcitabine
42603790_Patient	patientDrug	Durvalumab
42603790_Patient	treatmentType	Intravenous_Chemotherapy
42603790_Patient	treatmentType	Immunotherapy
52603790_Patient	hasGender	Male
52603790_Patient	hasAgeCategory	Young
52603790_Patient	hasStage	IV
52603790_Patient	hasSmokingHabit	CurrentSmoker
52603790_Patient	hasBiomarker	EGFR_Positive
52603790_Patient	hasRelapse_Progression	Progression
52603790_Patient	patientDrug	Cisplatin
52603790_Patient	patientDrug	Gemcitabine
52603790_Patient	patientDrug	Durvalumab
52603790_Patient	treatmentType	Intravenous_Chemotherapy
52603790_Patient	treatmentType	Immunotherapy
62603790_Patient	hasGender	Male
62603790_Patient	hasAgeCategory	Young
62603790_Patient	hasStage	IV
62603790_Patient	hasSmokingHabit	CurrentSmoker
62603790_Patient	hasBiomarker	EGFR_Positive
62603790_Patient	hasRelapse_Progression	Progression
62603790_Patient	patientDrug	Cisplatin
62603790_Patient	patientDrug	Gemcitabine
62603790_Patient	patientDrug	Durvalumab
62603790_Patient	treatmentType	Intravenous_Chemotherapy
62603790_Patient	treatmentType	Immunotherapy
72603790_Patient	hasGender	Male
72603790_Patient	hasAgeCategory	Young
72603790_Patient	hasStage	IV
72603790_Patient	hasSmokingHabit	CurrentSmoker
72603790_Patient	hasBiomarker	EGFR_Positive
72603790_Patient	hasRelapse_Progression	Progression
72603790_Patient	patientDrug	Cisplatin
72603790_Patient	patientDrug	Gemcitabine
72603790_Patient	patientDrug	Durvalumab
72603790_Patient	treatmentType	Intravenous_Chemotherapy
72603790_Patient	treatmentType	Immunotherapy
82603790_Patient	hasGender	Male
82603790_Patient	hasAgeCategory	Young
82603790_Patient	hasStage	IV
82603790_Patient	hasSmokingHabit	CurrentSmoker
82603790_Patient	hasBiomarker	EGFR_Positive
82603790_Patient	hasRelapse_Progression	Progression
82603790_Patient	patientDrug	Cisplatin
82603790_Patient	patientDrug	Gemcitabine
82603790_Patient	patientDrug	Durvalumab
82603790_Patient	treatmentType	Intravenous_Chemotherapy
82603790_Patient	treatmentType	Immunotherapy
92603790_Patient	hasGender	Male
92603790_Patient	hasAgeCategory	Young
92603790_Patient	hasStage	IV
92603790_Patient	hasSmokingHabit	CurrentSmoker
92603790_Patient	hasBiomarker	EGFR_Positive
92603790_Patient	hasRelapse_Progression	Progression
92603790_Patient	patientDrug	Cisplatin
92603790_Patient	patientDrug	Gemcitabine
92603790_Patient	patientDrug	Durvalumab
92603790_Patient	treatmentType	Intravenous_Chemotherapy
92603790_Patient	treatmentType	Immunotherapy
02845808_Patient	hasGender	Male
02845808_Patient	hasAgeCategory	Old
02845808_Patient	hasStage	IV
02845808_Patient	hasSmokingHabit	CurrentSmoker
02845808_Patient	hasBiomarker	EGFR_Positive
02845808_Patient	hasRelapse_Progression	Progression
02845808_Patient	patientDrug	Carboplatin
02845808_Patient	patientDrug	Atezolizumab
02845808_Patient	patientDrug	Paclitaxel
02845808_Patient	patientDrug	Gemcitabine
02845808_Patient	treatmentType	Intravenous_Chemotherapy
02845808_Patient	treatmentType	Immunotherapy
02845808_Patient	treatmentType	Radiotherapy_To_Lung
12845808_Patient	hasGender	Male
12845808_Patient	hasAgeCategory	Old
12845808_Patient	hasStage	IV
12845808_Patient	hasSmokingHabit	CurrentSmoker
12845808_Patient	hasBiomarker	EGFR_Positive
12845808_Patient	hasRelapse_Progression	Progression
12845808_Patient	patientDrug	Carboplatin
12845808_Patient	patientDrug	Atezolizumab
12845808_Patient	patientDrug	Paclitaxel
12845808_Patient	patientDrug	Gemcitabine
12845808_Patient	treatmentType	Intravenous_Chemotherapy
12845808_Patient	treatmentType	Immunotherapy
12845808_Patient	treatmentType	Radiotherapy_To_Lung
22845808_Patient	hasGender	Male
22845808_Patient	hasAgeCategory	Old
22845808_Patient	hasStage	IV
22845808_Patient	hasSmokingHabit	CurrentSmoker
22845808_Patient	hasBiomarker	EGFR_Positive
22845808_Patient	hasRelapse_Progression	Progression
22845808_Patient	patientDrug	Carboplatin
22845808_Patient	patientDrug	Atezolizumab
22845808_Patient	patientDrug	Paclitaxel
22845808_Patient	patientDrug	Gemcitabine
22845808_Patient	treatmentType	Intravenous_Chemotherapy
22845808_Patient	treatmentType	Immunotherapy
22845808_Patient	treatmentType	Radiotherapy_To_Lung
32845808_Patient	hasGender	Male
32845808_Patient	hasAgeCategory	Old
32845808_Patient	hasStage	IV
32845808_Patient	hasSmokingHabit	CurrentSmoker
32845808_Patient	hasBiomarker	EGFR_Positive
32845808_Patient	hasRelapse_Progression	Progression
32845808_Patient	patientDrug	Carboplatin
32845808_Patient	patientDrug	Atezolizumab
32845808_Patient	patientDrug	Paclitaxel
32845808_Patient	patientDrug	Gemcitabine
32845808_Patient	treatmentType	Intravenous_Chemotherapy
32845808_Patient	treatmentType	Immunotherapy
32845808_Patient	treatmentType	Radiotherapy_To_Lung
42845808_Patient	hasGender	Male
42845808_Patient	hasAgeCategory	Old
42845808_Patient	hasStage	IV
42845808_Patient	hasSmokingHabit	CurrentSmoker
42845808_Patient	hasBiomarker	EGFR_Positive
42845808_Patient	hasRelapse_Progression	Progression
42845808_Patient	patientDrug	Carboplatin
42845808_Patient	patientDrug	Atezolizumab
42845808_Patient	patientDrug	Paclitaxel
42845808_Patient	patientDrug	Gemcitabine
42845808_Patient	treatmentType	Intravenous_Chemotherapy
42845808_Patient	treatmentType	Immunotherapy
42845808_Patient	treatmentType	Radiotherapy_To_Lung
52845808_Patient	hasGender	Male
52845808_Patient	hasAgeCategory	Old
52845808_Patient	hasStage	IV
52845808_Patient	hasSmokingHabit	CurrentSmoker
52845808_Patient	hasBiomarker	EGFR_Positive
52845808_Patient	hasRelapse_Progression	Progression
52845808_Patient	patientDrug	Carboplatin
52845808_Patient	patientDrug	Atezolizumab
52845808_Patient	patientDrug	Paclitaxel
52845808_Patient	patientDrug	Gemcitabine
52845808_Patient	treatmentType	Intravenous_Chemotherapy
52845808_Patient	treatmentType	Immunotherapy
52845808_Patient	treatmentType	Radiotherapy_To_Lung
62845808_Patient	hasGender	Male
62845808_Patient	hasAgeCategory	Old
62845808_Patient	hasStage	IV
62845808_Patient	hasSmokingHabit	CurrentSmoker
62845808_Patient	hasBiomarker	EGFR_Positive
62845808_Patient	hasRelapse_Progression	Progression
62845808_Patient	patientDrug	Carboplatin
62845808_Patient	patientDrug	Atezolizumab
62845808_Patient	patientDrug	Paclitaxel
62845808_Patient	patientDrug	Gemcitabine
62845808_Patient	treatmentType	Intravenous_Chemotherapy
62845808_Patient	treatmentType	Immunotherapy
62845808_Patient	treatmentType	Radiotherapy_To_Lung
72845808_Patient	hasGender	Male
72845808_Patient	hasAgeCategory	Old
72845808_Patient	hasStage	IV
72845808_Patient	hasSmokingHabit	CurrentSmoker
72845808_Patient	hasBiomarker	EGFR_Positive
72845808_Patient	hasRelapse_Progression	Progression
72845808_Patient	patientDrug	Carboplatin
72845808_Patient	patientDrug	Atezolizumab
72845808_Patient	patientDrug	Paclitaxel
72845808_Patient	patientDrug	Gemcitabine
72845808_Patient	treatmentType	Intravenous_Chemotherapy
72845808_Patient	treatmentType	Immunotherapy
72845808_Patient	treatmentType	Radiotherapy_To_Lung
82845808_Patient	hasGender	Male
82845808_Patient	hasAgeCategory	Old
82845808_Patient	hasStage	IV
82845808_Patient	hasSmokingHabit	CurrentSmoker
82845808_Patient	hasBiomarker	EGFR_Positive
82845808_Patient	hasRelapse_Progression	Progression
82845808_Patient	patientDrug	Carboplatin
82845808_Patient	patientDrug	Atezolizumab
82845808_Patient	patientDrug	Paclitaxel
82845808_Patient	patientDrug	Gemcitabine
82845808_Patient	treatmentType	Intravenous_Chemotherapy
82845808_Patient	treatmentType	Immunotherapy
82845808_Patient	treatmentType	Radiotherapy_To_Lung
92845808_Patient	hasGender	Male
92845808_Patient	hasAgeCategory	Old
92845808_Patient	hasStage	IV
92845808_Patient	hasSmokingHabit	CurrentSmoker
92845808_Patient	hasBiomarker	EGFR_Positive
92845808_Patient	hasRelapse_Progression	Progression
92845808_Patient	patientDrug	Carboplatin
92845808_Patient	patientDrug	Atezolizumab
92845808_Patient	patientDrug	Paclitaxel
92845808_Patient	patientDrug	Gemcitabine
92845808_Patient	treatmentType	Intravenous_Chemotherapy
92845808_Patient	treatmentType	Immunotherapy
92845808_Patient	treatmentType	Radiotherapy_To_Lung
01042707_Patient	hasGender	Male
01042707_Patient	hasAgeCategory	Old
01042707_Patient	hasStage	IIIA
01042707_Patient	hasSmokingHabit	CurrentSmoker
01042707_Patient	hasBiomarker	ALK_Negative
01042707_Patient	hasBiomarker	BRAF_Negative
01042707_Patient	hasBiomarker	EGFR_Negative
01042707_Patient	hasBiomarker	ROS1_Negative
01042707_Patient	hasRelapse_Progression	No_Progression
01042707_Patient	patientDrug	Carboplatin
01042707_Patient	patientDrug	Paclitaxel
01042707_Patient	patientDrug	Vinorelbine
01042707_Patient	patientDrug	Durvalumab
01042707_Patient	treatmentType	Intravenous_Chemotherapy
01042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
01042707_Patient	treatmentType	Immunotherapy
01042707_Patient	treatmentType	Radiotherapy_To_Lung
01042707_Patient	patientDrug	Nivolumab
11042707_Patient	hasGender	Male
11042707_Patient	hasAgeCategory	Old
11042707_Patient	hasStage	IIIA
11042707_Patient	hasSmokingHabit	CurrentSmoker
11042707_Patient	hasBiomarker	ALK_Negative
11042707_Patient	hasBiomarker	BRAF_Negative
11042707_Patient	hasBiomarker	EGFR_Negative
11042707_Patient	hasBiomarker	ROS1_Negative
11042707_Patient	hasRelapse_Progression	No_Progression
11042707_Patient	patientDrug	Carboplatin
11042707_Patient	patientDrug	Paclitaxel
11042707_Patient	patientDrug	Vinorelbine
11042707_Patient	patientDrug	Durvalumab
11042707_Patient	treatmentType	Intravenous_Chemotherapy
11042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
11042707_Patient	treatmentType	Immunotherapy
11042707_Patient	treatmentType	Radiotherapy_To_Lung
11042707_Patient	patientDrug	Nivolumab
21042707_Patient	hasGender	Male
21042707_Patient	hasAgeCategory	Old
21042707_Patient	hasStage	IIIA
21042707_Patient	hasSmokingHabit	CurrentSmoker
21042707_Patient	hasBiomarker	ALK_Negative
21042707_Patient	hasBiomarker	BRAF_Negative
21042707_Patient	hasBiomarker	EGFR_Negative
21042707_Patient	hasBiomarker	ROS1_Negative
21042707_Patient	hasRelapse_Progression	No_Progression
21042707_Patient	patientDrug	Carboplatin
21042707_Patient	patientDrug	Paclitaxel
21042707_Patient	patientDrug	Vinorelbine
21042707_Patient	patientDrug	Durvalumab
21042707_Patient	treatmentType	Intravenous_Chemotherapy
21042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
21042707_Patient	treatmentType	Immunotherapy
21042707_Patient	treatmentType	Radiotherapy_To_Lung
21042707_Patient	patientDrug	Nivolumab
31042707_Patient	hasGender	Male
31042707_Patient	hasAgeCategory	Old
31042707_Patient	hasStage	IIIA
31042707_Patient	hasSmokingHabit	CurrentSmoker
31042707_Patient	hasBiomarker	ALK_Negative
31042707_Patient	hasBiomarker	BRAF_Negative
31042707_Patient	hasBiomarker	EGFR_Negative
31042707_Patient	hasBiomarker	ROS1_Negative
31042707_Patient	hasRelapse_Progression	No_Progression
31042707_Patient	patientDrug	Carboplatin
31042707_Patient	patientDrug	Paclitaxel
31042707_Patient	patientDrug	Vinorelbine
31042707_Patient	patientDrug	Durvalumab
31042707_Patient	treatmentType	Intravenous_Chemotherapy
31042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
31042707_Patient	treatmentType	Immunotherapy
31042707_Patient	treatmentType	Radiotherapy_To_Lung
31042707_Patient	patientDrug	Nivolumab
41042707_Patient	hasGender	Male
41042707_Patient	hasAgeCategory	Old
41042707_Patient	hasStage	IIIA
41042707_Patient	hasSmokingHabit	CurrentSmoker
41042707_Patient	hasBiomarker	ALK_Negative
41042707_Patient	hasBiomarker	BRAF_Negative
41042707_Patient	hasBiomarker	EGFR_Negative
41042707_Patient	hasBiomarker	ROS1_Negative
41042707_Patient	hasRelapse_Progression	No_Progression
41042707_Patient	patientDrug	Carboplatin
41042707_Patient	patientDrug	Paclitaxel
41042707_Patient	patientDrug	Vinorelbine
41042707_Patient	patientDrug	Durvalumab
41042707_Patient	treatmentType	Intravenous_Chemotherapy
41042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
41042707_Patient	treatmentType	Immunotherapy
41042707_Patient	treatmentType	Radiotherapy_To_Lung
41042707_Patient	patientDrug	Nivolumab
51042707_Patient	hasGender	Male
51042707_Patient	hasAgeCategory	Old
51042707_Patient	hasStage	IIIA
51042707_Patient	hasSmokingHabit	CurrentSmoker
51042707_Patient	hasBiomarker	ALK_Negative
51042707_Patient	hasBiomarker	BRAF_Negative
51042707_Patient	hasBiomarker	EGFR_Negative
51042707_Patient	hasBiomarker	ROS1_Negative
51042707_Patient	hasRelapse_Progression	No_Progression
51042707_Patient	patientDrug	Carboplatin
51042707_Patient	patientDrug	Paclitaxel
51042707_Patient	patientDrug	Vinorelbine
51042707_Patient	patientDrug	Durvalumab
51042707_Patient	treatmentType	Intravenous_Chemotherapy
51042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
51042707_Patient	treatmentType	Immunotherapy
51042707_Patient	treatmentType	Radiotherapy_To_Lung
51042707_Patient	patientDrug	Nivolumab
61042707_Patient	hasGender	Male
61042707_Patient	hasAgeCategory	Old
61042707_Patient	hasStage	IIIA
61042707_Patient	hasSmokingHabit	CurrentSmoker
61042707_Patient	hasBiomarker	ALK_Negative
61042707_Patient	hasBiomarker	BRAF_Negative
61042707_Patient	hasBiomarker	EGFR_Negative
61042707_Patient	hasBiomarker	ROS1_Negative
61042707_Patient	hasRelapse_Progression	No_Progression
61042707_Patient	patientDrug	Carboplatin
61042707_Patient	patientDrug	Paclitaxel
61042707_Patient	patientDrug	Vinorelbine
61042707_Patient	patientDrug	Durvalumab
61042707_Patient	treatmentType	Intravenous_Chemotherapy
61042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
61042707_Patient	treatmentType	Immunotherapy
61042707_Patient	treatmentType	Radiotherapy_To_Lung
61042707_Patient	patientDrug	Nivolumab
71042707_Patient	hasGender	Male
71042707_Patient	hasAgeCategory	Old
71042707_Patient	hasStage	IIIA
71042707_Patient	hasSmokingHabit	CurrentSmoker
71042707_Patient	hasBiomarker	ALK_Negative
71042707_Patient	hasBiomarker	BRAF_Negative
71042707_Patient	hasBiomarker	EGFR_Negative
71042707_Patient	hasBiomarker	ROS1_Negative
71042707_Patient	hasRelapse_Progression	No_Progression
71042707_Patient	patientDrug	Carboplatin
71042707_Patient	patientDrug	Paclitaxel
71042707_Patient	patientDrug	Vinorelbine
71042707_Patient	patientDrug	Durvalumab
71042707_Patient	treatmentType	Intravenous_Chemotherapy
71042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
71042707_Patient	treatmentType	Immunotherapy
71042707_Patient	treatmentType	Radiotherapy_To_Lung
71042707_Patient	patientDrug	Nivolumab
81042707_Patient	hasGender	Male
81042707_Patient	hasAgeCategory	Old
81042707_Patient	hasStage	IIIA
81042707_Patient	hasSmokingHabit	CurrentSmoker
81042707_Patient	hasBiomarker	ALK_Negative
81042707_Patient	hasBiomarker	BRAF_Negative
81042707_Patient	hasBiomarker	EGFR_Negative
81042707_Patient	hasBiomarker	ROS1_Negative
81042707_Patient	hasRelapse_Progression	No_Progression
81042707_Patient	patientDrug	Carboplatin
81042707_Patient	patientDrug	Paclitaxel
81042707_Patient	patientDrug	Vinorelbine
81042707_Patient	patientDrug	Durvalumab
81042707_Patient	treatmentType	Intravenous_Chemotherapy
81042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
81042707_Patient	treatmentType	Immunotherapy
81042707_Patient	treatmentType	Radiotherapy_To_Lung
81042707_Patient	patientDrug	Nivolumab
91042707_Patient	hasGender	Male
91042707_Patient	hasAgeCategory	Old
91042707_Patient	hasStage	IIIA
91042707_Patient	hasSmokingHabit	CurrentSmoker
91042707_Patient	hasBiomarker	ALK_Negative
91042707_Patient	hasBiomarker	BRAF_Negative
91042707_Patient	hasBiomarker	EGFR_Negative
91042707_Patient	hasBiomarker	ROS1_Negative
91042707_Patient	hasRelapse_Progression	No_Progression
91042707_Patient	patientDrug	Carboplatin
91042707_Patient	patientDrug	Paclitaxel
91042707_Patient	patientDrug	Vinorelbine
91042707_Patient	patientDrug	Durvalumab
91042707_Patient	treatmentType	Intravenous_Chemotherapy
91042707_Patient	treatmentType	Concurrent_Chemoradiotherapy
91042707_Patient	treatmentType	Immunotherapy
91042707_Patient	treatmentType	Radiotherapy_To_Lung
91042707_Patient	patientDrug	Nivolumab
01267046_Patient	hasGender	Female
01267046_Patient	hasAgeCategory	Old
01267046_Patient	hasStage	IVB
01267046_Patient	hasSmokingHabit	CurrentSmoker
01267046_Patient	hasBiomarker	PDL1_Positive
01267046_Patient	hasBiomarker	ALK_Negative
01267046_Patient	hasBiomarker	EGFR_Negative
01267046_Patient	hasBiomarker	ROS1_Negative
01267046_Patient	hasRelapse_Progression	Progression
01267046_Patient	patientDrug	Carboplatin
01267046_Patient	patientDrug	Pemetrexed
01267046_Patient	patientDrug	Other
01267046_Patient	patientDrug	Pembrolizumab
01267046_Patient	treatmentType	Intravenous_Chemotherapy
01267046_Patient	treatmentType	Immunotherapy
01267046_Patient	treatmentType	Radiotherapy_To_Bone
01267046_Patient	patientDrug	Nivolumab
11267046_Patient	hasGender	Female
11267046_Patient	hasAgeCategory	Old
11267046_Patient	hasStage	IVB
11267046_Patient	hasSmokingHabit	CurrentSmoker
11267046_Patient	hasBiomarker	PDL1_Positive
11267046_Patient	hasBiomarker	ALK_Negative
11267046_Patient	hasBiomarker	EGFR_Negative
11267046_Patient	hasBiomarker	ROS1_Negative
11267046_Patient	hasRelapse_Progression	Progression
11267046_Patient	patientDrug	Carboplatin
11267046_Patient	patientDrug	Pemetrexed
11267046_Patient	patientDrug	Other
11267046_Patient	patientDrug	Pembrolizumab
11267046_Patient	treatmentType	Intravenous_Chemotherapy
11267046_Patient	treatmentType	Immunotherapy
11267046_Patient	treatmentType	Radiotherapy_To_Bone
11267046_Patient	patientDrug	Nivolumab
21267046_Patient	hasGender	Female
21267046_Patient	hasAgeCategory	Old
21267046_Patient	hasStage	IVB
21267046_Patient	hasSmokingHabit	CurrentSmoker
21267046_Patient	hasBiomarker	PDL1_Positive
21267046_Patient	hasBiomarker	ALK_Negative
21267046_Patient	hasBiomarker	EGFR_Negative
21267046_Patient	hasBiomarker	ROS1_Negative
21267046_Patient	hasRelapse_Progression	Progression
21267046_Patient	patientDrug	Carboplatin
21267046_Patient	patientDrug	Pemetrexed
21267046_Patient	patientDrug	Other
21267046_Patient	patientDrug	Pembrolizumab
21267046_Patient	treatmentType	Intravenous_Chemotherapy
21267046_Patient	treatmentType	Immunotherapy
21267046_Patient	treatmentType	Radiotherapy_To_Bone
21267046_Patient	patientDrug	Nivolumab
31267046_Patient	hasGender	Female
31267046_Patient	hasAgeCategory	Old
31267046_Patient	hasStage	IVB
31267046_Patient	hasSmokingHabit	CurrentSmoker
31267046_Patient	hasBiomarker	PDL1_Positive
31267046_Patient	hasBiomarker	ALK_Negative
31267046_Patient	hasBiomarker	EGFR_Negative
31267046_Patient	hasBiomarker	ROS1_Negative
31267046_Patient	hasRelapse_Progression	Progression
31267046_Patient	patientDrug	Carboplatin
31267046_Patient	patientDrug	Pemetrexed
31267046_Patient	patientDrug	Other
31267046_Patient	patientDrug	Pembrolizumab
31267046_Patient	treatmentType	Intravenous_Chemotherapy
31267046_Patient	treatmentType	Immunotherapy
31267046_Patient	treatmentType	Radiotherapy_To_Bone
31267046_Patient	patientDrug	Nivolumab
41267046_Patient	hasGender	Female
41267046_Patient	hasAgeCategory	Old
41267046_Patient	hasStage	IVB
41267046_Patient	hasSmokingHabit	CurrentSmoker
41267046_Patient	hasBiomarker	PDL1_Positive
41267046_Patient	hasBiomarker	ALK_Negative
41267046_Patient	hasBiomarker	EGFR_Negative
41267046_Patient	hasBiomarker	ROS1_Negative
41267046_Patient	hasRelapse_Progression	Progression
41267046_Patient	patientDrug	Carboplatin
41267046_Patient	patientDrug	Pemetrexed
41267046_Patient	patientDrug	Other
41267046_Patient	patientDrug	Pembrolizumab
41267046_Patient	treatmentType	Intravenous_Chemotherapy
41267046_Patient	treatmentType	Immunotherapy
41267046_Patient	treatmentType	Radiotherapy_To_Bone
41267046_Patient	patientDrug	Nivolumab
51267046_Patient	hasGender	Female
51267046_Patient	hasAgeCategory	Old
51267046_Patient	hasStage	IVB
51267046_Patient	hasSmokingHabit	CurrentSmoker
51267046_Patient	hasBiomarker	PDL1_Positive
51267046_Patient	hasBiomarker	ALK_Negative
51267046_Patient	hasBiomarker	EGFR_Negative
51267046_Patient	hasBiomarker	ROS1_Negative
51267046_Patient	hasRelapse_Progression	Progression
51267046_Patient	patientDrug	Carboplatin
51267046_Patient	patientDrug	Pemetrexed
51267046_Patient	patientDrug	Other
51267046_Patient	patientDrug	Pembrolizumab
51267046_Patient	treatmentType	Intravenous_Chemotherapy
51267046_Patient	treatmentType	Immunotherapy
51267046_Patient	treatmentType	Radiotherapy_To_Bone
51267046_Patient	patientDrug	Nivolumab
61267046_Patient	hasGender	Female
61267046_Patient	hasAgeCategory	Old
61267046_Patient	hasStage	IVB
61267046_Patient	hasSmokingHabit	CurrentSmoker
61267046_Patient	hasBiomarker	PDL1_Positive
61267046_Patient	hasBiomarker	ALK_Negative
61267046_Patient	hasBiomarker	EGFR_Negative
61267046_Patient	hasBiomarker	ROS1_Negative
61267046_Patient	hasRelapse_Progression	Progression
61267046_Patient	patientDrug	Carboplatin
61267046_Patient	patientDrug	Pemetrexed
61267046_Patient	patientDrug	Other
61267046_Patient	patientDrug	Pembrolizumab
61267046_Patient	treatmentType	Intravenous_Chemotherapy
61267046_Patient	treatmentType	Immunotherapy
61267046_Patient	treatmentType	Radiotherapy_To_Bone
61267046_Patient	patientDrug	Nivolumab
71267046_Patient	hasGender	Female
71267046_Patient	hasAgeCategory	Old
71267046_Patient	hasStage	IVB
71267046_Patient	hasSmokingHabit	CurrentSmoker
71267046_Patient	hasBiomarker	PDL1_Positive
71267046_Patient	hasBiomarker	ALK_Negative
71267046_Patient	hasBiomarker	EGFR_Negative
71267046_Patient	hasBiomarker	ROS1_Negative
71267046_Patient	hasRelapse_Progression	Progression
71267046_Patient	patientDrug	Carboplatin
71267046_Patient	patientDrug	Pemetrexed
71267046_Patient	patientDrug	Other
71267046_Patient	patientDrug	Pembrolizumab
71267046_Patient	treatmentType	Intravenous_Chemotherapy
71267046_Patient	treatmentType	Immunotherapy
71267046_Patient	treatmentType	Radiotherapy_To_Bone
71267046_Patient	patientDrug	Nivolumab
81267046_Patient	hasGender	Female
81267046_Patient	hasAgeCategory	Old
81267046_Patient	hasStage	IVB
81267046_Patient	hasSmokingHabit	CurrentSmoker
81267046_Patient	hasBiomarker	PDL1_Positive
81267046_Patient	hasBiomarker	ALK_Negative
81267046_Patient	hasBiomarker	EGFR_Negative
81267046_Patient	hasBiomarker	ROS1_Negative
81267046_Patient	hasRelapse_Progression	Progression
81267046_Patient	patientDrug	Carboplatin
81267046_Patient	patientDrug	Pemetrexed
81267046_Patient	patientDrug	Other
81267046_Patient	patientDrug	Pembrolizumab
81267046_Patient	treatmentType	Intravenous_Chemotherapy
81267046_Patient	treatmentType	Immunotherapy
81267046_Patient	treatmentType	Radiotherapy_To_Bone
81267046_Patient	patientDrug	Nivolumab
91267046_Patient	hasGender	Female
91267046_Patient	hasAgeCategory	Old
91267046_Patient	hasStage	IVB
91267046_Patient	hasSmokingHabit	CurrentSmoker
91267046_Patient	hasBiomarker	PDL1_Positive
91267046_Patient	hasBiomarker	ALK_Negative
91267046_Patient	hasBiomarker	EGFR_Negative
91267046_Patient	hasBiomarker	ROS1_Negative
91267046_Patient	hasRelapse_Progression	Progression
91267046_Patient	patientDrug	Carboplatin
91267046_Patient	patientDrug	Pemetrexed
91267046_Patient	patientDrug	Other
91267046_Patient	patientDrug	Pembrolizumab
91267046_Patient	treatmentType	Intravenous_Chemotherapy
91267046_Patient	treatmentType	Immunotherapy
91267046_Patient	treatmentType	Radiotherapy_To_Bone
91267046_Patient	patientDrug	Nivolumab
02325330_Patient	hasGender	Male
02325330_Patient	hasAgeCategory	Young
02325330_Patient	hasStage	IVA
02325330_Patient	hasSmokingHabit	CurrentSmoker
02325330_Patient	hasBiomarker	PDL1_Positive
02325330_Patient	hasBiomarker	ALK_Negative
02325330_Patient	hasBiomarker	BRAF_Negative
02325330_Patient	hasBiomarker	EGFR_Negative
02325330_Patient	hasBiomarker	ROS1_Negative
02325330_Patient	hasRelapse_Progression	Progression
02325330_Patient	patientDrug	Carboplatin
02325330_Patient	patientDrug	Paclitaxel
02325330_Patient	patientDrug	Pembrolizumab
02325330_Patient	treatmentType	Intravenous_Chemotherapy
02325330_Patient	treatmentType	Immunotherapy
02325330_Patient	treatmentType	Radiotherapy_To_Bone
02325330_Patient	patientDrug	Nivolumab
12325330_Patient	hasGender	Male
12325330_Patient	hasAgeCategory	Young
12325330_Patient	hasStage	IVA
12325330_Patient	hasSmokingHabit	CurrentSmoker
12325330_Patient	hasBiomarker	PDL1_Positive
12325330_Patient	hasBiomarker	ALK_Negative
12325330_Patient	hasBiomarker	BRAF_Negative
12325330_Patient	hasBiomarker	EGFR_Negative
12325330_Patient	hasBiomarker	ROS1_Negative
12325330_Patient	hasRelapse_Progression	Progression
12325330_Patient	patientDrug	Carboplatin
12325330_Patient	patientDrug	Paclitaxel
12325330_Patient	patientDrug	Pembrolizumab
12325330_Patient	treatmentType	Intravenous_Chemotherapy
12325330_Patient	treatmentType	Immunotherapy
12325330_Patient	treatmentType	Radiotherapy_To_Bone
12325330_Patient	patientDrug	Nivolumab
22325330_Patient	hasGender	Male
22325330_Patient	hasAgeCategory	Young
22325330_Patient	hasStage	IVA
22325330_Patient	hasSmokingHabit	CurrentSmoker
22325330_Patient	hasBiomarker	PDL1_Positive
22325330_Patient	hasBiomarker	ALK_Negative
22325330_Patient	hasBiomarker	BRAF_Negative
22325330_Patient	hasBiomarker	EGFR_Negative
22325330_Patient	hasBiomarker	ROS1_Negative
22325330_Patient	hasRelapse_Progression	Progression
22325330_Patient	patientDrug	Carboplatin
22325330_Patient	patientDrug	Paclitaxel
22325330_Patient	patientDrug	Pembrolizumab
22325330_Patient	treatmentType	Intravenous_Chemotherapy
22325330_Patient	treatmentType	Immunotherapy
22325330_Patient	treatmentType	Radiotherapy_To_Bone
22325330_Patient	patientDrug	Nivolumab
32325330_Patient	hasGender	Male
32325330_Patient	hasAgeCategory	Young
32325330_Patient	hasStage	IVA
32325330_Patient	hasSmokingHabit	CurrentSmoker
32325330_Patient	hasBiomarker	PDL1_Positive
32325330_Patient	hasBiomarker	ALK_Negative
32325330_Patient	hasBiomarker	BRAF_Negative
32325330_Patient	hasBiomarker	EGFR_Negative
32325330_Patient	hasBiomarker	ROS1_Negative
32325330_Patient	hasRelapse_Progression	Progression
32325330_Patient	patientDrug	Carboplatin
32325330_Patient	patientDrug	Paclitaxel
32325330_Patient	patientDrug	Pembrolizumab
32325330_Patient	treatmentType	Intravenous_Chemotherapy
32325330_Patient	treatmentType	Immunotherapy
32325330_Patient	treatmentType	Radiotherapy_To_Bone
32325330_Patient	patientDrug	Nivolumab
42325330_Patient	hasGender	Male
42325330_Patient	hasAgeCategory	Young
42325330_Patient	hasStage	IVA
42325330_Patient	hasSmokingHabit	CurrentSmoker
42325330_Patient	hasBiomarker	PDL1_Positive
42325330_Patient	hasBiomarker	ALK_Negative
42325330_Patient	hasBiomarker	BRAF_Negative
42325330_Patient	hasBiomarker	EGFR_Negative
42325330_Patient	hasBiomarker	ROS1_Negative
42325330_Patient	hasRelapse_Progression	Progression
42325330_Patient	patientDrug	Carboplatin
42325330_Patient	patientDrug	Paclitaxel
42325330_Patient	patientDrug	Pembrolizumab
42325330_Patient	treatmentType	Intravenous_Chemotherapy
42325330_Patient	treatmentType	Immunotherapy
42325330_Patient	treatmentType	Radiotherapy_To_Bone
42325330_Patient	patientDrug	Nivolumab
52325330_Patient	hasGender	Male
52325330_Patient	hasAgeCategory	Young
52325330_Patient	hasStage	IVA
52325330_Patient	hasSmokingHabit	CurrentSmoker
52325330_Patient	hasBiomarker	PDL1_Positive
52325330_Patient	hasBiomarker	ALK_Negative
52325330_Patient	hasBiomarker	BRAF_Negative
52325330_Patient	hasBiomarker	EGFR_Negative
52325330_Patient	hasBiomarker	ROS1_Negative
52325330_Patient	hasRelapse_Progression	Progression
52325330_Patient	patientDrug	Carboplatin
52325330_Patient	patientDrug	Paclitaxel
52325330_Patient	patientDrug	Pembrolizumab
52325330_Patient	treatmentType	Intravenous_Chemotherapy
52325330_Patient	treatmentType	Immunotherapy
52325330_Patient	treatmentType	Radiotherapy_To_Bone
52325330_Patient	patientDrug	Nivolumab
62325330_Patient	hasGender	Male
62325330_Patient	hasAgeCategory	Young
62325330_Patient	hasStage	IVA
62325330_Patient	hasSmokingHabit	CurrentSmoker
62325330_Patient	hasBiomarker	PDL1_Positive
62325330_Patient	hasBiomarker	ALK_Negative
62325330_Patient	hasBiomarker	BRAF_Negative
62325330_Patient	hasBiomarker	EGFR_Negative
62325330_Patient	hasBiomarker	ROS1_Negative
62325330_Patient	hasRelapse_Progression	Progression
62325330_Patient	patientDrug	Carboplatin
62325330_Patient	patientDrug	Paclitaxel
62325330_Patient	patientDrug	Pembrolizumab
62325330_Patient	treatmentType	Intravenous_Chemotherapy
62325330_Patient	treatmentType	Immunotherapy
62325330_Patient	treatmentType	Radiotherapy_To_Bone
62325330_Patient	patientDrug	Nivolumab
72325330_Patient	hasGender	Male
72325330_Patient	hasAgeCategory	Young
72325330_Patient	hasStage	IVA
72325330_Patient	hasSmokingHabit	CurrentSmoker
72325330_Patient	hasBiomarker	PDL1_Positive
72325330_Patient	hasBiomarker	ALK_Negative
72325330_Patient	hasBiomarker	BRAF_Negative
72325330_Patient	hasBiomarker	EGFR_Negative
72325330_Patient	hasBiomarker	ROS1_Negative
72325330_Patient	hasRelapse_Progression	Progression
72325330_Patient	patientDrug	Carboplatin
72325330_Patient	patientDrug	Paclitaxel
72325330_Patient	patientDrug	Pembrolizumab
72325330_Patient	treatmentType	Intravenous_Chemotherapy
72325330_Patient	treatmentType	Immunotherapy
72325330_Patient	treatmentType	Radiotherapy_To_Bone
72325330_Patient	patientDrug	Nivolumab
82325330_Patient	hasGender	Male
82325330_Patient	hasAgeCategory	Young
82325330_Patient	hasStage	IVA
82325330_Patient	hasSmokingHabit	CurrentSmoker
82325330_Patient	hasBiomarker	PDL1_Positive
82325330_Patient	hasBiomarker	ALK_Negative
82325330_Patient	hasBiomarker	BRAF_Negative
82325330_Patient	hasBiomarker	EGFR_Negative
82325330_Patient	hasBiomarker	ROS1_Negative
82325330_Patient	hasRelapse_Progression	Progression
82325330_Patient	patientDrug	Carboplatin
82325330_Patient	patientDrug	Paclitaxel
82325330_Patient	patientDrug	Pembrolizumab
82325330_Patient	treatmentType	Intravenous_Chemotherapy
82325330_Patient	treatmentType	Immunotherapy
82325330_Patient	treatmentType	Radiotherapy_To_Bone
82325330_Patient	patientDrug	Nivolumab
92325330_Patient	hasGender	Male
92325330_Patient	hasAgeCategory	Young
92325330_Patient	hasStage	IVA
92325330_Patient	hasSmokingHabit	CurrentSmoker
92325330_Patient	hasBiomarker	PDL1_Positive
92325330_Patient	hasBiomarker	ALK_Negative
92325330_Patient	hasBiomarker	BRAF_Negative
92325330_Patient	hasBiomarker	EGFR_Negative
92325330_Patient	hasBiomarker	ROS1_Negative
92325330_Patient	hasRelapse_Progression	Progression
92325330_Patient	patientDrug	Carboplatin
92325330_Patient	patientDrug	Paclitaxel
92325330_Patient	patientDrug	Pembrolizumab
92325330_Patient	treatmentType	Intravenous_Chemotherapy
92325330_Patient	treatmentType	Immunotherapy
92325330_Patient	treatmentType	Radiotherapy_To_Bone
92325330_Patient	patientDrug	Nivolumab
02369878_Patient	hasGender	Male
02369878_Patient	hasAgeCategory	Young
02369878_Patient	hasStage	IIIB
02369878_Patient	hasSmokingHabit	NonSmoker
02369878_Patient	hasBiomarker	ALK_Positive
02369878_Patient	hasBiomarker	EGFR_Negative
02369878_Patient	hasRelapse_Progression	Progression
02369878_Patient	patientDrug	Cisplatin
02369878_Patient	patientDrug	Vinorelbine
02369878_Patient	patientDrug	Pembrolizumab
02369878_Patient	patientDrug	Crizotinib
02369878_Patient	treatmentType	Intravenous_Chemotherapy
02369878_Patient	treatmentType	Molecular_Targeted_Therapy
02369878_Patient	treatmentType	Immunotherapy
02369878_Patient	patientDrug	Nivolumab
12369878_Patient	hasGender	Male
12369878_Patient	hasAgeCategory	Young
12369878_Patient	hasStage	IIIB
12369878_Patient	hasSmokingHabit	NonSmoker
12369878_Patient	hasBiomarker	ALK_Positive
12369878_Patient	hasBiomarker	EGFR_Negative
12369878_Patient	hasRelapse_Progression	Progression
12369878_Patient	patientDrug	Cisplatin
12369878_Patient	patientDrug	Vinorelbine
12369878_Patient	patientDrug	Pembrolizumab
12369878_Patient	patientDrug	Crizotinib
12369878_Patient	treatmentType	Intravenous_Chemotherapy
12369878_Patient	treatmentType	Molecular_Targeted_Therapy
12369878_Patient	treatmentType	Immunotherapy
12369878_Patient	patientDrug	Nivolumab
22369878_Patient	hasGender	Male
22369878_Patient	hasAgeCategory	Young
22369878_Patient	hasStage	IIIB
22369878_Patient	hasSmokingHabit	NonSmoker
22369878_Patient	hasBiomarker	ALK_Positive
22369878_Patient	hasBiomarker	EGFR_Negative
22369878_Patient	hasRelapse_Progression	Progression
22369878_Patient	patientDrug	Cisplatin
22369878_Patient	patientDrug	Vinorelbine
22369878_Patient	patientDrug	Pembrolizumab
22369878_Patient	patientDrug	Crizotinib
22369878_Patient	treatmentType	Intravenous_Chemotherapy
22369878_Patient	treatmentType	Molecular_Targeted_Therapy
22369878_Patient	treatmentType	Immunotherapy
22369878_Patient	patientDrug	Nivolumab
32369878_Patient	hasGender	Male
32369878_Patient	hasAgeCategory	Young
32369878_Patient	hasStage	IIIB
32369878_Patient	hasSmokingHabit	NonSmoker
32369878_Patient	hasBiomarker	ALK_Positive
32369878_Patient	hasBiomarker	EGFR_Negative
32369878_Patient	hasRelapse_Progression	Progression
32369878_Patient	patientDrug	Cisplatin
32369878_Patient	patientDrug	Vinorelbine
32369878_Patient	patientDrug	Pembrolizumab
32369878_Patient	patientDrug	Crizotinib
32369878_Patient	treatmentType	Intravenous_Chemotherapy
32369878_Patient	treatmentType	Molecular_Targeted_Therapy
32369878_Patient	treatmentType	Immunotherapy
32369878_Patient	patientDrug	Nivolumab
42369878_Patient	hasGender	Male
42369878_Patient	hasAgeCategory	Young
42369878_Patient	hasStage	IIIB
42369878_Patient	hasSmokingHabit	NonSmoker
42369878_Patient	hasBiomarker	ALK_Positive
42369878_Patient	hasBiomarker	EGFR_Negative
42369878_Patient	hasRelapse_Progression	Progression
42369878_Patient	patientDrug	Cisplatin
42369878_Patient	patientDrug	Vinorelbine
42369878_Patient	patientDrug	Pembrolizumab
42369878_Patient	patientDrug	Crizotinib
42369878_Patient	treatmentType	Intravenous_Chemotherapy
42369878_Patient	treatmentType	Molecular_Targeted_Therapy
42369878_Patient	treatmentType	Immunotherapy
42369878_Patient	patientDrug	Nivolumab
52369878_Patient	hasGender	Male
52369878_Patient	hasAgeCategory	Young
52369878_Patient	hasStage	IIIB
52369878_Patient	hasSmokingHabit	NonSmoker
52369878_Patient	hasBiomarker	ALK_Positive
52369878_Patient	hasBiomarker	EGFR_Negative
52369878_Patient	hasRelapse_Progression	Progression
52369878_Patient	patientDrug	Cisplatin
52369878_Patient	patientDrug	Vinorelbine
52369878_Patient	patientDrug	Pembrolizumab
52369878_Patient	patientDrug	Crizotinib
52369878_Patient	treatmentType	Intravenous_Chemotherapy
52369878_Patient	treatmentType	Molecular_Targeted_Therapy
52369878_Patient	treatmentType	Immunotherapy
52369878_Patient	patientDrug	Nivolumab
62369878_Patient	hasGender	Male
62369878_Patient	hasAgeCategory	Young
62369878_Patient	hasStage	IIIB
62369878_Patient	hasSmokingHabit	NonSmoker
62369878_Patient	hasBiomarker	ALK_Positive
62369878_Patient	hasBiomarker	EGFR_Negative
62369878_Patient	hasRelapse_Progression	Progression
62369878_Patient	patientDrug	Cisplatin
62369878_Patient	patientDrug	Vinorelbine
62369878_Patient	patientDrug	Pembrolizumab
62369878_Patient	patientDrug	Crizotinib
62369878_Patient	treatmentType	Intravenous_Chemotherapy
62369878_Patient	treatmentType	Molecular_Targeted_Therapy
62369878_Patient	treatmentType	Immunotherapy
62369878_Patient	patientDrug	Nivolumab
72369878_Patient	hasGender	Male
72369878_Patient	hasAgeCategory	Young
72369878_Patient	hasStage	IIIB
72369878_Patient	hasSmokingHabit	NonSmoker
72369878_Patient	hasBiomarker	ALK_Positive
72369878_Patient	hasBiomarker	EGFR_Negative
72369878_Patient	hasRelapse_Progression	Progression
72369878_Patient	patientDrug	Cisplatin
72369878_Patient	patientDrug	Vinorelbine
72369878_Patient	patientDrug	Pembrolizumab
72369878_Patient	patientDrug	Crizotinib
72369878_Patient	treatmentType	Intravenous_Chemotherapy
72369878_Patient	treatmentType	Molecular_Targeted_Therapy
72369878_Patient	treatmentType	Immunotherapy
72369878_Patient	patientDrug	Nivolumab
82369878_Patient	hasGender	Male
82369878_Patient	hasAgeCategory	Young
82369878_Patient	hasStage	IIIB
82369878_Patient	hasSmokingHabit	NonSmoker
82369878_Patient	hasBiomarker	ALK_Positive
82369878_Patient	hasBiomarker	EGFR_Negative
82369878_Patient	hasRelapse_Progression	Progression
82369878_Patient	patientDrug	Cisplatin
82369878_Patient	patientDrug	Vinorelbine
82369878_Patient	patientDrug	Pembrolizumab
82369878_Patient	patientDrug	Crizotinib
82369878_Patient	treatmentType	Intravenous_Chemotherapy
82369878_Patient	treatmentType	Molecular_Targeted_Therapy
82369878_Patient	treatmentType	Immunotherapy
82369878_Patient	patientDrug	Nivolumab
92369878_Patient	hasGender	Male
92369878_Patient	hasAgeCategory	Young
92369878_Patient	hasStage	IIIB
92369878_Patient	hasSmokingHabit	NonSmoker
92369878_Patient	hasBiomarker	ALK_Positive
92369878_Patient	hasBiomarker	EGFR_Negative
92369878_Patient	hasRelapse_Progression	Progression
92369878_Patient	patientDrug	Cisplatin
92369878_Patient	patientDrug	Vinorelbine
92369878_Patient	patientDrug	Pembrolizumab
92369878_Patient	patientDrug	Crizotinib
92369878_Patient	treatmentType	Intravenous_Chemotherapy
92369878_Patient	treatmentType	Molecular_Targeted_Therapy
92369878_Patient	treatmentType	Immunotherapy
92369878_Patient	patientDrug	Nivolumab
02670938_Patient	hasGender	Male
02670938_Patient	hasAgeCategory	Old
02670938_Patient	hasStage	IIA
02670938_Patient	hasSmokingHabit	CurrentSmoker
02670938_Patient	hasBiomarker	ALK_Negative
02670938_Patient	hasBiomarker	EGFR_Negative
02670938_Patient	hasRelapse_Progression	Progression
02670938_Patient	patientDrug	Carboplatin
02670938_Patient	patientDrug	Paclitaxel
02670938_Patient	patientDrug	Cisplatin
02670938_Patient	patientDrug	Vinorelbine
02670938_Patient	patientDrug	Pembrolizumab
02670938_Patient	patientDrug	Docetaxel
02670938_Patient	treatmentType	Intravenous_Chemotherapy
02670938_Patient	treatmentType	Immunotherapy
02670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
02670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02670938_Patient	treatmentType	Thoracoscopy
02670938_Patient	patientDrug	Nivolumab
12670938_Patient	hasGender	Male
12670938_Patient	hasAgeCategory	Old
12670938_Patient	hasStage	IIA
12670938_Patient	hasSmokingHabit	CurrentSmoker
12670938_Patient	hasBiomarker	ALK_Negative
12670938_Patient	hasBiomarker	EGFR_Negative
12670938_Patient	hasRelapse_Progression	Progression
12670938_Patient	patientDrug	Carboplatin
12670938_Patient	patientDrug	Paclitaxel
12670938_Patient	patientDrug	Cisplatin
12670938_Patient	patientDrug	Vinorelbine
12670938_Patient	patientDrug	Pembrolizumab
12670938_Patient	patientDrug	Docetaxel
12670938_Patient	treatmentType	Intravenous_Chemotherapy
12670938_Patient	treatmentType	Immunotherapy
12670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
12670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12670938_Patient	treatmentType	Thoracoscopy
12670938_Patient	patientDrug	Nivolumab
22670938_Patient	hasGender	Male
22670938_Patient	hasAgeCategory	Old
22670938_Patient	hasStage	IIA
22670938_Patient	hasSmokingHabit	CurrentSmoker
22670938_Patient	hasBiomarker	ALK_Negative
22670938_Patient	hasBiomarker	EGFR_Negative
22670938_Patient	hasRelapse_Progression	Progression
22670938_Patient	patientDrug	Carboplatin
22670938_Patient	patientDrug	Paclitaxel
22670938_Patient	patientDrug	Cisplatin
22670938_Patient	patientDrug	Vinorelbine
22670938_Patient	patientDrug	Pembrolizumab
22670938_Patient	patientDrug	Docetaxel
22670938_Patient	treatmentType	Intravenous_Chemotherapy
22670938_Patient	treatmentType	Immunotherapy
22670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
22670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22670938_Patient	treatmentType	Thoracoscopy
22670938_Patient	patientDrug	Nivolumab
32670938_Patient	hasGender	Male
32670938_Patient	hasAgeCategory	Old
32670938_Patient	hasStage	IIA
32670938_Patient	hasSmokingHabit	CurrentSmoker
32670938_Patient	hasBiomarker	ALK_Negative
32670938_Patient	hasBiomarker	EGFR_Negative
32670938_Patient	hasRelapse_Progression	Progression
32670938_Patient	patientDrug	Carboplatin
32670938_Patient	patientDrug	Paclitaxel
32670938_Patient	patientDrug	Cisplatin
32670938_Patient	patientDrug	Vinorelbine
32670938_Patient	patientDrug	Pembrolizumab
32670938_Patient	patientDrug	Docetaxel
32670938_Patient	treatmentType	Intravenous_Chemotherapy
32670938_Patient	treatmentType	Immunotherapy
32670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
32670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32670938_Patient	treatmentType	Thoracoscopy
32670938_Patient	patientDrug	Nivolumab
42670938_Patient	hasGender	Male
42670938_Patient	hasAgeCategory	Old
42670938_Patient	hasStage	IIA
42670938_Patient	hasSmokingHabit	CurrentSmoker
42670938_Patient	hasBiomarker	ALK_Negative
42670938_Patient	hasBiomarker	EGFR_Negative
42670938_Patient	hasRelapse_Progression	Progression
42670938_Patient	patientDrug	Carboplatin
42670938_Patient	patientDrug	Paclitaxel
42670938_Patient	patientDrug	Cisplatin
42670938_Patient	patientDrug	Vinorelbine
42670938_Patient	patientDrug	Pembrolizumab
42670938_Patient	patientDrug	Docetaxel
42670938_Patient	treatmentType	Intravenous_Chemotherapy
42670938_Patient	treatmentType	Immunotherapy
42670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
42670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42670938_Patient	treatmentType	Thoracoscopy
42670938_Patient	patientDrug	Nivolumab
52670938_Patient	hasGender	Male
52670938_Patient	hasAgeCategory	Old
52670938_Patient	hasStage	IIA
52670938_Patient	hasSmokingHabit	CurrentSmoker
52670938_Patient	hasBiomarker	ALK_Negative
52670938_Patient	hasBiomarker	EGFR_Negative
52670938_Patient	hasRelapse_Progression	Progression
52670938_Patient	patientDrug	Carboplatin
52670938_Patient	patientDrug	Paclitaxel
52670938_Patient	patientDrug	Cisplatin
52670938_Patient	patientDrug	Vinorelbine
52670938_Patient	patientDrug	Pembrolizumab
52670938_Patient	patientDrug	Docetaxel
52670938_Patient	treatmentType	Intravenous_Chemotherapy
52670938_Patient	treatmentType	Immunotherapy
52670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
52670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52670938_Patient	treatmentType	Thoracoscopy
52670938_Patient	patientDrug	Nivolumab
62670938_Patient	hasGender	Male
62670938_Patient	hasAgeCategory	Old
62670938_Patient	hasStage	IIA
62670938_Patient	hasSmokingHabit	CurrentSmoker
62670938_Patient	hasBiomarker	ALK_Negative
62670938_Patient	hasBiomarker	EGFR_Negative
62670938_Patient	hasRelapse_Progression	Progression
62670938_Patient	patientDrug	Carboplatin
62670938_Patient	patientDrug	Paclitaxel
62670938_Patient	patientDrug	Cisplatin
62670938_Patient	patientDrug	Vinorelbine
62670938_Patient	patientDrug	Pembrolizumab
62670938_Patient	patientDrug	Docetaxel
62670938_Patient	treatmentType	Intravenous_Chemotherapy
62670938_Patient	treatmentType	Immunotherapy
62670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
62670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
62670938_Patient	treatmentType	Thoracoscopy
62670938_Patient	patientDrug	Nivolumab
72670938_Patient	hasGender	Male
72670938_Patient	hasAgeCategory	Old
72670938_Patient	hasStage	IIA
72670938_Patient	hasSmokingHabit	CurrentSmoker
72670938_Patient	hasBiomarker	ALK_Negative
72670938_Patient	hasBiomarker	EGFR_Negative
72670938_Patient	hasRelapse_Progression	Progression
72670938_Patient	patientDrug	Carboplatin
72670938_Patient	patientDrug	Paclitaxel
72670938_Patient	patientDrug	Cisplatin
72670938_Patient	patientDrug	Vinorelbine
72670938_Patient	patientDrug	Pembrolizumab
72670938_Patient	patientDrug	Docetaxel
72670938_Patient	treatmentType	Intravenous_Chemotherapy
72670938_Patient	treatmentType	Immunotherapy
72670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
72670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
72670938_Patient	treatmentType	Thoracoscopy
72670938_Patient	patientDrug	Nivolumab
82670938_Patient	hasGender	Male
82670938_Patient	hasAgeCategory	Old
82670938_Patient	hasStage	IIA
82670938_Patient	hasSmokingHabit	CurrentSmoker
82670938_Patient	hasBiomarker	ALK_Negative
82670938_Patient	hasBiomarker	EGFR_Negative
82670938_Patient	hasRelapse_Progression	Progression
82670938_Patient	patientDrug	Carboplatin
82670938_Patient	patientDrug	Paclitaxel
82670938_Patient	patientDrug	Cisplatin
82670938_Patient	patientDrug	Vinorelbine
82670938_Patient	patientDrug	Pembrolizumab
82670938_Patient	patientDrug	Docetaxel
82670938_Patient	treatmentType	Intravenous_Chemotherapy
82670938_Patient	treatmentType	Immunotherapy
82670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
82670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
82670938_Patient	treatmentType	Thoracoscopy
82670938_Patient	patientDrug	Nivolumab
92670938_Patient	hasGender	Male
92670938_Patient	hasAgeCategory	Old
92670938_Patient	hasStage	IIA
92670938_Patient	hasSmokingHabit	CurrentSmoker
92670938_Patient	hasBiomarker	ALK_Negative
92670938_Patient	hasBiomarker	EGFR_Negative
92670938_Patient	hasRelapse_Progression	Progression
92670938_Patient	patientDrug	Carboplatin
92670938_Patient	patientDrug	Paclitaxel
92670938_Patient	patientDrug	Cisplatin
92670938_Patient	patientDrug	Vinorelbine
92670938_Patient	patientDrug	Pembrolizumab
92670938_Patient	patientDrug	Docetaxel
92670938_Patient	treatmentType	Intravenous_Chemotherapy
92670938_Patient	treatmentType	Immunotherapy
92670938_Patient	treatmentType	Neoadjuvant_Chemotherapy
92670938_Patient	treatmentType	Whole_Brain_Radiation_Therapy
92670938_Patient	treatmentType	Thoracoscopy
92670938_Patient	patientDrug	Nivolumab
02777040_Patient	hasGender	Female
02777040_Patient	hasAgeCategory	Young
02777040_Patient	hasStage	IVB
02777040_Patient	hasSmokingHabit	CurrentSmoker
02777040_Patient	hasBiomarker	PDL1_Positive
02777040_Patient	hasBiomarker	ALK_Negative
02777040_Patient	hasBiomarker	EGFR_Negative
02777040_Patient	hasBiomarker	ROS1_Negative
02777040_Patient	hasRelapse_Progression	Progression
02777040_Patient	patientDrug	Carboplatin
02777040_Patient	patientDrug	Pemetrexed
02777040_Patient	patientDrug	Pembrolizumab
02777040_Patient	treatmentType	Intravenous_Chemotherapy
02777040_Patient	treatmentType	Immunotherapy
02777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02777040_Patient	patientDrug	Nivolumab
12777040_Patient	hasGender	Female
12777040_Patient	hasAgeCategory	Young
12777040_Patient	hasStage	IVB
12777040_Patient	hasSmokingHabit	CurrentSmoker
12777040_Patient	hasBiomarker	PDL1_Positive
12777040_Patient	hasBiomarker	ALK_Negative
12777040_Patient	hasBiomarker	EGFR_Negative
12777040_Patient	hasBiomarker	ROS1_Negative
12777040_Patient	hasRelapse_Progression	Progression
12777040_Patient	patientDrug	Carboplatin
12777040_Patient	patientDrug	Pemetrexed
12777040_Patient	patientDrug	Pembrolizumab
12777040_Patient	treatmentType	Intravenous_Chemotherapy
12777040_Patient	treatmentType	Immunotherapy
12777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12777040_Patient	patientDrug	Nivolumab
22777040_Patient	hasGender	Female
22777040_Patient	hasAgeCategory	Young
22777040_Patient	hasStage	IVB
22777040_Patient	hasSmokingHabit	CurrentSmoker
22777040_Patient	hasBiomarker	PDL1_Positive
22777040_Patient	hasBiomarker	ALK_Negative
22777040_Patient	hasBiomarker	EGFR_Negative
22777040_Patient	hasBiomarker	ROS1_Negative
22777040_Patient	hasRelapse_Progression	Progression
22777040_Patient	patientDrug	Carboplatin
22777040_Patient	patientDrug	Pemetrexed
22777040_Patient	patientDrug	Pembrolizumab
22777040_Patient	treatmentType	Intravenous_Chemotherapy
22777040_Patient	treatmentType	Immunotherapy
22777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22777040_Patient	patientDrug	Nivolumab
32777040_Patient	hasGender	Female
32777040_Patient	hasAgeCategory	Young
32777040_Patient	hasStage	IVB
32777040_Patient	hasSmokingHabit	CurrentSmoker
32777040_Patient	hasBiomarker	PDL1_Positive
32777040_Patient	hasBiomarker	ALK_Negative
32777040_Patient	hasBiomarker	EGFR_Negative
32777040_Patient	hasBiomarker	ROS1_Negative
32777040_Patient	hasRelapse_Progression	Progression
32777040_Patient	patientDrug	Carboplatin
32777040_Patient	patientDrug	Pemetrexed
32777040_Patient	patientDrug	Pembrolizumab
32777040_Patient	treatmentType	Intravenous_Chemotherapy
32777040_Patient	treatmentType	Immunotherapy
32777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32777040_Patient	patientDrug	Nivolumab
42777040_Patient	hasGender	Female
42777040_Patient	hasAgeCategory	Young
42777040_Patient	hasStage	IVB
42777040_Patient	hasSmokingHabit	CurrentSmoker
42777040_Patient	hasBiomarker	PDL1_Positive
42777040_Patient	hasBiomarker	ALK_Negative
42777040_Patient	hasBiomarker	EGFR_Negative
42777040_Patient	hasBiomarker	ROS1_Negative
42777040_Patient	hasRelapse_Progression	Progression
42777040_Patient	patientDrug	Carboplatin
42777040_Patient	patientDrug	Pemetrexed
42777040_Patient	patientDrug	Pembrolizumab
42777040_Patient	treatmentType	Intravenous_Chemotherapy
42777040_Patient	treatmentType	Immunotherapy
42777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42777040_Patient	patientDrug	Nivolumab
52777040_Patient	hasGender	Female
52777040_Patient	hasAgeCategory	Young
52777040_Patient	hasStage	IVB
52777040_Patient	hasSmokingHabit	CurrentSmoker
52777040_Patient	hasBiomarker	PDL1_Positive
52777040_Patient	hasBiomarker	ALK_Negative
52777040_Patient	hasBiomarker	EGFR_Negative
52777040_Patient	hasBiomarker	ROS1_Negative
52777040_Patient	hasRelapse_Progression	Progression
52777040_Patient	patientDrug	Carboplatin
52777040_Patient	patientDrug	Pemetrexed
52777040_Patient	patientDrug	Pembrolizumab
52777040_Patient	treatmentType	Intravenous_Chemotherapy
52777040_Patient	treatmentType	Immunotherapy
52777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52777040_Patient	patientDrug	Nivolumab
62777040_Patient	hasGender	Female
62777040_Patient	hasAgeCategory	Young
62777040_Patient	hasStage	IVB
62777040_Patient	hasSmokingHabit	CurrentSmoker
62777040_Patient	hasBiomarker	PDL1_Positive
62777040_Patient	hasBiomarker	ALK_Negative
62777040_Patient	hasBiomarker	EGFR_Negative
62777040_Patient	hasBiomarker	ROS1_Negative
62777040_Patient	hasRelapse_Progression	Progression
62777040_Patient	patientDrug	Carboplatin
62777040_Patient	patientDrug	Pemetrexed
62777040_Patient	patientDrug	Pembrolizumab
62777040_Patient	treatmentType	Intravenous_Chemotherapy
62777040_Patient	treatmentType	Immunotherapy
62777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
62777040_Patient	patientDrug	Nivolumab
72777040_Patient	hasGender	Female
72777040_Patient	hasAgeCategory	Young
72777040_Patient	hasStage	IVB
72777040_Patient	hasSmokingHabit	CurrentSmoker
72777040_Patient	hasBiomarker	PDL1_Positive
72777040_Patient	hasBiomarker	ALK_Negative
72777040_Patient	hasBiomarker	EGFR_Negative
72777040_Patient	hasBiomarker	ROS1_Negative
72777040_Patient	hasRelapse_Progression	Progression
72777040_Patient	patientDrug	Carboplatin
72777040_Patient	patientDrug	Pemetrexed
72777040_Patient	patientDrug	Pembrolizumab
72777040_Patient	treatmentType	Intravenous_Chemotherapy
72777040_Patient	treatmentType	Immunotherapy
72777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
72777040_Patient	patientDrug	Nivolumab
82777040_Patient	hasGender	Female
82777040_Patient	hasAgeCategory	Young
82777040_Patient	hasStage	IVB
82777040_Patient	hasSmokingHabit	CurrentSmoker
82777040_Patient	hasBiomarker	PDL1_Positive
82777040_Patient	hasBiomarker	ALK_Negative
82777040_Patient	hasBiomarker	EGFR_Negative
82777040_Patient	hasBiomarker	ROS1_Negative
82777040_Patient	hasRelapse_Progression	Progression
82777040_Patient	patientDrug	Carboplatin
82777040_Patient	patientDrug	Pemetrexed
82777040_Patient	patientDrug	Pembrolizumab
82777040_Patient	treatmentType	Intravenous_Chemotherapy
82777040_Patient	treatmentType	Immunotherapy
82777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
82777040_Patient	patientDrug	Nivolumab
92777040_Patient	hasGender	Female
92777040_Patient	hasAgeCategory	Young
92777040_Patient	hasStage	IVB
92777040_Patient	hasSmokingHabit	CurrentSmoker
92777040_Patient	hasBiomarker	PDL1_Positive
92777040_Patient	hasBiomarker	ALK_Negative
92777040_Patient	hasBiomarker	EGFR_Negative
92777040_Patient	hasBiomarker	ROS1_Negative
92777040_Patient	hasRelapse_Progression	Progression
92777040_Patient	patientDrug	Carboplatin
92777040_Patient	patientDrug	Pemetrexed
92777040_Patient	patientDrug	Pembrolizumab
92777040_Patient	treatmentType	Intravenous_Chemotherapy
92777040_Patient	treatmentType	Immunotherapy
92777040_Patient	treatmentType	Whole_Brain_Radiation_Therapy
92777040_Patient	patientDrug	Nivolumab
02803612_Patient	hasGender	Male
02803612_Patient	hasAgeCategory	Old
02803612_Patient	hasStage	IVA
02803612_Patient	hasSmokingHabit	CurrentSmoker
02803612_Patient	hasBiomarker	PDL1_Positive
02803612_Patient	hasBiomarker	ALK_Negative
02803612_Patient	hasBiomarker	EGFR_Negative
02803612_Patient	hasBiomarker	ROS1_Negative
02803612_Patient	hasRelapse_Progression	Progression
02803612_Patient	hasRelapse_Progression	Relapse
02803612_Patient	patientDrug	Paclitaxel
02803612_Patient	patientDrug	Pemetrexed
02803612_Patient	patientDrug	Cisplatin
02803612_Patient	patientDrug	Pembrolizumab
02803612_Patient	treatmentType	Intravenous_Chemotherapy
02803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
02803612_Patient	treatmentType	Immunotherapy
02803612_Patient	treatmentType	Radiotherapy_To_Lung
02803612_Patient	patientDrug	Nivolumab
12803612_Patient	hasGender	Male
12803612_Patient	hasAgeCategory	Old
12803612_Patient	hasStage	IVA
12803612_Patient	hasSmokingHabit	CurrentSmoker
12803612_Patient	hasBiomarker	PDL1_Positive
12803612_Patient	hasBiomarker	ALK_Negative
12803612_Patient	hasBiomarker	EGFR_Negative
12803612_Patient	hasBiomarker	ROS1_Negative
12803612_Patient	hasRelapse_Progression	Progression
12803612_Patient	hasRelapse_Progression	Relapse
12803612_Patient	patientDrug	Paclitaxel
12803612_Patient	patientDrug	Pemetrexed
12803612_Patient	patientDrug	Cisplatin
12803612_Patient	patientDrug	Pembrolizumab
12803612_Patient	treatmentType	Intravenous_Chemotherapy
12803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
12803612_Patient	treatmentType	Immunotherapy
12803612_Patient	treatmentType	Radiotherapy_To_Lung
12803612_Patient	patientDrug	Nivolumab
22803612_Patient	hasGender	Male
22803612_Patient	hasAgeCategory	Old
22803612_Patient	hasStage	IVA
22803612_Patient	hasSmokingHabit	CurrentSmoker
22803612_Patient	hasBiomarker	PDL1_Positive
22803612_Patient	hasBiomarker	ALK_Negative
22803612_Patient	hasBiomarker	EGFR_Negative
22803612_Patient	hasBiomarker	ROS1_Negative
22803612_Patient	hasRelapse_Progression	Progression
22803612_Patient	hasRelapse_Progression	Relapse
22803612_Patient	patientDrug	Paclitaxel
22803612_Patient	patientDrug	Pemetrexed
22803612_Patient	patientDrug	Cisplatin
22803612_Patient	patientDrug	Pembrolizumab
22803612_Patient	treatmentType	Intravenous_Chemotherapy
22803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
22803612_Patient	treatmentType	Immunotherapy
22803612_Patient	treatmentType	Radiotherapy_To_Lung
22803612_Patient	patientDrug	Nivolumab
32803612_Patient	hasGender	Male
32803612_Patient	hasAgeCategory	Old
32803612_Patient	hasStage	IVA
32803612_Patient	hasSmokingHabit	CurrentSmoker
32803612_Patient	hasBiomarker	PDL1_Positive
32803612_Patient	hasBiomarker	ALK_Negative
32803612_Patient	hasBiomarker	EGFR_Negative
32803612_Patient	hasBiomarker	ROS1_Negative
32803612_Patient	hasRelapse_Progression	Progression
32803612_Patient	hasRelapse_Progression	Relapse
32803612_Patient	patientDrug	Paclitaxel
32803612_Patient	patientDrug	Pemetrexed
32803612_Patient	patientDrug	Cisplatin
32803612_Patient	patientDrug	Pembrolizumab
32803612_Patient	treatmentType	Intravenous_Chemotherapy
32803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
32803612_Patient	treatmentType	Immunotherapy
32803612_Patient	treatmentType	Radiotherapy_To_Lung
32803612_Patient	patientDrug	Nivolumab
42803612_Patient	hasGender	Male
42803612_Patient	hasAgeCategory	Old
42803612_Patient	hasStage	IVA
42803612_Patient	hasSmokingHabit	CurrentSmoker
42803612_Patient	hasBiomarker	PDL1_Positive
42803612_Patient	hasBiomarker	ALK_Negative
42803612_Patient	hasBiomarker	EGFR_Negative
42803612_Patient	hasBiomarker	ROS1_Negative
42803612_Patient	hasRelapse_Progression	Progression
42803612_Patient	hasRelapse_Progression	Relapse
42803612_Patient	patientDrug	Paclitaxel
42803612_Patient	patientDrug	Pemetrexed
42803612_Patient	patientDrug	Cisplatin
42803612_Patient	patientDrug	Pembrolizumab
42803612_Patient	treatmentType	Intravenous_Chemotherapy
42803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
42803612_Patient	treatmentType	Immunotherapy
42803612_Patient	treatmentType	Radiotherapy_To_Lung
42803612_Patient	patientDrug	Nivolumab
52803612_Patient	hasGender	Male
52803612_Patient	hasAgeCategory	Old
52803612_Patient	hasStage	IVA
52803612_Patient	hasSmokingHabit	CurrentSmoker
52803612_Patient	hasBiomarker	PDL1_Positive
52803612_Patient	hasBiomarker	ALK_Negative
52803612_Patient	hasBiomarker	EGFR_Negative
52803612_Patient	hasBiomarker	ROS1_Negative
52803612_Patient	hasRelapse_Progression	Progression
52803612_Patient	hasRelapse_Progression	Relapse
52803612_Patient	patientDrug	Paclitaxel
52803612_Patient	patientDrug	Pemetrexed
52803612_Patient	patientDrug	Cisplatin
52803612_Patient	patientDrug	Pembrolizumab
52803612_Patient	treatmentType	Intravenous_Chemotherapy
52803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
52803612_Patient	treatmentType	Immunotherapy
52803612_Patient	treatmentType	Radiotherapy_To_Lung
52803612_Patient	patientDrug	Nivolumab
62803612_Patient	hasGender	Male
62803612_Patient	hasAgeCategory	Old
62803612_Patient	hasStage	IVA
62803612_Patient	hasSmokingHabit	CurrentSmoker
62803612_Patient	hasBiomarker	PDL1_Positive
62803612_Patient	hasBiomarker	ALK_Negative
62803612_Patient	hasBiomarker	EGFR_Negative
62803612_Patient	hasBiomarker	ROS1_Negative
62803612_Patient	hasRelapse_Progression	Progression
62803612_Patient	hasRelapse_Progression	Relapse
62803612_Patient	patientDrug	Paclitaxel
62803612_Patient	patientDrug	Pemetrexed
62803612_Patient	patientDrug	Cisplatin
62803612_Patient	patientDrug	Pembrolizumab
62803612_Patient	treatmentType	Intravenous_Chemotherapy
62803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
62803612_Patient	treatmentType	Immunotherapy
62803612_Patient	treatmentType	Radiotherapy_To_Lung
62803612_Patient	patientDrug	Nivolumab
72803612_Patient	hasGender	Male
72803612_Patient	hasAgeCategory	Old
72803612_Patient	hasStage	IVA
72803612_Patient	hasSmokingHabit	CurrentSmoker
72803612_Patient	hasBiomarker	PDL1_Positive
72803612_Patient	hasBiomarker	ALK_Negative
72803612_Patient	hasBiomarker	EGFR_Negative
72803612_Patient	hasBiomarker	ROS1_Negative
72803612_Patient	hasRelapse_Progression	Progression
72803612_Patient	hasRelapse_Progression	Relapse
72803612_Patient	patientDrug	Paclitaxel
72803612_Patient	patientDrug	Pemetrexed
72803612_Patient	patientDrug	Cisplatin
72803612_Patient	patientDrug	Pembrolizumab
72803612_Patient	treatmentType	Intravenous_Chemotherapy
72803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
72803612_Patient	treatmentType	Immunotherapy
72803612_Patient	treatmentType	Radiotherapy_To_Lung
72803612_Patient	patientDrug	Nivolumab
82803612_Patient	hasGender	Male
82803612_Patient	hasAgeCategory	Old
82803612_Patient	hasStage	IVA
82803612_Patient	hasSmokingHabit	CurrentSmoker
82803612_Patient	hasBiomarker	PDL1_Positive
82803612_Patient	hasBiomarker	ALK_Negative
82803612_Patient	hasBiomarker	EGFR_Negative
82803612_Patient	hasBiomarker	ROS1_Negative
82803612_Patient	hasRelapse_Progression	Progression
82803612_Patient	hasRelapse_Progression	Relapse
82803612_Patient	patientDrug	Paclitaxel
82803612_Patient	patientDrug	Pemetrexed
82803612_Patient	patientDrug	Cisplatin
82803612_Patient	patientDrug	Pembrolizumab
82803612_Patient	treatmentType	Intravenous_Chemotherapy
82803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
82803612_Patient	treatmentType	Immunotherapy
82803612_Patient	treatmentType	Radiotherapy_To_Lung
82803612_Patient	patientDrug	Nivolumab
92803612_Patient	hasGender	Male
92803612_Patient	hasAgeCategory	Old
92803612_Patient	hasStage	IVA
92803612_Patient	hasSmokingHabit	CurrentSmoker
92803612_Patient	hasBiomarker	PDL1_Positive
92803612_Patient	hasBiomarker	ALK_Negative
92803612_Patient	hasBiomarker	EGFR_Negative
92803612_Patient	hasBiomarker	ROS1_Negative
92803612_Patient	hasRelapse_Progression	Progression
92803612_Patient	hasRelapse_Progression	Relapse
92803612_Patient	patientDrug	Paclitaxel
92803612_Patient	patientDrug	Pemetrexed
92803612_Patient	patientDrug	Cisplatin
92803612_Patient	patientDrug	Pembrolizumab
92803612_Patient	treatmentType	Intravenous_Chemotherapy
92803612_Patient	treatmentType	Concurrent_Chemoradiotherapy
92803612_Patient	treatmentType	Immunotherapy
92803612_Patient	treatmentType	Radiotherapy_To_Lung
92803612_Patient	patientDrug	Nivolumab
02825213_Patient	hasGender	Female
02825213_Patient	hasAgeCategory	Young
02825213_Patient	hasStage	IVB
02825213_Patient	hasSmokingHabit	FormerSmoker
02825213_Patient	hasBiomarker	PDL1_Positive
02825213_Patient	hasBiomarker	ALK_Negative
02825213_Patient	hasBiomarker	EGFR_Negative
02825213_Patient	hasBiomarker	ROS1_Negative
02825213_Patient	hasRelapse_Progression	Progression
02825213_Patient	patientDrug	Carboplatin
02825213_Patient	patientDrug	Paclitaxel
02825213_Patient	patientDrug	Other
02825213_Patient	patientDrug	Pembrolizumab
02825213_Patient	patientDrug	Docetaxel
02825213_Patient	treatmentType	Intravenous_Chemotherapy
02825213_Patient	treatmentType	Immunotherapy
02825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02825213_Patient	treatmentType	Open_Surgical_Procedure
02825213_Patient	patientDrug	Nivolumab
12825213_Patient	hasGender	Female
12825213_Patient	hasAgeCategory	Young
12825213_Patient	hasStage	IVB
12825213_Patient	hasSmokingHabit	FormerSmoker
12825213_Patient	hasBiomarker	PDL1_Positive
12825213_Patient	hasBiomarker	ALK_Negative
12825213_Patient	hasBiomarker	EGFR_Negative
12825213_Patient	hasBiomarker	ROS1_Negative
12825213_Patient	hasRelapse_Progression	Progression
12825213_Patient	patientDrug	Carboplatin
12825213_Patient	patientDrug	Paclitaxel
12825213_Patient	patientDrug	Other
12825213_Patient	patientDrug	Pembrolizumab
12825213_Patient	patientDrug	Docetaxel
12825213_Patient	treatmentType	Intravenous_Chemotherapy
12825213_Patient	treatmentType	Immunotherapy
12825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12825213_Patient	treatmentType	Open_Surgical_Procedure
12825213_Patient	patientDrug	Nivolumab
22825213_Patient	hasGender	Female
22825213_Patient	hasAgeCategory	Young
22825213_Patient	hasStage	IVB
22825213_Patient	hasSmokingHabit	FormerSmoker
22825213_Patient	hasBiomarker	PDL1_Positive
22825213_Patient	hasBiomarker	ALK_Negative
22825213_Patient	hasBiomarker	EGFR_Negative
22825213_Patient	hasBiomarker	ROS1_Negative
22825213_Patient	hasRelapse_Progression	Progression
22825213_Patient	patientDrug	Carboplatin
22825213_Patient	patientDrug	Paclitaxel
22825213_Patient	patientDrug	Other
22825213_Patient	patientDrug	Pembrolizumab
22825213_Patient	patientDrug	Docetaxel
22825213_Patient	treatmentType	Intravenous_Chemotherapy
22825213_Patient	treatmentType	Immunotherapy
22825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22825213_Patient	treatmentType	Open_Surgical_Procedure
22825213_Patient	patientDrug	Nivolumab
32825213_Patient	hasGender	Female
32825213_Patient	hasAgeCategory	Young
32825213_Patient	hasStage	IVB
32825213_Patient	hasSmokingHabit	FormerSmoker
32825213_Patient	hasBiomarker	PDL1_Positive
32825213_Patient	hasBiomarker	ALK_Negative
32825213_Patient	hasBiomarker	EGFR_Negative
32825213_Patient	hasBiomarker	ROS1_Negative
32825213_Patient	hasRelapse_Progression	Progression
32825213_Patient	patientDrug	Carboplatin
32825213_Patient	patientDrug	Paclitaxel
32825213_Patient	patientDrug	Other
32825213_Patient	patientDrug	Pembrolizumab
32825213_Patient	patientDrug	Docetaxel
32825213_Patient	treatmentType	Intravenous_Chemotherapy
32825213_Patient	treatmentType	Immunotherapy
32825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32825213_Patient	treatmentType	Open_Surgical_Procedure
32825213_Patient	patientDrug	Nivolumab
42825213_Patient	hasGender	Female
42825213_Patient	hasAgeCategory	Young
42825213_Patient	hasStage	IVB
42825213_Patient	hasSmokingHabit	FormerSmoker
42825213_Patient	hasBiomarker	PDL1_Positive
42825213_Patient	hasBiomarker	ALK_Negative
42825213_Patient	hasBiomarker	EGFR_Negative
42825213_Patient	hasBiomarker	ROS1_Negative
42825213_Patient	hasRelapse_Progression	Progression
42825213_Patient	patientDrug	Carboplatin
42825213_Patient	patientDrug	Paclitaxel
42825213_Patient	patientDrug	Other
42825213_Patient	patientDrug	Pembrolizumab
42825213_Patient	patientDrug	Docetaxel
42825213_Patient	treatmentType	Intravenous_Chemotherapy
42825213_Patient	treatmentType	Immunotherapy
42825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42825213_Patient	treatmentType	Open_Surgical_Procedure
42825213_Patient	patientDrug	Nivolumab
52825213_Patient	hasGender	Female
52825213_Patient	hasAgeCategory	Young
52825213_Patient	hasStage	IVB
52825213_Patient	hasSmokingHabit	FormerSmoker
52825213_Patient	hasBiomarker	PDL1_Positive
52825213_Patient	hasBiomarker	ALK_Negative
52825213_Patient	hasBiomarker	EGFR_Negative
52825213_Patient	hasBiomarker	ROS1_Negative
52825213_Patient	hasRelapse_Progression	Progression
52825213_Patient	patientDrug	Carboplatin
52825213_Patient	patientDrug	Paclitaxel
52825213_Patient	patientDrug	Other
52825213_Patient	patientDrug	Pembrolizumab
52825213_Patient	patientDrug	Docetaxel
52825213_Patient	treatmentType	Intravenous_Chemotherapy
52825213_Patient	treatmentType	Immunotherapy
52825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52825213_Patient	treatmentType	Open_Surgical_Procedure
52825213_Patient	patientDrug	Nivolumab
62825213_Patient	hasGender	Female
62825213_Patient	hasAgeCategory	Young
62825213_Patient	hasStage	IVB
62825213_Patient	hasSmokingHabit	FormerSmoker
62825213_Patient	hasBiomarker	PDL1_Positive
62825213_Patient	hasBiomarker	ALK_Negative
62825213_Patient	hasBiomarker	EGFR_Negative
62825213_Patient	hasBiomarker	ROS1_Negative
62825213_Patient	hasRelapse_Progression	Progression
62825213_Patient	patientDrug	Carboplatin
62825213_Patient	patientDrug	Paclitaxel
62825213_Patient	patientDrug	Other
62825213_Patient	patientDrug	Pembrolizumab
62825213_Patient	patientDrug	Docetaxel
62825213_Patient	treatmentType	Intravenous_Chemotherapy
62825213_Patient	treatmentType	Immunotherapy
62825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
62825213_Patient	treatmentType	Open_Surgical_Procedure
62825213_Patient	patientDrug	Nivolumab
72825213_Patient	hasGender	Female
72825213_Patient	hasAgeCategory	Young
72825213_Patient	hasStage	IVB
72825213_Patient	hasSmokingHabit	FormerSmoker
72825213_Patient	hasBiomarker	PDL1_Positive
72825213_Patient	hasBiomarker	ALK_Negative
72825213_Patient	hasBiomarker	EGFR_Negative
72825213_Patient	hasBiomarker	ROS1_Negative
72825213_Patient	hasRelapse_Progression	Progression
72825213_Patient	patientDrug	Carboplatin
72825213_Patient	patientDrug	Paclitaxel
72825213_Patient	patientDrug	Other
72825213_Patient	patientDrug	Pembrolizumab
72825213_Patient	patientDrug	Docetaxel
72825213_Patient	treatmentType	Intravenous_Chemotherapy
72825213_Patient	treatmentType	Immunotherapy
72825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
72825213_Patient	treatmentType	Open_Surgical_Procedure
72825213_Patient	patientDrug	Nivolumab
82825213_Patient	hasGender	Female
82825213_Patient	hasAgeCategory	Young
82825213_Patient	hasStage	IVB
82825213_Patient	hasSmokingHabit	FormerSmoker
82825213_Patient	hasBiomarker	PDL1_Positive
82825213_Patient	hasBiomarker	ALK_Negative
82825213_Patient	hasBiomarker	EGFR_Negative
82825213_Patient	hasBiomarker	ROS1_Negative
82825213_Patient	hasRelapse_Progression	Progression
82825213_Patient	patientDrug	Carboplatin
82825213_Patient	patientDrug	Paclitaxel
82825213_Patient	patientDrug	Other
82825213_Patient	patientDrug	Pembrolizumab
82825213_Patient	patientDrug	Docetaxel
82825213_Patient	treatmentType	Intravenous_Chemotherapy
82825213_Patient	treatmentType	Immunotherapy
82825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
82825213_Patient	treatmentType	Open_Surgical_Procedure
82825213_Patient	patientDrug	Nivolumab
92825213_Patient	hasGender	Female
92825213_Patient	hasAgeCategory	Young
92825213_Patient	hasStage	IVB
92825213_Patient	hasSmokingHabit	FormerSmoker
92825213_Patient	hasBiomarker	PDL1_Positive
92825213_Patient	hasBiomarker	ALK_Negative
92825213_Patient	hasBiomarker	EGFR_Negative
92825213_Patient	hasBiomarker	ROS1_Negative
92825213_Patient	hasRelapse_Progression	Progression
92825213_Patient	patientDrug	Carboplatin
92825213_Patient	patientDrug	Paclitaxel
92825213_Patient	patientDrug	Other
92825213_Patient	patientDrug	Pembrolizumab
92825213_Patient	patientDrug	Docetaxel
92825213_Patient	treatmentType	Intravenous_Chemotherapy
92825213_Patient	treatmentType	Immunotherapy
92825213_Patient	treatmentType	Whole_Brain_Radiation_Therapy
92825213_Patient	treatmentType	Open_Surgical_Procedure
92825213_Patient	patientDrug	Nivolumab
02834441_Patient	hasGender	Male
02834441_Patient	hasAgeCategory	Young
02834441_Patient	hasStage	IVB
02834441_Patient	hasSmokingHabit	CurrentSmoker
02834441_Patient	hasBiomarker	PDL1_Positive
02834441_Patient	hasBiomarker	ALK_Negative
02834441_Patient	hasBiomarker	EGFR_Negative
02834441_Patient	hasBiomarker	KRAS_Negative
02834441_Patient	hasBiomarker	MET_Negative
02834441_Patient	hasBiomarker	RET_Negative
02834441_Patient	hasBiomarker	ROS1_Negative
02834441_Patient	hasRelapse_Progression	Progression
02834441_Patient	patientDrug	Atezolizumab
02834441_Patient	patientDrug	Pemetrexed
02834441_Patient	patientDrug	Cisplatin
02834441_Patient	patientDrug	Gemcitabine
02834441_Patient	patientDrug	Other
02834441_Patient	patientDrug	Docetaxel
02834441_Patient	patientDrug	Nintedanib
02834441_Patient	treatmentType	Intravenous_Chemotherapy
02834441_Patient	treatmentType	Immunotherapy
02834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
02834441_Patient	patientDrug	Nivolumab
12834441_Patient	hasGender	Male
12834441_Patient	hasAgeCategory	Young
12834441_Patient	hasStage	IVB
12834441_Patient	hasSmokingHabit	CurrentSmoker
12834441_Patient	hasBiomarker	PDL1_Positive
12834441_Patient	hasBiomarker	ALK_Negative
12834441_Patient	hasBiomarker	EGFR_Negative
12834441_Patient	hasBiomarker	KRAS_Negative
12834441_Patient	hasBiomarker	MET_Negative
12834441_Patient	hasBiomarker	RET_Negative
12834441_Patient	hasBiomarker	ROS1_Negative
12834441_Patient	hasRelapse_Progression	Progression
12834441_Patient	patientDrug	Atezolizumab
12834441_Patient	patientDrug	Pemetrexed
12834441_Patient	patientDrug	Cisplatin
12834441_Patient	patientDrug	Gemcitabine
12834441_Patient	patientDrug	Other
12834441_Patient	patientDrug	Docetaxel
12834441_Patient	patientDrug	Nintedanib
12834441_Patient	treatmentType	Intravenous_Chemotherapy
12834441_Patient	treatmentType	Immunotherapy
12834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
12834441_Patient	patientDrug	Nivolumab
22834441_Patient	hasGender	Male
22834441_Patient	hasAgeCategory	Young
22834441_Patient	hasStage	IVB
22834441_Patient	hasSmokingHabit	CurrentSmoker
22834441_Patient	hasBiomarker	PDL1_Positive
22834441_Patient	hasBiomarker	ALK_Negative
22834441_Patient	hasBiomarker	EGFR_Negative
22834441_Patient	hasBiomarker	KRAS_Negative
22834441_Patient	hasBiomarker	MET_Negative
22834441_Patient	hasBiomarker	RET_Negative
22834441_Patient	hasBiomarker	ROS1_Negative
22834441_Patient	hasRelapse_Progression	Progression
22834441_Patient	patientDrug	Atezolizumab
22834441_Patient	patientDrug	Pemetrexed
22834441_Patient	patientDrug	Cisplatin
22834441_Patient	patientDrug	Gemcitabine
22834441_Patient	patientDrug	Other
22834441_Patient	patientDrug	Docetaxel
22834441_Patient	patientDrug	Nintedanib
22834441_Patient	treatmentType	Intravenous_Chemotherapy
22834441_Patient	treatmentType	Immunotherapy
22834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
22834441_Patient	patientDrug	Nivolumab
32834441_Patient	hasGender	Male
32834441_Patient	hasAgeCategory	Young
32834441_Patient	hasStage	IVB
32834441_Patient	hasSmokingHabit	CurrentSmoker
32834441_Patient	hasBiomarker	PDL1_Positive
32834441_Patient	hasBiomarker	ALK_Negative
32834441_Patient	hasBiomarker	EGFR_Negative
32834441_Patient	hasBiomarker	KRAS_Negative
32834441_Patient	hasBiomarker	MET_Negative
32834441_Patient	hasBiomarker	RET_Negative
32834441_Patient	hasBiomarker	ROS1_Negative
32834441_Patient	hasRelapse_Progression	Progression
32834441_Patient	patientDrug	Atezolizumab
32834441_Patient	patientDrug	Pemetrexed
32834441_Patient	patientDrug	Cisplatin
32834441_Patient	patientDrug	Gemcitabine
32834441_Patient	patientDrug	Other
32834441_Patient	patientDrug	Docetaxel
32834441_Patient	patientDrug	Nintedanib
32834441_Patient	treatmentType	Intravenous_Chemotherapy
32834441_Patient	treatmentType	Immunotherapy
32834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
32834441_Patient	patientDrug	Nivolumab
42834441_Patient	hasGender	Male
42834441_Patient	hasAgeCategory	Young
42834441_Patient	hasStage	IVB
42834441_Patient	hasSmokingHabit	CurrentSmoker
42834441_Patient	hasBiomarker	PDL1_Positive
42834441_Patient	hasBiomarker	ALK_Negative
42834441_Patient	hasBiomarker	EGFR_Negative
42834441_Patient	hasBiomarker	KRAS_Negative
42834441_Patient	hasBiomarker	MET_Negative
42834441_Patient	hasBiomarker	RET_Negative
42834441_Patient	hasBiomarker	ROS1_Negative
42834441_Patient	hasRelapse_Progression	Progression
42834441_Patient	patientDrug	Atezolizumab
42834441_Patient	patientDrug	Pemetrexed
42834441_Patient	patientDrug	Cisplatin
42834441_Patient	patientDrug	Gemcitabine
42834441_Patient	patientDrug	Other
42834441_Patient	patientDrug	Docetaxel
42834441_Patient	patientDrug	Nintedanib
42834441_Patient	treatmentType	Intravenous_Chemotherapy
42834441_Patient	treatmentType	Immunotherapy
42834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
42834441_Patient	patientDrug	Nivolumab
52834441_Patient	hasGender	Male
52834441_Patient	hasAgeCategory	Young
52834441_Patient	hasStage	IVB
52834441_Patient	hasSmokingHabit	CurrentSmoker
52834441_Patient	hasBiomarker	PDL1_Positive
52834441_Patient	hasBiomarker	ALK_Negative
52834441_Patient	hasBiomarker	EGFR_Negative
52834441_Patient	hasBiomarker	KRAS_Negative
52834441_Patient	hasBiomarker	MET_Negative
52834441_Patient	hasBiomarker	RET_Negative
52834441_Patient	hasBiomarker	ROS1_Negative
52834441_Patient	hasRelapse_Progression	Progression
52834441_Patient	patientDrug	Atezolizumab
52834441_Patient	patientDrug	Pemetrexed
52834441_Patient	patientDrug	Cisplatin
52834441_Patient	patientDrug	Gemcitabine
52834441_Patient	patientDrug	Other
52834441_Patient	patientDrug	Docetaxel
52834441_Patient	patientDrug	Nintedanib
52834441_Patient	treatmentType	Intravenous_Chemotherapy
52834441_Patient	treatmentType	Immunotherapy
52834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
52834441_Patient	patientDrug	Nivolumab
62834441_Patient	hasGender	Male
62834441_Patient	hasAgeCategory	Young
62834441_Patient	hasStage	IVB
62834441_Patient	hasSmokingHabit	CurrentSmoker
62834441_Patient	hasBiomarker	PDL1_Positive
62834441_Patient	hasBiomarker	ALK_Negative
62834441_Patient	hasBiomarker	EGFR_Negative
62834441_Patient	hasBiomarker	KRAS_Negative
62834441_Patient	hasBiomarker	MET_Negative
62834441_Patient	hasBiomarker	RET_Negative
62834441_Patient	hasBiomarker	ROS1_Negative
62834441_Patient	hasRelapse_Progression	Progression
62834441_Patient	patientDrug	Atezolizumab
62834441_Patient	patientDrug	Pemetrexed
62834441_Patient	patientDrug	Cisplatin
62834441_Patient	patientDrug	Gemcitabine
62834441_Patient	patientDrug	Other
62834441_Patient	patientDrug	Docetaxel
62834441_Patient	patientDrug	Nintedanib
62834441_Patient	treatmentType	Intravenous_Chemotherapy
62834441_Patient	treatmentType	Immunotherapy
62834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
62834441_Patient	patientDrug	Nivolumab
72834441_Patient	hasGender	Male
72834441_Patient	hasAgeCategory	Young
72834441_Patient	hasStage	IVB
72834441_Patient	hasSmokingHabit	CurrentSmoker
72834441_Patient	hasBiomarker	PDL1_Positive
72834441_Patient	hasBiomarker	ALK_Negative
72834441_Patient	hasBiomarker	EGFR_Negative
72834441_Patient	hasBiomarker	KRAS_Negative
72834441_Patient	hasBiomarker	MET_Negative
72834441_Patient	hasBiomarker	RET_Negative
72834441_Patient	hasBiomarker	ROS1_Negative
72834441_Patient	hasRelapse_Progression	Progression
72834441_Patient	patientDrug	Atezolizumab
72834441_Patient	patientDrug	Pemetrexed
72834441_Patient	patientDrug	Cisplatin
72834441_Patient	patientDrug	Gemcitabine
72834441_Patient	patientDrug	Other
72834441_Patient	patientDrug	Docetaxel
72834441_Patient	patientDrug	Nintedanib
72834441_Patient	treatmentType	Intravenous_Chemotherapy
72834441_Patient	treatmentType	Immunotherapy
72834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
72834441_Patient	patientDrug	Nivolumab
82834441_Patient	hasGender	Male
82834441_Patient	hasAgeCategory	Young
82834441_Patient	hasStage	IVB
82834441_Patient	hasSmokingHabit	CurrentSmoker
82834441_Patient	hasBiomarker	PDL1_Positive
82834441_Patient	hasBiomarker	ALK_Negative
82834441_Patient	hasBiomarker	EGFR_Negative
82834441_Patient	hasBiomarker	KRAS_Negative
82834441_Patient	hasBiomarker	MET_Negative
82834441_Patient	hasBiomarker	RET_Negative
82834441_Patient	hasBiomarker	ROS1_Negative
82834441_Patient	hasRelapse_Progression	Progression
82834441_Patient	patientDrug	Atezolizumab
82834441_Patient	patientDrug	Pemetrexed
82834441_Patient	patientDrug	Cisplatin
82834441_Patient	patientDrug	Gemcitabine
82834441_Patient	patientDrug	Other
82834441_Patient	patientDrug	Docetaxel
82834441_Patient	patientDrug	Nintedanib
82834441_Patient	treatmentType	Intravenous_Chemotherapy
82834441_Patient	treatmentType	Immunotherapy
82834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
82834441_Patient	patientDrug	Nivolumab
92834441_Patient	hasGender	Male
92834441_Patient	hasAgeCategory	Young
92834441_Patient	hasStage	IVB
92834441_Patient	hasSmokingHabit	CurrentSmoker
92834441_Patient	hasBiomarker	PDL1_Positive
92834441_Patient	hasBiomarker	ALK_Negative
92834441_Patient	hasBiomarker	EGFR_Negative
92834441_Patient	hasBiomarker	KRAS_Negative
92834441_Patient	hasBiomarker	MET_Negative
92834441_Patient	hasBiomarker	RET_Negative
92834441_Patient	hasBiomarker	ROS1_Negative
92834441_Patient	hasRelapse_Progression	Progression
92834441_Patient	patientDrug	Atezolizumab
92834441_Patient	patientDrug	Pemetrexed
92834441_Patient	patientDrug	Cisplatin
92834441_Patient	patientDrug	Gemcitabine
92834441_Patient	patientDrug	Other
92834441_Patient	patientDrug	Docetaxel
92834441_Patient	patientDrug	Nintedanib
92834441_Patient	treatmentType	Intravenous_Chemotherapy
92834441_Patient	treatmentType	Immunotherapy
92834441_Patient	treatmentType	Whole_Brain_Radiation_Therapy
92834441_Patient	patientDrug	Nivolumab
0438540_Patient	hasGender	Male
0438540_Patient	hasAgeCategory	Old
0438540_Patient	hasStage	IVA
0438540_Patient	hasSmokingHabit	FormerSmoker
0438540_Patient	hasBiomarker	EGFR_Positive
0438540_Patient	hasBiomarker	ALK_Negative
0438540_Patient	hasBiomarker	PDL1_Negative
0438540_Patient	hasBiomarker	ROS1_Negative
0438540_Patient	hasRelapse_Progression	Progression
0438540_Patient	patientDrug	Carboplatin
0438540_Patient	patientDrug	Atezolizumab
0438540_Patient	patientDrug	Pemetrexed
0438540_Patient	treatmentType	Intravenous_Chemotherapy
0438540_Patient	treatmentType	Immunotherapy
0438540_Patient	treatmentType	Thoracoscopy
1438540_Patient	hasGender	Male
1438540_Patient	hasAgeCategory	Old
1438540_Patient	hasStage	IVA
1438540_Patient	hasSmokingHabit	FormerSmoker
1438540_Patient	hasBiomarker	EGFR_Positive
1438540_Patient	hasBiomarker	ALK_Negative
1438540_Patient	hasBiomarker	PDL1_Negative
1438540_Patient	hasBiomarker	ROS1_Negative
1438540_Patient	hasRelapse_Progression	Progression
1438540_Patient	patientDrug	Carboplatin
1438540_Patient	patientDrug	Atezolizumab
1438540_Patient	patientDrug	Pemetrexed
1438540_Patient	treatmentType	Intravenous_Chemotherapy
1438540_Patient	treatmentType	Immunotherapy
1438540_Patient	treatmentType	Thoracoscopy
2438540_Patient	hasGender	Male
2438540_Patient	hasAgeCategory	Old
2438540_Patient	hasStage	IVA
2438540_Patient	hasSmokingHabit	FormerSmoker
2438540_Patient	hasBiomarker	EGFR_Positive
2438540_Patient	hasBiomarker	ALK_Negative
2438540_Patient	hasBiomarker	PDL1_Negative
2438540_Patient	hasBiomarker	ROS1_Negative
2438540_Patient	hasRelapse_Progression	Progression
2438540_Patient	patientDrug	Carboplatin
2438540_Patient	patientDrug	Atezolizumab
2438540_Patient	patientDrug	Pemetrexed
2438540_Patient	treatmentType	Intravenous_Chemotherapy
2438540_Patient	treatmentType	Immunotherapy
2438540_Patient	treatmentType	Thoracoscopy
3438540_Patient	hasGender	Male
3438540_Patient	hasAgeCategory	Old
3438540_Patient	hasStage	IVA
3438540_Patient	hasSmokingHabit	FormerSmoker
3438540_Patient	hasBiomarker	EGFR_Positive
3438540_Patient	hasBiomarker	ALK_Negative
3438540_Patient	hasBiomarker	PDL1_Negative
3438540_Patient	hasBiomarker	ROS1_Negative
3438540_Patient	hasRelapse_Progression	Progression
3438540_Patient	patientDrug	Carboplatin
3438540_Patient	patientDrug	Atezolizumab
3438540_Patient	patientDrug	Pemetrexed
3438540_Patient	treatmentType	Intravenous_Chemotherapy
3438540_Patient	treatmentType	Immunotherapy
3438540_Patient	treatmentType	Thoracoscopy
4438540_Patient	hasGender	Male
4438540_Patient	hasAgeCategory	Old
4438540_Patient	hasStage	IVA
4438540_Patient	hasSmokingHabit	FormerSmoker
4438540_Patient	hasBiomarker	EGFR_Positive
4438540_Patient	hasBiomarker	ALK_Negative
4438540_Patient	hasBiomarker	PDL1_Negative
4438540_Patient	hasBiomarker	ROS1_Negative
4438540_Patient	hasRelapse_Progression	Progression
4438540_Patient	patientDrug	Carboplatin
4438540_Patient	patientDrug	Atezolizumab
4438540_Patient	patientDrug	Pemetrexed
4438540_Patient	treatmentType	Intravenous_Chemotherapy
4438540_Patient	treatmentType	Immunotherapy
4438540_Patient	treatmentType	Thoracoscopy
5438540_Patient	hasGender	Male
5438540_Patient	hasAgeCategory	Old
5438540_Patient	hasStage	IVA
5438540_Patient	hasSmokingHabit	FormerSmoker
5438540_Patient	hasBiomarker	EGFR_Positive
5438540_Patient	hasBiomarker	ALK_Negative
5438540_Patient	hasBiomarker	PDL1_Negative
5438540_Patient	hasBiomarker	ROS1_Negative
5438540_Patient	hasRelapse_Progression	Progression
5438540_Patient	patientDrug	Carboplatin
5438540_Patient	patientDrug	Atezolizumab
5438540_Patient	patientDrug	Pemetrexed
5438540_Patient	treatmentType	Intravenous_Chemotherapy
5438540_Patient	treatmentType	Immunotherapy
5438540_Patient	treatmentType	Thoracoscopy
6438540_Patient	hasGender	Male
6438540_Patient	hasAgeCategory	Old
6438540_Patient	hasStage	IVA
6438540_Patient	hasSmokingHabit	FormerSmoker
6438540_Patient	hasBiomarker	EGFR_Positive
6438540_Patient	hasBiomarker	ALK_Negative
6438540_Patient	hasBiomarker	PDL1_Negative
6438540_Patient	hasBiomarker	ROS1_Negative
6438540_Patient	hasRelapse_Progression	Progression
6438540_Patient	patientDrug	Carboplatin
6438540_Patient	patientDrug	Atezolizumab
6438540_Patient	patientDrug	Pemetrexed
6438540_Patient	treatmentType	Intravenous_Chemotherapy
6438540_Patient	treatmentType	Immunotherapy
6438540_Patient	treatmentType	Thoracoscopy
7438540_Patient	hasGender	Male
7438540_Patient	hasAgeCategory	Old
7438540_Patient	hasStage	IVA
7438540_Patient	hasSmokingHabit	FormerSmoker
7438540_Patient	hasBiomarker	EGFR_Positive
7438540_Patient	hasBiomarker	ALK_Negative
7438540_Patient	hasBiomarker	PDL1_Negative
7438540_Patient	hasBiomarker	ROS1_Negative
7438540_Patient	hasRelapse_Progression	Progression
7438540_Patient	patientDrug	Carboplatin
7438540_Patient	patientDrug	Atezolizumab
7438540_Patient	patientDrug	Pemetrexed
7438540_Patient	treatmentType	Intravenous_Chemotherapy
7438540_Patient	treatmentType	Immunotherapy
7438540_Patient	treatmentType	Thoracoscopy
8438540_Patient	hasGender	Male
8438540_Patient	hasAgeCategory	Old
8438540_Patient	hasStage	IVA
8438540_Patient	hasSmokingHabit	FormerSmoker
8438540_Patient	hasBiomarker	EGFR_Positive
8438540_Patient	hasBiomarker	ALK_Negative
8438540_Patient	hasBiomarker	PDL1_Negative
8438540_Patient	hasBiomarker	ROS1_Negative
8438540_Patient	hasRelapse_Progression	Progression
8438540_Patient	patientDrug	Carboplatin
8438540_Patient	patientDrug	Atezolizumab
8438540_Patient	patientDrug	Pemetrexed
8438540_Patient	treatmentType	Intravenous_Chemotherapy
8438540_Patient	treatmentType	Immunotherapy
8438540_Patient	treatmentType	Thoracoscopy
9438540_Patient	hasGender	Male
9438540_Patient	hasAgeCategory	Old
9438540_Patient	hasStage	IVA
9438540_Patient	hasSmokingHabit	FormerSmoker
9438540_Patient	hasBiomarker	EGFR_Positive
9438540_Patient	hasBiomarker	ALK_Negative
9438540_Patient	hasBiomarker	PDL1_Negative
9438540_Patient	hasBiomarker	ROS1_Negative
9438540_Patient	hasRelapse_Progression	Progression
9438540_Patient	patientDrug	Carboplatin
9438540_Patient	patientDrug	Atezolizumab
9438540_Patient	patientDrug	Pemetrexed
9438540_Patient	treatmentType	Intravenous_Chemotherapy
9438540_Patient	treatmentType	Immunotherapy
9438540_Patient	treatmentType	Thoracoscopy
0576411_Patient	hasGender	Female
0576411_Patient	hasAgeCategory	Young
0576411_Patient	hasStage	IIIB
0576411_Patient	hasSmokingHabit	FormerSmoker
0576411_Patient	hasBiomarker	EGFR_Positive
0576411_Patient	hasRelapse_Progression	Progression
0576411_Patient	patientDrug	Paclitaxel
0576411_Patient	patientDrug	Pemetrexed
0576411_Patient	patientDrug	Cisplatin
0576411_Patient	patientDrug	Pembrolizumab
0576411_Patient	treatmentType	Intravenous_Chemotherapy
0576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
0576411_Patient	treatmentType	Immunotherapy
0576411_Patient	treatmentType	Radiotherapy_To_Lung
1576411_Patient	hasGender	Female
1576411_Patient	hasAgeCategory	Young
1576411_Patient	hasStage	IIIB
1576411_Patient	hasSmokingHabit	FormerSmoker
1576411_Patient	hasBiomarker	EGFR_Positive
1576411_Patient	hasRelapse_Progression	Progression
1576411_Patient	patientDrug	Paclitaxel
1576411_Patient	patientDrug	Pemetrexed
1576411_Patient	patientDrug	Cisplatin
1576411_Patient	patientDrug	Pembrolizumab
1576411_Patient	treatmentType	Intravenous_Chemotherapy
1576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
1576411_Patient	treatmentType	Immunotherapy
1576411_Patient	treatmentType	Radiotherapy_To_Lung
2576411_Patient	hasGender	Female
2576411_Patient	hasAgeCategory	Young
2576411_Patient	hasStage	IIIB
2576411_Patient	hasSmokingHabit	FormerSmoker
2576411_Patient	hasBiomarker	EGFR_Positive
2576411_Patient	hasRelapse_Progression	Progression
2576411_Patient	patientDrug	Paclitaxel
2576411_Patient	patientDrug	Pemetrexed
2576411_Patient	patientDrug	Cisplatin
2576411_Patient	patientDrug	Pembrolizumab
2576411_Patient	treatmentType	Intravenous_Chemotherapy
2576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
2576411_Patient	treatmentType	Immunotherapy
2576411_Patient	treatmentType	Radiotherapy_To_Lung
3576411_Patient	hasGender	Female
3576411_Patient	hasAgeCategory	Young
3576411_Patient	hasStage	IIIB
3576411_Patient	hasSmokingHabit	FormerSmoker
3576411_Patient	hasBiomarker	EGFR_Positive
3576411_Patient	hasRelapse_Progression	Progression
3576411_Patient	patientDrug	Paclitaxel
3576411_Patient	patientDrug	Pemetrexed
3576411_Patient	patientDrug	Cisplatin
3576411_Patient	patientDrug	Pembrolizumab
3576411_Patient	treatmentType	Intravenous_Chemotherapy
3576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
3576411_Patient	treatmentType	Immunotherapy
3576411_Patient	treatmentType	Radiotherapy_To_Lung
4576411_Patient	hasGender	Female
4576411_Patient	hasAgeCategory	Young
4576411_Patient	hasStage	IIIB
4576411_Patient	hasSmokingHabit	FormerSmoker
4576411_Patient	hasBiomarker	EGFR_Positive
4576411_Patient	hasRelapse_Progression	Progression
4576411_Patient	patientDrug	Paclitaxel
4576411_Patient	patientDrug	Pemetrexed
4576411_Patient	patientDrug	Cisplatin
4576411_Patient	patientDrug	Pembrolizumab
4576411_Patient	treatmentType	Intravenous_Chemotherapy
4576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
4576411_Patient	treatmentType	Immunotherapy
4576411_Patient	treatmentType	Radiotherapy_To_Lung
5576411_Patient	hasGender	Female
5576411_Patient	hasAgeCategory	Young
5576411_Patient	hasStage	IIIB
5576411_Patient	hasSmokingHabit	FormerSmoker
5576411_Patient	hasBiomarker	EGFR_Positive
5576411_Patient	hasRelapse_Progression	Progression
5576411_Patient	patientDrug	Paclitaxel
5576411_Patient	patientDrug	Pemetrexed
5576411_Patient	patientDrug	Cisplatin
5576411_Patient	patientDrug	Pembrolizumab
5576411_Patient	treatmentType	Intravenous_Chemotherapy
5576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
5576411_Patient	treatmentType	Immunotherapy
5576411_Patient	treatmentType	Radiotherapy_To_Lung
6576411_Patient	hasGender	Female
6576411_Patient	hasAgeCategory	Young
6576411_Patient	hasStage	IIIB
6576411_Patient	hasSmokingHabit	FormerSmoker
6576411_Patient	hasBiomarker	EGFR_Positive
6576411_Patient	hasRelapse_Progression	Progression
6576411_Patient	patientDrug	Paclitaxel
6576411_Patient	patientDrug	Pemetrexed
6576411_Patient	patientDrug	Cisplatin
6576411_Patient	patientDrug	Pembrolizumab
6576411_Patient	treatmentType	Intravenous_Chemotherapy
6576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
6576411_Patient	treatmentType	Immunotherapy
6576411_Patient	treatmentType	Radiotherapy_To_Lung
7576411_Patient	hasGender	Female
7576411_Patient	hasAgeCategory	Young
7576411_Patient	hasStage	IIIB
7576411_Patient	hasSmokingHabit	FormerSmoker
7576411_Patient	hasBiomarker	EGFR_Positive
7576411_Patient	hasRelapse_Progression	Progression
7576411_Patient	patientDrug	Paclitaxel
7576411_Patient	patientDrug	Pemetrexed
7576411_Patient	patientDrug	Cisplatin
7576411_Patient	patientDrug	Pembrolizumab
7576411_Patient	treatmentType	Intravenous_Chemotherapy
7576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
7576411_Patient	treatmentType	Immunotherapy
7576411_Patient	treatmentType	Radiotherapy_To_Lung
8576411_Patient	hasGender	Female
8576411_Patient	hasAgeCategory	Young
8576411_Patient	hasStage	IIIB
8576411_Patient	hasSmokingHabit	FormerSmoker
8576411_Patient	hasBiomarker	EGFR_Positive
8576411_Patient	hasRelapse_Progression	Progression
8576411_Patient	patientDrug	Paclitaxel
8576411_Patient	patientDrug	Pemetrexed
8576411_Patient	patientDrug	Cisplatin
8576411_Patient	patientDrug	Pembrolizumab
8576411_Patient	treatmentType	Intravenous_Chemotherapy
8576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
8576411_Patient	treatmentType	Immunotherapy
8576411_Patient	treatmentType	Radiotherapy_To_Lung
9576411_Patient	hasGender	Female
9576411_Patient	hasAgeCategory	Young
9576411_Patient	hasStage	IIIB
9576411_Patient	hasSmokingHabit	FormerSmoker
9576411_Patient	hasBiomarker	EGFR_Positive
9576411_Patient	hasRelapse_Progression	Progression
9576411_Patient	patientDrug	Paclitaxel
9576411_Patient	patientDrug	Pemetrexed
9576411_Patient	patientDrug	Cisplatin
9576411_Patient	patientDrug	Pembrolizumab
9576411_Patient	treatmentType	Intravenous_Chemotherapy
9576411_Patient	treatmentType	Concurrent_Chemoradiotherapy
9576411_Patient	treatmentType	Immunotherapy
9576411_Patient	treatmentType	Radiotherapy_To_Lung
0583611_Patient	hasGender	Female
0583611_Patient	hasAgeCategory	Old
0583611_Patient	hasStage	IIIC
0583611_Patient	hasSmokingHabit	CurrentSmoker
0583611_Patient	hasBiomarker	EGFR_Positive
0583611_Patient	hasBiomarker	PDL1_Positive
0583611_Patient	hasBiomarker	ALK_Negative
0583611_Patient	hasBiomarker	ROS1_Negative
0583611_Patient	hasRelapse_Progression	No_Progression
0583611_Patient	patientDrug	Carboplatin
0583611_Patient	patientDrug	Vinorelbine
0583611_Patient	patientDrug	Durvalumab
0583611_Patient	treatmentType	Intravenous_Chemotherapy
0583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
0583611_Patient	treatmentType	Immunotherapy
0583611_Patient	treatmentType	Radiotherapy_To_Lung
1583611_Patient	hasGender	Female
1583611_Patient	hasAgeCategory	Old
1583611_Patient	hasStage	IIIC
1583611_Patient	hasSmokingHabit	CurrentSmoker
1583611_Patient	hasBiomarker	EGFR_Positive
1583611_Patient	hasBiomarker	PDL1_Positive
1583611_Patient	hasBiomarker	ALK_Negative
1583611_Patient	hasBiomarker	ROS1_Negative
1583611_Patient	hasRelapse_Progression	No_Progression
1583611_Patient	patientDrug	Carboplatin
1583611_Patient	patientDrug	Vinorelbine
1583611_Patient	patientDrug	Durvalumab
1583611_Patient	treatmentType	Intravenous_Chemotherapy
1583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
1583611_Patient	treatmentType	Immunotherapy
1583611_Patient	treatmentType	Radiotherapy_To_Lung
2583611_Patient	hasGender	Female
2583611_Patient	hasAgeCategory	Old
2583611_Patient	hasStage	IIIC
2583611_Patient	hasSmokingHabit	CurrentSmoker
2583611_Patient	hasBiomarker	EGFR_Positive
2583611_Patient	hasBiomarker	PDL1_Positive
2583611_Patient	hasBiomarker	ALK_Negative
2583611_Patient	hasBiomarker	ROS1_Negative
2583611_Patient	hasRelapse_Progression	No_Progression
2583611_Patient	patientDrug	Carboplatin
2583611_Patient	patientDrug	Vinorelbine
2583611_Patient	patientDrug	Durvalumab
2583611_Patient	treatmentType	Intravenous_Chemotherapy
2583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
2583611_Patient	treatmentType	Immunotherapy
2583611_Patient	treatmentType	Radiotherapy_To_Lung
3583611_Patient	hasGender	Female
3583611_Patient	hasAgeCategory	Old
3583611_Patient	hasStage	IIIC
3583611_Patient	hasSmokingHabit	CurrentSmoker
3583611_Patient	hasBiomarker	EGFR_Positive
3583611_Patient	hasBiomarker	PDL1_Positive
3583611_Patient	hasBiomarker	ALK_Negative
3583611_Patient	hasBiomarker	ROS1_Negative
3583611_Patient	hasRelapse_Progression	No_Progression
3583611_Patient	patientDrug	Carboplatin
3583611_Patient	patientDrug	Vinorelbine
3583611_Patient	patientDrug	Durvalumab
3583611_Patient	treatmentType	Intravenous_Chemotherapy
3583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
3583611_Patient	treatmentType	Immunotherapy
3583611_Patient	treatmentType	Radiotherapy_To_Lung
4583611_Patient	hasGender	Female
4583611_Patient	hasAgeCategory	Old
4583611_Patient	hasStage	IIIC
4583611_Patient	hasSmokingHabit	CurrentSmoker
4583611_Patient	hasBiomarker	EGFR_Positive
4583611_Patient	hasBiomarker	PDL1_Positive
4583611_Patient	hasBiomarker	ALK_Negative
4583611_Patient	hasBiomarker	ROS1_Negative
4583611_Patient	hasRelapse_Progression	No_Progression
4583611_Patient	patientDrug	Carboplatin
4583611_Patient	patientDrug	Vinorelbine
4583611_Patient	patientDrug	Durvalumab
4583611_Patient	treatmentType	Intravenous_Chemotherapy
4583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
4583611_Patient	treatmentType	Immunotherapy
4583611_Patient	treatmentType	Radiotherapy_To_Lung
5583611_Patient	hasGender	Female
5583611_Patient	hasAgeCategory	Old
5583611_Patient	hasStage	IIIC
5583611_Patient	hasSmokingHabit	CurrentSmoker
5583611_Patient	hasBiomarker	EGFR_Positive
5583611_Patient	hasBiomarker	PDL1_Positive
5583611_Patient	hasBiomarker	ALK_Negative
5583611_Patient	hasBiomarker	ROS1_Negative
5583611_Patient	hasRelapse_Progression	No_Progression
5583611_Patient	patientDrug	Carboplatin
5583611_Patient	patientDrug	Vinorelbine
5583611_Patient	patientDrug	Durvalumab
5583611_Patient	treatmentType	Intravenous_Chemotherapy
5583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
5583611_Patient	treatmentType	Immunotherapy
5583611_Patient	treatmentType	Radiotherapy_To_Lung
6583611_Patient	hasGender	Female
6583611_Patient	hasAgeCategory	Old
6583611_Patient	hasStage	IIIC
6583611_Patient	hasSmokingHabit	CurrentSmoker
6583611_Patient	hasBiomarker	EGFR_Positive
6583611_Patient	hasBiomarker	PDL1_Positive
6583611_Patient	hasBiomarker	ALK_Negative
6583611_Patient	hasBiomarker	ROS1_Negative
6583611_Patient	hasRelapse_Progression	No_Progression
6583611_Patient	patientDrug	Carboplatin
6583611_Patient	patientDrug	Vinorelbine
6583611_Patient	patientDrug	Durvalumab
6583611_Patient	treatmentType	Intravenous_Chemotherapy
6583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
6583611_Patient	treatmentType	Immunotherapy
6583611_Patient	treatmentType	Radiotherapy_To_Lung
7583611_Patient	hasGender	Female
7583611_Patient	hasAgeCategory	Old
7583611_Patient	hasStage	IIIC
7583611_Patient	hasSmokingHabit	CurrentSmoker
7583611_Patient	hasBiomarker	EGFR_Positive
7583611_Patient	hasBiomarker	PDL1_Positive
7583611_Patient	hasBiomarker	ALK_Negative
7583611_Patient	hasBiomarker	ROS1_Negative
7583611_Patient	hasRelapse_Progression	No_Progression
7583611_Patient	patientDrug	Carboplatin
7583611_Patient	patientDrug	Vinorelbine
7583611_Patient	patientDrug	Durvalumab
7583611_Patient	treatmentType	Intravenous_Chemotherapy
7583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
7583611_Patient	treatmentType	Immunotherapy
7583611_Patient	treatmentType	Radiotherapy_To_Lung
8583611_Patient	hasGender	Female
8583611_Patient	hasAgeCategory	Old
8583611_Patient	hasStage	IIIC
8583611_Patient	hasSmokingHabit	CurrentSmoker
8583611_Patient	hasBiomarker	EGFR_Positive
8583611_Patient	hasBiomarker	PDL1_Positive
8583611_Patient	hasBiomarker	ALK_Negative
8583611_Patient	hasBiomarker	ROS1_Negative
8583611_Patient	hasRelapse_Progression	No_Progression
8583611_Patient	patientDrug	Carboplatin
8583611_Patient	patientDrug	Vinorelbine
8583611_Patient	patientDrug	Durvalumab
8583611_Patient	treatmentType	Intravenous_Chemotherapy
8583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
8583611_Patient	treatmentType	Immunotherapy
8583611_Patient	treatmentType	Radiotherapy_To_Lung
9583611_Patient	hasGender	Female
9583611_Patient	hasAgeCategory	Old
9583611_Patient	hasStage	IIIC
9583611_Patient	hasSmokingHabit	CurrentSmoker
9583611_Patient	hasBiomarker	EGFR_Positive
9583611_Patient	hasBiomarker	PDL1_Positive
9583611_Patient	hasBiomarker	ALK_Negative
9583611_Patient	hasBiomarker	ROS1_Negative
9583611_Patient	hasRelapse_Progression	No_Progression
9583611_Patient	patientDrug	Carboplatin
9583611_Patient	patientDrug	Vinorelbine
9583611_Patient	patientDrug	Durvalumab
9583611_Patient	treatmentType	Intravenous_Chemotherapy
9583611_Patient	treatmentType	Concurrent_Chemoradiotherapy
9583611_Patient	treatmentType	Immunotherapy
9583611_Patient	treatmentType	Radiotherapy_To_Lung
0619371_Patient	hasGender	Female
0619371_Patient	hasAgeCategory	Young
0619371_Patient	hasStage	IVB
0619371_Patient	hasSmokingHabit	CurrentSmoker
0619371_Patient	hasBiomarker	EGFR_Positive
0619371_Patient	hasBiomarker	PDL1_Positive
0619371_Patient	hasBiomarker	ALK_Negative
0619371_Patient	hasBiomarker	ROS1_Negative
0619371_Patient	hasRelapse_Progression	Progression
0619371_Patient	patientDrug	Carboplatin
0619371_Patient	patientDrug	Pemetrexed
0619371_Patient	patientDrug	Pembrolizumab
0619371_Patient	patientDrug	Docetaxel
0619371_Patient	treatmentType	Intravenous_Chemotherapy
0619371_Patient	treatmentType	Immunotherapy
0619371_Patient	treatmentType	Radiotherapy_To_Lung
0619371_Patient	treatmentType	Radiotherapy_To_Bone
1619371_Patient	hasGender	Female
1619371_Patient	hasAgeCategory	Young
1619371_Patient	hasStage	IVB
1619371_Patient	hasSmokingHabit	CurrentSmoker
1619371_Patient	hasBiomarker	EGFR_Positive
1619371_Patient	hasBiomarker	PDL1_Positive
1619371_Patient	hasBiomarker	ALK_Negative
1619371_Patient	hasBiomarker	ROS1_Negative
1619371_Patient	hasRelapse_Progression	Progression
1619371_Patient	patientDrug	Carboplatin
1619371_Patient	patientDrug	Pemetrexed
1619371_Patient	patientDrug	Pembrolizumab
1619371_Patient	patientDrug	Docetaxel
1619371_Patient	treatmentType	Intravenous_Chemotherapy
1619371_Patient	treatmentType	Immunotherapy
1619371_Patient	treatmentType	Radiotherapy_To_Lung
1619371_Patient	treatmentType	Radiotherapy_To_Bone
2619371_Patient	hasGender	Female
2619371_Patient	hasAgeCategory	Young
2619371_Patient	hasStage	IVB
2619371_Patient	hasSmokingHabit	CurrentSmoker
2619371_Patient	hasBiomarker	EGFR_Positive
2619371_Patient	hasBiomarker	PDL1_Positive
2619371_Patient	hasBiomarker	ALK_Negative
2619371_Patient	hasBiomarker	ROS1_Negative
2619371_Patient	hasRelapse_Progression	Progression
2619371_Patient	patientDrug	Carboplatin
2619371_Patient	patientDrug	Pemetrexed
2619371_Patient	patientDrug	Pembrolizumab
2619371_Patient	patientDrug	Docetaxel
2619371_Patient	treatmentType	Intravenous_Chemotherapy
2619371_Patient	treatmentType	Immunotherapy
2619371_Patient	treatmentType	Radiotherapy_To_Lung
2619371_Patient	treatmentType	Radiotherapy_To_Bone
3619371_Patient	hasGender	Female
3619371_Patient	hasAgeCategory	Young
3619371_Patient	hasStage	IVB
3619371_Patient	hasSmokingHabit	CurrentSmoker
3619371_Patient	hasBiomarker	EGFR_Positive
3619371_Patient	hasBiomarker	PDL1_Positive
3619371_Patient	hasBiomarker	ALK_Negative
3619371_Patient	hasBiomarker	ROS1_Negative
3619371_Patient	hasRelapse_Progression	Progression
3619371_Patient	patientDrug	Carboplatin
3619371_Patient	patientDrug	Pemetrexed
3619371_Patient	patientDrug	Pembrolizumab
3619371_Patient	patientDrug	Docetaxel
3619371_Patient	treatmentType	Intravenous_Chemotherapy
3619371_Patient	treatmentType	Immunotherapy
3619371_Patient	treatmentType	Radiotherapy_To_Lung
3619371_Patient	treatmentType	Radiotherapy_To_Bone
4619371_Patient	hasGender	Female
4619371_Patient	hasAgeCategory	Young
4619371_Patient	hasStage	IVB
4619371_Patient	hasSmokingHabit	CurrentSmoker
4619371_Patient	hasBiomarker	EGFR_Positive
4619371_Patient	hasBiomarker	PDL1_Positive
4619371_Patient	hasBiomarker	ALK_Negative
4619371_Patient	hasBiomarker	ROS1_Negative
4619371_Patient	hasRelapse_Progression	Progression
4619371_Patient	patientDrug	Carboplatin
4619371_Patient	patientDrug	Pemetrexed
4619371_Patient	patientDrug	Pembrolizumab
4619371_Patient	patientDrug	Docetaxel
4619371_Patient	treatmentType	Intravenous_Chemotherapy
4619371_Patient	treatmentType	Immunotherapy
4619371_Patient	treatmentType	Radiotherapy_To_Lung
4619371_Patient	treatmentType	Radiotherapy_To_Bone
5619371_Patient	hasGender	Female
5619371_Patient	hasAgeCategory	Young
5619371_Patient	hasStage	IVB
5619371_Patient	hasSmokingHabit	CurrentSmoker
5619371_Patient	hasBiomarker	EGFR_Positive
5619371_Patient	hasBiomarker	PDL1_Positive
5619371_Patient	hasBiomarker	ALK_Negative
5619371_Patient	hasBiomarker	ROS1_Negative
5619371_Patient	hasRelapse_Progression	Progression
5619371_Patient	patientDrug	Carboplatin
5619371_Patient	patientDrug	Pemetrexed
5619371_Patient	patientDrug	Pembrolizumab
5619371_Patient	patientDrug	Docetaxel
5619371_Patient	treatmentType	Intravenous_Chemotherapy
5619371_Patient	treatmentType	Immunotherapy
5619371_Patient	treatmentType	Radiotherapy_To_Lung
5619371_Patient	treatmentType	Radiotherapy_To_Bone
6619371_Patient	hasGender	Female
6619371_Patient	hasAgeCategory	Young
6619371_Patient	hasStage	IVB
6619371_Patient	hasSmokingHabit	CurrentSmoker
6619371_Patient	hasBiomarker	EGFR_Positive
6619371_Patient	hasBiomarker	PDL1_Positive
6619371_Patient	hasBiomarker	ALK_Negative
6619371_Patient	hasBiomarker	ROS1_Negative
6619371_Patient	hasRelapse_Progression	Progression
6619371_Patient	patientDrug	Carboplatin
6619371_Patient	patientDrug	Pemetrexed
6619371_Patient	patientDrug	Pembrolizumab
6619371_Patient	patientDrug	Docetaxel
6619371_Patient	treatmentType	Intravenous_Chemotherapy
6619371_Patient	treatmentType	Immunotherapy
6619371_Patient	treatmentType	Radiotherapy_To_Lung
6619371_Patient	treatmentType	Radiotherapy_To_Bone
7619371_Patient	hasGender	Female
7619371_Patient	hasAgeCategory	Young
7619371_Patient	hasStage	IVB
7619371_Patient	hasSmokingHabit	CurrentSmoker
7619371_Patient	hasBiomarker	EGFR_Positive
7619371_Patient	hasBiomarker	PDL1_Positive
7619371_Patient	hasBiomarker	ALK_Negative
7619371_Patient	hasBiomarker	ROS1_Negative
7619371_Patient	hasRelapse_Progression	Progression
7619371_Patient	patientDrug	Carboplatin
7619371_Patient	patientDrug	Pemetrexed
7619371_Patient	patientDrug	Pembrolizumab
7619371_Patient	patientDrug	Docetaxel
7619371_Patient	treatmentType	Intravenous_Chemotherapy
7619371_Patient	treatmentType	Immunotherapy
7619371_Patient	treatmentType	Radiotherapy_To_Lung
7619371_Patient	treatmentType	Radiotherapy_To_Bone
8619371_Patient	hasGender	Female
8619371_Patient	hasAgeCategory	Young
8619371_Patient	hasStage	IVB
8619371_Patient	hasSmokingHabit	CurrentSmoker
8619371_Patient	hasBiomarker	EGFR_Positive
8619371_Patient	hasBiomarker	PDL1_Positive
8619371_Patient	hasBiomarker	ALK_Negative
8619371_Patient	hasBiomarker	ROS1_Negative
8619371_Patient	hasRelapse_Progression	Progression
8619371_Patient	patientDrug	Carboplatin
8619371_Patient	patientDrug	Pemetrexed
8619371_Patient	patientDrug	Pembrolizumab
8619371_Patient	patientDrug	Docetaxel
8619371_Patient	treatmentType	Intravenous_Chemotherapy
8619371_Patient	treatmentType	Immunotherapy
8619371_Patient	treatmentType	Radiotherapy_To_Lung
8619371_Patient	treatmentType	Radiotherapy_To_Bone
9619371_Patient	hasGender	Female
9619371_Patient	hasAgeCategory	Young
9619371_Patient	hasStage	IVB
9619371_Patient	hasSmokingHabit	CurrentSmoker
9619371_Patient	hasBiomarker	EGFR_Positive
9619371_Patient	hasBiomarker	PDL1_Positive
9619371_Patient	hasBiomarker	ALK_Negative
9619371_Patient	hasBiomarker	ROS1_Negative
9619371_Patient	hasRelapse_Progression	Progression
9619371_Patient	patientDrug	Carboplatin
9619371_Patient	patientDrug	Pemetrexed
9619371_Patient	patientDrug	Pembrolizumab
9619371_Patient	patientDrug	Docetaxel
9619371_Patient	treatmentType	Intravenous_Chemotherapy
9619371_Patient	treatmentType	Immunotherapy
9619371_Patient	treatmentType	Radiotherapy_To_Lung
9619371_Patient	treatmentType	Radiotherapy_To_Bone
0623804_Patient	hasGender	Female
0623804_Patient	hasAgeCategory	Young
0623804_Patient	hasStage	IVB
0623804_Patient	hasSmokingHabit	CurrentSmoker
0623804_Patient	hasBiomarker	PDL1_Positive
0623804_Patient	hasBiomarker	ALK_Negative
0623804_Patient	hasBiomarker	EGFR_Negative
0623804_Patient	hasBiomarker	ROS1_Negative
0623804_Patient	hasRelapse_Progression	Progression
0623804_Patient	patientDrug	Atezolizumab
0623804_Patient	patientDrug	Pemetrexed
0623804_Patient	patientDrug	Cisplatin
0623804_Patient	patientDrug	Vinorelbine
0623804_Patient	patientDrug	Docetaxel
0623804_Patient	treatmentType	Intravenous_Chemotherapy
0623804_Patient	treatmentType	Immunotherapy
0623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
0623804_Patient	treatmentType	Radiotherapy_To_Bone
1623804_Patient	hasGender	Female
1623804_Patient	hasAgeCategory	Young
1623804_Patient	hasStage	IVB
1623804_Patient	hasSmokingHabit	CurrentSmoker
1623804_Patient	hasBiomarker	PDL1_Positive
1623804_Patient	hasBiomarker	ALK_Negative
1623804_Patient	hasBiomarker	EGFR_Negative
1623804_Patient	hasBiomarker	ROS1_Negative
1623804_Patient	hasRelapse_Progression	Progression
1623804_Patient	patientDrug	Atezolizumab
1623804_Patient	patientDrug	Pemetrexed
1623804_Patient	patientDrug	Cisplatin
1623804_Patient	patientDrug	Vinorelbine
1623804_Patient	patientDrug	Docetaxel
1623804_Patient	treatmentType	Intravenous_Chemotherapy
1623804_Patient	treatmentType	Immunotherapy
1623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1623804_Patient	treatmentType	Radiotherapy_To_Bone
2623804_Patient	hasGender	Female
2623804_Patient	hasAgeCategory	Young
2623804_Patient	hasStage	IVB
2623804_Patient	hasSmokingHabit	CurrentSmoker
2623804_Patient	hasBiomarker	PDL1_Positive
2623804_Patient	hasBiomarker	ALK_Negative
2623804_Patient	hasBiomarker	EGFR_Negative
2623804_Patient	hasBiomarker	ROS1_Negative
2623804_Patient	hasRelapse_Progression	Progression
2623804_Patient	patientDrug	Atezolizumab
2623804_Patient	patientDrug	Pemetrexed
2623804_Patient	patientDrug	Cisplatin
2623804_Patient	patientDrug	Vinorelbine
2623804_Patient	patientDrug	Docetaxel
2623804_Patient	treatmentType	Intravenous_Chemotherapy
2623804_Patient	treatmentType	Immunotherapy
2623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2623804_Patient	treatmentType	Radiotherapy_To_Bone
3623804_Patient	hasGender	Female
3623804_Patient	hasAgeCategory	Young
3623804_Patient	hasStage	IVB
3623804_Patient	hasSmokingHabit	CurrentSmoker
3623804_Patient	hasBiomarker	PDL1_Positive
3623804_Patient	hasBiomarker	ALK_Negative
3623804_Patient	hasBiomarker	EGFR_Negative
3623804_Patient	hasBiomarker	ROS1_Negative
3623804_Patient	hasRelapse_Progression	Progression
3623804_Patient	patientDrug	Atezolizumab
3623804_Patient	patientDrug	Pemetrexed
3623804_Patient	patientDrug	Cisplatin
3623804_Patient	patientDrug	Vinorelbine
3623804_Patient	patientDrug	Docetaxel
3623804_Patient	treatmentType	Intravenous_Chemotherapy
3623804_Patient	treatmentType	Immunotherapy
3623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
3623804_Patient	treatmentType	Radiotherapy_To_Bone
4623804_Patient	hasGender	Female
4623804_Patient	hasAgeCategory	Young
4623804_Patient	hasStage	IVB
4623804_Patient	hasSmokingHabit	CurrentSmoker
4623804_Patient	hasBiomarker	PDL1_Positive
4623804_Patient	hasBiomarker	ALK_Negative
4623804_Patient	hasBiomarker	EGFR_Negative
4623804_Patient	hasBiomarker	ROS1_Negative
4623804_Patient	hasRelapse_Progression	Progression
4623804_Patient	patientDrug	Atezolizumab
4623804_Patient	patientDrug	Pemetrexed
4623804_Patient	patientDrug	Cisplatin
4623804_Patient	patientDrug	Vinorelbine
4623804_Patient	patientDrug	Docetaxel
4623804_Patient	treatmentType	Intravenous_Chemotherapy
4623804_Patient	treatmentType	Immunotherapy
4623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
4623804_Patient	treatmentType	Radiotherapy_To_Bone
5623804_Patient	hasGender	Female
5623804_Patient	hasAgeCategory	Young
5623804_Patient	hasStage	IVB
5623804_Patient	hasSmokingHabit	CurrentSmoker
5623804_Patient	hasBiomarker	PDL1_Positive
5623804_Patient	hasBiomarker	ALK_Negative
5623804_Patient	hasBiomarker	EGFR_Negative
5623804_Patient	hasBiomarker	ROS1_Negative
5623804_Patient	hasRelapse_Progression	Progression
5623804_Patient	patientDrug	Atezolizumab
5623804_Patient	patientDrug	Pemetrexed
5623804_Patient	patientDrug	Cisplatin
5623804_Patient	patientDrug	Vinorelbine
5623804_Patient	patientDrug	Docetaxel
5623804_Patient	treatmentType	Intravenous_Chemotherapy
5623804_Patient	treatmentType	Immunotherapy
5623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
5623804_Patient	treatmentType	Radiotherapy_To_Bone
6623804_Patient	hasGender	Female
6623804_Patient	hasAgeCategory	Young
6623804_Patient	hasStage	IVB
6623804_Patient	hasSmokingHabit	CurrentSmoker
6623804_Patient	hasBiomarker	PDL1_Positive
6623804_Patient	hasBiomarker	ALK_Negative
6623804_Patient	hasBiomarker	EGFR_Negative
6623804_Patient	hasBiomarker	ROS1_Negative
6623804_Patient	hasRelapse_Progression	Progression
6623804_Patient	patientDrug	Atezolizumab
6623804_Patient	patientDrug	Pemetrexed
6623804_Patient	patientDrug	Cisplatin
6623804_Patient	patientDrug	Vinorelbine
6623804_Patient	patientDrug	Docetaxel
6623804_Patient	treatmentType	Intravenous_Chemotherapy
6623804_Patient	treatmentType	Immunotherapy
6623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
6623804_Patient	treatmentType	Radiotherapy_To_Bone
7623804_Patient	hasGender	Female
7623804_Patient	hasAgeCategory	Young
7623804_Patient	hasStage	IVB
7623804_Patient	hasSmokingHabit	CurrentSmoker
7623804_Patient	hasBiomarker	PDL1_Positive
7623804_Patient	hasBiomarker	ALK_Negative
7623804_Patient	hasBiomarker	EGFR_Negative
7623804_Patient	hasBiomarker	ROS1_Negative
7623804_Patient	hasRelapse_Progression	Progression
7623804_Patient	patientDrug	Atezolizumab
7623804_Patient	patientDrug	Pemetrexed
7623804_Patient	patientDrug	Cisplatin
7623804_Patient	patientDrug	Vinorelbine
7623804_Patient	patientDrug	Docetaxel
7623804_Patient	treatmentType	Intravenous_Chemotherapy
7623804_Patient	treatmentType	Immunotherapy
7623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
7623804_Patient	treatmentType	Radiotherapy_To_Bone
8623804_Patient	hasGender	Female
8623804_Patient	hasAgeCategory	Young
8623804_Patient	hasStage	IVB
8623804_Patient	hasSmokingHabit	CurrentSmoker
8623804_Patient	hasBiomarker	PDL1_Positive
8623804_Patient	hasBiomarker	ALK_Negative
8623804_Patient	hasBiomarker	EGFR_Negative
8623804_Patient	hasBiomarker	ROS1_Negative
8623804_Patient	hasRelapse_Progression	Progression
8623804_Patient	patientDrug	Atezolizumab
8623804_Patient	patientDrug	Pemetrexed
8623804_Patient	patientDrug	Cisplatin
8623804_Patient	patientDrug	Vinorelbine
8623804_Patient	patientDrug	Docetaxel
8623804_Patient	treatmentType	Intravenous_Chemotherapy
8623804_Patient	treatmentType	Immunotherapy
8623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
8623804_Patient	treatmentType	Radiotherapy_To_Bone
9623804_Patient	hasGender	Female
9623804_Patient	hasAgeCategory	Young
9623804_Patient	hasStage	IVB
9623804_Patient	hasSmokingHabit	CurrentSmoker
9623804_Patient	hasBiomarker	PDL1_Positive
9623804_Patient	hasBiomarker	ALK_Negative
9623804_Patient	hasBiomarker	EGFR_Negative
9623804_Patient	hasBiomarker	ROS1_Negative
9623804_Patient	hasRelapse_Progression	Progression
9623804_Patient	patientDrug	Atezolizumab
9623804_Patient	patientDrug	Pemetrexed
9623804_Patient	patientDrug	Cisplatin
9623804_Patient	patientDrug	Vinorelbine
9623804_Patient	patientDrug	Docetaxel
9623804_Patient	treatmentType	Intravenous_Chemotherapy
9623804_Patient	treatmentType	Immunotherapy
9623804_Patient	treatmentType	Whole_Brain_Radiation_Therapy
9623804_Patient	treatmentType	Radiotherapy_To_Bone
0810098_Patient	hasGender	Female
0810098_Patient	hasAgeCategory	Young
0810098_Patient	hasStage	IIIA
0810098_Patient	hasSmokingHabit	FormerSmoker
0810098_Patient	hasBiomarker	EGFR_Positive
0810098_Patient	hasRelapse_Progression	Progression
0810098_Patient	patientDrug	Carboplatin
0810098_Patient	patientDrug	Atezolizumab
0810098_Patient	patientDrug	Pemetrexed
0810098_Patient	patientDrug	Vinorelbine
0810098_Patient	patientDrug	Other
0810098_Patient	patientDrug	Docetaxel
0810098_Patient	treatmentType	Intravenous_Chemotherapy
0810098_Patient	treatmentType	Chemotherapy_Adjuvant
0810098_Patient	treatmentType	Molecular_Targeted_Therapy
0810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
0810098_Patient	treatmentType	Immunotherapy
0810098_Patient	treatmentType	Radiotherapy_To_Lung
0810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
0810098_Patient	treatmentType	Open_Surgical_Procedure
1810098_Patient	hasGender	Female
1810098_Patient	hasAgeCategory	Young
1810098_Patient	hasStage	IIIA
1810098_Patient	hasSmokingHabit	FormerSmoker
1810098_Patient	hasBiomarker	EGFR_Positive
1810098_Patient	hasRelapse_Progression	Progression
1810098_Patient	patientDrug	Carboplatin
1810098_Patient	patientDrug	Atezolizumab
1810098_Patient	patientDrug	Pemetrexed
1810098_Patient	patientDrug	Vinorelbine
1810098_Patient	patientDrug	Other
1810098_Patient	patientDrug	Docetaxel
1810098_Patient	treatmentType	Intravenous_Chemotherapy
1810098_Patient	treatmentType	Chemotherapy_Adjuvant
1810098_Patient	treatmentType	Molecular_Targeted_Therapy
1810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
1810098_Patient	treatmentType	Immunotherapy
1810098_Patient	treatmentType	Radiotherapy_To_Lung
1810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
1810098_Patient	treatmentType	Open_Surgical_Procedure
2810098_Patient	hasGender	Female
2810098_Patient	hasAgeCategory	Young
2810098_Patient	hasStage	IIIA
2810098_Patient	hasSmokingHabit	FormerSmoker
2810098_Patient	hasBiomarker	EGFR_Positive
2810098_Patient	hasRelapse_Progression	Progression
2810098_Patient	patientDrug	Carboplatin
2810098_Patient	patientDrug	Atezolizumab
2810098_Patient	patientDrug	Pemetrexed
2810098_Patient	patientDrug	Vinorelbine
2810098_Patient	patientDrug	Other
2810098_Patient	patientDrug	Docetaxel
2810098_Patient	treatmentType	Intravenous_Chemotherapy
2810098_Patient	treatmentType	Chemotherapy_Adjuvant
2810098_Patient	treatmentType	Molecular_Targeted_Therapy
2810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
2810098_Patient	treatmentType	Immunotherapy
2810098_Patient	treatmentType	Radiotherapy_To_Lung
2810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
2810098_Patient	treatmentType	Open_Surgical_Procedure
3810098_Patient	hasGender	Female
3810098_Patient	hasAgeCategory	Young
3810098_Patient	hasStage	IIIA
3810098_Patient	hasSmokingHabit	FormerSmoker
3810098_Patient	hasBiomarker	EGFR_Positive
3810098_Patient	hasRelapse_Progression	Progression
3810098_Patient	patientDrug	Carboplatin
3810098_Patient	patientDrug	Atezolizumab
3810098_Patient	patientDrug	Pemetrexed
3810098_Patient	patientDrug	Vinorelbine
3810098_Patient	patientDrug	Other
3810098_Patient	patientDrug	Docetaxel
3810098_Patient	treatmentType	Intravenous_Chemotherapy
3810098_Patient	treatmentType	Chemotherapy_Adjuvant
3810098_Patient	treatmentType	Molecular_Targeted_Therapy
3810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
3810098_Patient	treatmentType	Immunotherapy
3810098_Patient	treatmentType	Radiotherapy_To_Lung
3810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
3810098_Patient	treatmentType	Open_Surgical_Procedure
4810098_Patient	hasGender	Female
4810098_Patient	hasAgeCategory	Young
4810098_Patient	hasStage	IIIA
4810098_Patient	hasSmokingHabit	FormerSmoker
4810098_Patient	hasBiomarker	EGFR_Positive
4810098_Patient	hasRelapse_Progression	Progression
4810098_Patient	patientDrug	Carboplatin
4810098_Patient	patientDrug	Atezolizumab
4810098_Patient	patientDrug	Pemetrexed
4810098_Patient	patientDrug	Vinorelbine
4810098_Patient	patientDrug	Other
4810098_Patient	patientDrug	Docetaxel
4810098_Patient	treatmentType	Intravenous_Chemotherapy
4810098_Patient	treatmentType	Chemotherapy_Adjuvant
4810098_Patient	treatmentType	Molecular_Targeted_Therapy
4810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
4810098_Patient	treatmentType	Immunotherapy
4810098_Patient	treatmentType	Radiotherapy_To_Lung
4810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
4810098_Patient	treatmentType	Open_Surgical_Procedure
5810098_Patient	hasGender	Female
5810098_Patient	hasAgeCategory	Young
5810098_Patient	hasStage	IIIA
5810098_Patient	hasSmokingHabit	FormerSmoker
5810098_Patient	hasBiomarker	EGFR_Positive
5810098_Patient	hasRelapse_Progression	Progression
5810098_Patient	patientDrug	Carboplatin
5810098_Patient	patientDrug	Atezolizumab
5810098_Patient	patientDrug	Pemetrexed
5810098_Patient	patientDrug	Vinorelbine
5810098_Patient	patientDrug	Other
5810098_Patient	patientDrug	Docetaxel
5810098_Patient	treatmentType	Intravenous_Chemotherapy
5810098_Patient	treatmentType	Chemotherapy_Adjuvant
5810098_Patient	treatmentType	Molecular_Targeted_Therapy
5810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
5810098_Patient	treatmentType	Immunotherapy
5810098_Patient	treatmentType	Radiotherapy_To_Lung
5810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
5810098_Patient	treatmentType	Open_Surgical_Procedure
6810098_Patient	hasGender	Female
6810098_Patient	hasAgeCategory	Young
6810098_Patient	hasStage	IIIA
6810098_Patient	hasSmokingHabit	FormerSmoker
6810098_Patient	hasBiomarker	EGFR_Positive
6810098_Patient	hasRelapse_Progression	Progression
6810098_Patient	patientDrug	Carboplatin
6810098_Patient	patientDrug	Atezolizumab
6810098_Patient	patientDrug	Pemetrexed
6810098_Patient	patientDrug	Vinorelbine
6810098_Patient	patientDrug	Other
6810098_Patient	patientDrug	Docetaxel
6810098_Patient	treatmentType	Intravenous_Chemotherapy
6810098_Patient	treatmentType	Chemotherapy_Adjuvant
6810098_Patient	treatmentType	Molecular_Targeted_Therapy
6810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
6810098_Patient	treatmentType	Immunotherapy
6810098_Patient	treatmentType	Radiotherapy_To_Lung
6810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
6810098_Patient	treatmentType	Open_Surgical_Procedure
7810098_Patient	hasGender	Female
7810098_Patient	hasAgeCategory	Young
7810098_Patient	hasStage	IIIA
7810098_Patient	hasSmokingHabit	FormerSmoker
7810098_Patient	hasBiomarker	EGFR_Positive
7810098_Patient	hasRelapse_Progression	Progression
7810098_Patient	patientDrug	Carboplatin
7810098_Patient	patientDrug	Atezolizumab
7810098_Patient	patientDrug	Pemetrexed
7810098_Patient	patientDrug	Vinorelbine
7810098_Patient	patientDrug	Other
7810098_Patient	patientDrug	Docetaxel
7810098_Patient	treatmentType	Intravenous_Chemotherapy
7810098_Patient	treatmentType	Chemotherapy_Adjuvant
7810098_Patient	treatmentType	Molecular_Targeted_Therapy
7810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
7810098_Patient	treatmentType	Immunotherapy
7810098_Patient	treatmentType	Radiotherapy_To_Lung
7810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
7810098_Patient	treatmentType	Open_Surgical_Procedure
8810098_Patient	hasGender	Female
8810098_Patient	hasAgeCategory	Young
8810098_Patient	hasStage	IIIA
8810098_Patient	hasSmokingHabit	FormerSmoker
8810098_Patient	hasBiomarker	EGFR_Positive
8810098_Patient	hasRelapse_Progression	Progression
8810098_Patient	patientDrug	Carboplatin
8810098_Patient	patientDrug	Atezolizumab
8810098_Patient	patientDrug	Pemetrexed
8810098_Patient	patientDrug	Vinorelbine
8810098_Patient	patientDrug	Other
8810098_Patient	patientDrug	Docetaxel
8810098_Patient	treatmentType	Intravenous_Chemotherapy
8810098_Patient	treatmentType	Chemotherapy_Adjuvant
8810098_Patient	treatmentType	Molecular_Targeted_Therapy
8810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
8810098_Patient	treatmentType	Immunotherapy
8810098_Patient	treatmentType	Radiotherapy_To_Lung
8810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
8810098_Patient	treatmentType	Open_Surgical_Procedure
9810098_Patient	hasGender	Female
9810098_Patient	hasAgeCategory	Young
9810098_Patient	hasStage	IIIA
9810098_Patient	hasSmokingHabit	FormerSmoker
9810098_Patient	hasBiomarker	EGFR_Positive
9810098_Patient	hasRelapse_Progression	Progression
9810098_Patient	patientDrug	Carboplatin
9810098_Patient	patientDrug	Atezolizumab
9810098_Patient	patientDrug	Pemetrexed
9810098_Patient	patientDrug	Vinorelbine
9810098_Patient	patientDrug	Other
9810098_Patient	patientDrug	Docetaxel
9810098_Patient	treatmentType	Intravenous_Chemotherapy
9810098_Patient	treatmentType	Chemotherapy_Adjuvant
9810098_Patient	treatmentType	Molecular_Targeted_Therapy
9810098_Patient	treatmentType	Concurrent_Chemoradiotherapy
9810098_Patient	treatmentType	Immunotherapy
9810098_Patient	treatmentType	Radiotherapy_To_Lung
9810098_Patient	treatmentType	Whole_Brain_Radiation_Therapy
9810098_Patient	treatmentType	Open_Surgical_Procedure
0829640_Patient	hasGender	Female
0829640_Patient	hasAgeCategory	Young
0829640_Patient	hasStage	IVA
0829640_Patient	hasSmokingHabit	CurrentSmoker
0829640_Patient	hasBiomarker	EGFR_Positive
0829640_Patient	hasBiomarker	PDL1_Positive
0829640_Patient	hasBiomarker	ALK_Negative
0829640_Patient	hasBiomarker	ROS1_Negative
0829640_Patient	hasRelapse_Progression	Progression
0829640_Patient	patientDrug	Carboplatin
0829640_Patient	patientDrug	Pemetrexed
0829640_Patient	patientDrug	Pembrolizumab
0829640_Patient	patientDrug	Docetaxel
0829640_Patient	treatmentType	Intravenous_Chemotherapy
0829640_Patient	treatmentType	Immunotherapy
0829640_Patient	treatmentType	Radiotherapy_To_Lung
1829640_Patient	hasGender	Female
1829640_Patient	hasAgeCategory	Young
1829640_Patient	hasStage	IVA
1829640_Patient	hasSmokingHabit	CurrentSmoker
1829640_Patient	hasBiomarker	EGFR_Positive
1829640_Patient	hasBiomarker	PDL1_Positive
1829640_Patient	hasBiomarker	ALK_Negative
1829640_Patient	hasBiomarker	ROS1_Negative
1829640_Patient	hasRelapse_Progression	Progression
1829640_Patient	patientDrug	Carboplatin
1829640_Patient	patientDrug	Pemetrexed
1829640_Patient	patientDrug	Pembrolizumab
1829640_Patient	patientDrug	Docetaxel
1829640_Patient	treatmentType	Intravenous_Chemotherapy
1829640_Patient	treatmentType	Immunotherapy
1829640_Patient	treatmentType	Radiotherapy_To_Lung
2829640_Patient	hasGender	Female
2829640_Patient	hasAgeCategory	Young
2829640_Patient	hasStage	IVA
2829640_Patient	hasSmokingHabit	CurrentSmoker
2829640_Patient	hasBiomarker	EGFR_Positive
2829640_Patient	hasBiomarker	PDL1_Positive
2829640_Patient	hasBiomarker	ALK_Negative
2829640_Patient	hasBiomarker	ROS1_Negative
2829640_Patient	hasRelapse_Progression	Progression
2829640_Patient	patientDrug	Carboplatin
2829640_Patient	patientDrug	Pemetrexed
2829640_Patient	patientDrug	Pembrolizumab
2829640_Patient	patientDrug	Docetaxel
2829640_Patient	treatmentType	Intravenous_Chemotherapy
2829640_Patient	treatmentType	Immunotherapy
2829640_Patient	treatmentType	Radiotherapy_To_Lung
3829640_Patient	hasGender	Female
3829640_Patient	hasAgeCategory	Young
3829640_Patient	hasStage	IVA
3829640_Patient	hasSmokingHabit	CurrentSmoker
3829640_Patient	hasBiomarker	EGFR_Positive
3829640_Patient	hasBiomarker	PDL1_Positive
3829640_Patient	hasBiomarker	ALK_Negative
3829640_Patient	hasBiomarker	ROS1_Negative
3829640_Patient	hasRelapse_Progression	Progression
3829640_Patient	patientDrug	Carboplatin
3829640_Patient	patientDrug	Pemetrexed
3829640_Patient	patientDrug	Pembrolizumab
3829640_Patient	patientDrug	Docetaxel
3829640_Patient	treatmentType	Intravenous_Chemotherapy
3829640_Patient	treatmentType	Immunotherapy
3829640_Patient	treatmentType	Radiotherapy_To_Lung
4829640_Patient	hasGender	Female
4829640_Patient	hasAgeCategory	Young
4829640_Patient	hasStage	IVA
4829640_Patient	hasSmokingHabit	CurrentSmoker
4829640_Patient	hasBiomarker	EGFR_Positive
4829640_Patient	hasBiomarker	PDL1_Positive
4829640_Patient	hasBiomarker	ALK_Negative
4829640_Patient	hasBiomarker	ROS1_Negative
4829640_Patient	hasRelapse_Progression	Progression
4829640_Patient	patientDrug	Carboplatin
4829640_Patient	patientDrug	Pemetrexed
4829640_Patient	patientDrug	Pembrolizumab
4829640_Patient	patientDrug	Docetaxel
4829640_Patient	treatmentType	Intravenous_Chemotherapy
4829640_Patient	treatmentType	Immunotherapy
4829640_Patient	treatmentType	Radiotherapy_To_Lung
5829640_Patient	hasGender	Female
5829640_Patient	hasAgeCategory	Young
5829640_Patient	hasStage	IVA
5829640_Patient	hasSmokingHabit	CurrentSmoker
5829640_Patient	hasBiomarker	EGFR_Positive
5829640_Patient	hasBiomarker	PDL1_Positive
5829640_Patient	hasBiomarker	ALK_Negative
5829640_Patient	hasBiomarker	ROS1_Negative
5829640_Patient	hasRelapse_Progression	Progression
5829640_Patient	patientDrug	Carboplatin
5829640_Patient	patientDrug	Pemetrexed
5829640_Patient	patientDrug	Pembrolizumab
5829640_Patient	patientDrug	Docetaxel
5829640_Patient	treatmentType	Intravenous_Chemotherapy
5829640_Patient	treatmentType	Immunotherapy
5829640_Patient	treatmentType	Radiotherapy_To_Lung
6829640_Patient	hasGender	Female
6829640_Patient	hasAgeCategory	Young
6829640_Patient	hasStage	IVA
6829640_Patient	hasSmokingHabit	CurrentSmoker
6829640_Patient	hasBiomarker	EGFR_Positive
6829640_Patient	hasBiomarker	PDL1_Positive
6829640_Patient	hasBiomarker	ALK_Negative
6829640_Patient	hasBiomarker	ROS1_Negative
6829640_Patient	hasRelapse_Progression	Progression
6829640_Patient	patientDrug	Carboplatin
6829640_Patient	patientDrug	Pemetrexed
6829640_Patient	patientDrug	Pembrolizumab
6829640_Patient	patientDrug	Docetaxel
6829640_Patient	treatmentType	Intravenous_Chemotherapy
6829640_Patient	treatmentType	Immunotherapy
6829640_Patient	treatmentType	Radiotherapy_To_Lung
7829640_Patient	hasGender	Female
7829640_Patient	hasAgeCategory	Young
7829640_Patient	hasStage	IVA
7829640_Patient	hasSmokingHabit	CurrentSmoker
7829640_Patient	hasBiomarker	EGFR_Positive
7829640_Patient	hasBiomarker	PDL1_Positive
7829640_Patient	hasBiomarker	ALK_Negative
7829640_Patient	hasBiomarker	ROS1_Negative
7829640_Patient	hasRelapse_Progression	Progression
7829640_Patient	patientDrug	Carboplatin
7829640_Patient	patientDrug	Pemetrexed
7829640_Patient	patientDrug	Pembrolizumab
7829640_Patient	patientDrug	Docetaxel
7829640_Patient	treatmentType	Intravenous_Chemotherapy
7829640_Patient	treatmentType	Immunotherapy
7829640_Patient	treatmentType	Radiotherapy_To_Lung
8829640_Patient	hasGender	Female
8829640_Patient	hasAgeCategory	Young
8829640_Patient	hasStage	IVA
8829640_Patient	hasSmokingHabit	CurrentSmoker
8829640_Patient	hasBiomarker	EGFR_Positive
8829640_Patient	hasBiomarker	PDL1_Positive
8829640_Patient	hasBiomarker	ALK_Negative
8829640_Patient	hasBiomarker	ROS1_Negative
8829640_Patient	hasRelapse_Progression	Progression
8829640_Patient	patientDrug	Carboplatin
8829640_Patient	patientDrug	Pemetrexed
8829640_Patient	patientDrug	Pembrolizumab
8829640_Patient	patientDrug	Docetaxel
8829640_Patient	treatmentType	Intravenous_Chemotherapy
8829640_Patient	treatmentType	Immunotherapy
8829640_Patient	treatmentType	Radiotherapy_To_Lung
9829640_Patient	hasGender	Female
9829640_Patient	hasAgeCategory	Young
9829640_Patient	hasStage	IVA
9829640_Patient	hasSmokingHabit	CurrentSmoker
9829640_Patient	hasBiomarker	EGFR_Positive
9829640_Patient	hasBiomarker	PDL1_Positive
9829640_Patient	hasBiomarker	ALK_Negative
9829640_Patient	hasBiomarker	ROS1_Negative
9829640_Patient	hasRelapse_Progression	Progression
9829640_Patient	patientDrug	Carboplatin
9829640_Patient	patientDrug	Pemetrexed
9829640_Patient	patientDrug	Pembrolizumab
9829640_Patient	patientDrug	Docetaxel
9829640_Patient	treatmentType	Intravenous_Chemotherapy
9829640_Patient	treatmentType	Immunotherapy
9829640_Patient	treatmentType	Radiotherapy_To_Lung
0790159_Patient	hasGender	Male
0790159_Patient	hasAgeCategory	Old
0790159_Patient	hasStage	IVA
0790159_Patient	hasSmokingHabit	FormerSmoker
0790159_Patient	hasBiomarker	PDL1_Positive
0790159_Patient	hasRelapse_Progression	Progression
0790159_Patient	patientDrug	Pembrolizumab
0790159_Patient	patientDrug	Afatinib
0790159_Patient	treatmentType	Immunotherapy
0790159_Patient	treatmentType	Radiotherapy_To_Lung
1790159_Patient	hasGender	Male
1790159_Patient	hasAgeCategory	Old
1790159_Patient	hasStage	IVA
1790159_Patient	hasSmokingHabit	FormerSmoker
1790159_Patient	hasBiomarker	PDL1_Positive
1790159_Patient	hasRelapse_Progression	Progression
1790159_Patient	patientDrug	Pembrolizumab
1790159_Patient	patientDrug	Afatinib
1790159_Patient	treatmentType	Immunotherapy
1790159_Patient	treatmentType	Radiotherapy_To_Lung
2790159_Patient	hasGender	Male
2790159_Patient	hasAgeCategory	Old
2790159_Patient	hasStage	IVA
2790159_Patient	hasSmokingHabit	FormerSmoker
2790159_Patient	hasBiomarker	PDL1_Positive
2790159_Patient	hasRelapse_Progression	Progression
2790159_Patient	patientDrug	Pembrolizumab
2790159_Patient	patientDrug	Afatinib
2790159_Patient	treatmentType	Immunotherapy
2790159_Patient	treatmentType	Radiotherapy_To_Lung
3790159_Patient	hasGender	Male
3790159_Patient	hasAgeCategory	Old
3790159_Patient	hasStage	IVA
3790159_Patient	hasSmokingHabit	FormerSmoker
3790159_Patient	hasBiomarker	PDL1_Positive
3790159_Patient	hasRelapse_Progression	Progression
3790159_Patient	patientDrug	Pembrolizumab
3790159_Patient	patientDrug	Afatinib
3790159_Patient	treatmentType	Immunotherapy
3790159_Patient	treatmentType	Radiotherapy_To_Lung
4790159_Patient	hasGender	Male
4790159_Patient	hasAgeCategory	Old
4790159_Patient	hasStage	IVA
4790159_Patient	hasSmokingHabit	FormerSmoker
4790159_Patient	hasBiomarker	PDL1_Positive
4790159_Patient	hasRelapse_Progression	Progression
4790159_Patient	patientDrug	Pembrolizumab
4790159_Patient	patientDrug	Afatinib
4790159_Patient	treatmentType	Immunotherapy
4790159_Patient	treatmentType	Radiotherapy_To_Lung
5790159_Patient	hasGender	Male
5790159_Patient	hasAgeCategory	Old
5790159_Patient	hasStage	IVA
5790159_Patient	hasSmokingHabit	FormerSmoker
5790159_Patient	hasBiomarker	PDL1_Positive
5790159_Patient	hasRelapse_Progression	Progression
5790159_Patient	patientDrug	Pembrolizumab
5790159_Patient	patientDrug	Afatinib
5790159_Patient	treatmentType	Immunotherapy
5790159_Patient	treatmentType	Radiotherapy_To_Lung
6790159_Patient	hasGender	Male
6790159_Patient	hasAgeCategory	Old
6790159_Patient	hasStage	IVA
6790159_Patient	hasSmokingHabit	FormerSmoker
6790159_Patient	hasBiomarker	PDL1_Positive
6790159_Patient	hasRelapse_Progression	Progression
6790159_Patient	patientDrug	Pembrolizumab
6790159_Patient	patientDrug	Afatinib
6790159_Patient	treatmentType	Immunotherapy
6790159_Patient	treatmentType	Radiotherapy_To_Lung
7790159_Patient	hasGender	Male
7790159_Patient	hasAgeCategory	Old
7790159_Patient	hasStage	IVA
7790159_Patient	hasSmokingHabit	FormerSmoker
7790159_Patient	hasBiomarker	PDL1_Positive
7790159_Patient	hasRelapse_Progression	Progression
7790159_Patient	patientDrug	Pembrolizumab
7790159_Patient	patientDrug	Afatinib
7790159_Patient	treatmentType	Immunotherapy
7790159_Patient	treatmentType	Radiotherapy_To_Lung
8790159_Patient	hasGender	Male
8790159_Patient	hasAgeCategory	Old
8790159_Patient	hasStage	IVA
8790159_Patient	hasSmokingHabit	FormerSmoker
8790159_Patient	hasBiomarker	PDL1_Positive
8790159_Patient	hasRelapse_Progression	Progression
8790159_Patient	patientDrug	Pembrolizumab
8790159_Patient	patientDrug	Afatinib
8790159_Patient	treatmentType	Immunotherapy
8790159_Patient	treatmentType	Radiotherapy_To_Lung
9790159_Patient	hasGender	Male
9790159_Patient	hasAgeCategory	Old
9790159_Patient	hasStage	IVA
9790159_Patient	hasSmokingHabit	FormerSmoker
9790159_Patient	hasBiomarker	PDL1_Positive
9790159_Patient	hasRelapse_Progression	Progression
9790159_Patient	patientDrug	Pembrolizumab
9790159_Patient	patientDrug	Afatinib
9790159_Patient	treatmentType	Immunotherapy
9790159_Patient	treatmentType	Radiotherapy_To_Lung
01110078_Patient	hasGender	Male
01110078_Patient	hasAgeCategory	Young
01110078_Patient	hasStage	IVB
01110078_Patient	hasSmokingHabit	CurrentSmoker
01110078_Patient	hasBiomarker	EGFR_Positive
01110078_Patient	hasBiomarker	ALK_Negative
01110078_Patient	hasRelapse_Progression	Progression
01110078_Patient	patientDrug	Carboplatin
01110078_Patient	patientDrug	Paclitaxel
01110078_Patient	patientDrug	Pemetrexed
01110078_Patient	patientDrug	Cisplatin
01110078_Patient	patientDrug	Afatinib
01110078_Patient	patientDrug	Osimertinib
01110078_Patient	treatmentType	Intravenous_Chemotherapy
01110078_Patient	treatmentType	Molecular_Targeted_Therapy
01110078_Patient	treatmentType	Radiotherapy_To_Bone
11110078_Patient	hasGender	Male
11110078_Patient	hasAgeCategory	Young
11110078_Patient	hasStage	IVB
11110078_Patient	hasSmokingHabit	CurrentSmoker
11110078_Patient	hasBiomarker	EGFR_Positive
11110078_Patient	hasBiomarker	ALK_Negative
11110078_Patient	hasRelapse_Progression	Progression
11110078_Patient	patientDrug	Carboplatin
11110078_Patient	patientDrug	Paclitaxel
11110078_Patient	patientDrug	Pemetrexed
11110078_Patient	patientDrug	Cisplatin
11110078_Patient	patientDrug	Afatinib
11110078_Patient	patientDrug	Osimertinib
11110078_Patient	treatmentType	Intravenous_Chemotherapy
11110078_Patient	treatmentType	Molecular_Targeted_Therapy
11110078_Patient	treatmentType	Radiotherapy_To_Bone
21110078_Patient	hasGender	Male
21110078_Patient	hasAgeCategory	Young
21110078_Patient	hasStage	IVB
21110078_Patient	hasSmokingHabit	CurrentSmoker
21110078_Patient	hasBiomarker	EGFR_Positive
21110078_Patient	hasBiomarker	ALK_Negative
21110078_Patient	hasRelapse_Progression	Progression
21110078_Patient	patientDrug	Carboplatin
21110078_Patient	patientDrug	Paclitaxel
21110078_Patient	patientDrug	Pemetrexed
21110078_Patient	patientDrug	Cisplatin
21110078_Patient	patientDrug	Afatinib
21110078_Patient	patientDrug	Osimertinib
21110078_Patient	treatmentType	Intravenous_Chemotherapy
21110078_Patient	treatmentType	Molecular_Targeted_Therapy
21110078_Patient	treatmentType	Radiotherapy_To_Bone
31110078_Patient	hasGender	Male
31110078_Patient	hasAgeCategory	Young
31110078_Patient	hasStage	IVB
31110078_Patient	hasSmokingHabit	CurrentSmoker
31110078_Patient	hasBiomarker	EGFR_Positive
31110078_Patient	hasBiomarker	ALK_Negative
31110078_Patient	hasRelapse_Progression	Progression
31110078_Patient	patientDrug	Carboplatin
31110078_Patient	patientDrug	Paclitaxel
31110078_Patient	patientDrug	Pemetrexed
31110078_Patient	patientDrug	Cisplatin
31110078_Patient	patientDrug	Afatinib
31110078_Patient	patientDrug	Osimertinib
31110078_Patient	treatmentType	Intravenous_Chemotherapy
31110078_Patient	treatmentType	Molecular_Targeted_Therapy
31110078_Patient	treatmentType	Radiotherapy_To_Bone
41110078_Patient	hasGender	Male
41110078_Patient	hasAgeCategory	Young
41110078_Patient	hasStage	IVB
41110078_Patient	hasSmokingHabit	CurrentSmoker
41110078_Patient	hasBiomarker	EGFR_Positive
41110078_Patient	hasBiomarker	ALK_Negative
41110078_Patient	hasRelapse_Progression	Progression
41110078_Patient	patientDrug	Carboplatin
41110078_Patient	patientDrug	Paclitaxel
41110078_Patient	patientDrug	Pemetrexed
41110078_Patient	patientDrug	Cisplatin
41110078_Patient	patientDrug	Afatinib
41110078_Patient	patientDrug	Osimertinib
41110078_Patient	treatmentType	Intravenous_Chemotherapy
41110078_Patient	treatmentType	Molecular_Targeted_Therapy
41110078_Patient	treatmentType	Radiotherapy_To_Bone
51110078_Patient	hasGender	Male
51110078_Patient	hasAgeCategory	Young
51110078_Patient	hasStage	IVB
51110078_Patient	hasSmokingHabit	CurrentSmoker
51110078_Patient	hasBiomarker	EGFR_Positive
51110078_Patient	hasBiomarker	ALK_Negative
51110078_Patient	hasRelapse_Progression	Progression
51110078_Patient	patientDrug	Carboplatin
51110078_Patient	patientDrug	Paclitaxel
51110078_Patient	patientDrug	Pemetrexed
51110078_Patient	patientDrug	Cisplatin
51110078_Patient	patientDrug	Afatinib
51110078_Patient	patientDrug	Osimertinib
51110078_Patient	treatmentType	Intravenous_Chemotherapy
51110078_Patient	treatmentType	Molecular_Targeted_Therapy
51110078_Patient	treatmentType	Radiotherapy_To_Bone
61110078_Patient	hasGender	Male
61110078_Patient	hasAgeCategory	Young
61110078_Patient	hasStage	IVB
61110078_Patient	hasSmokingHabit	CurrentSmoker
61110078_Patient	hasBiomarker	EGFR_Positive
61110078_Patient	hasBiomarker	ALK_Negative
61110078_Patient	hasRelapse_Progression	Progression
61110078_Patient	patientDrug	Carboplatin
61110078_Patient	patientDrug	Paclitaxel
61110078_Patient	patientDrug	Pemetrexed
61110078_Patient	patientDrug	Cisplatin
61110078_Patient	patientDrug	Afatinib
61110078_Patient	patientDrug	Osimertinib
61110078_Patient	treatmentType	Intravenous_Chemotherapy
61110078_Patient	treatmentType	Molecular_Targeted_Therapy
61110078_Patient	treatmentType	Radiotherapy_To_Bone
71110078_Patient	hasGender	Male
71110078_Patient	hasAgeCategory	Young
71110078_Patient	hasStage	IVB
71110078_Patient	hasSmokingHabit	CurrentSmoker
71110078_Patient	hasBiomarker	EGFR_Positive
71110078_Patient	hasBiomarker	ALK_Negative
71110078_Patient	hasRelapse_Progression	Progression
71110078_Patient	patientDrug	Carboplatin
71110078_Patient	patientDrug	Paclitaxel
71110078_Patient	patientDrug	Pemetrexed
71110078_Patient	patientDrug	Cisplatin
71110078_Patient	patientDrug	Afatinib
71110078_Patient	patientDrug	Osimertinib
71110078_Patient	treatmentType	Intravenous_Chemotherapy
71110078_Patient	treatmentType	Molecular_Targeted_Therapy
71110078_Patient	treatmentType	Radiotherapy_To_Bone
81110078_Patient	hasGender	Male
81110078_Patient	hasAgeCategory	Young
81110078_Patient	hasStage	IVB
81110078_Patient	hasSmokingHabit	CurrentSmoker
81110078_Patient	hasBiomarker	EGFR_Positive
81110078_Patient	hasBiomarker	ALK_Negative
81110078_Patient	hasRelapse_Progression	Progression
81110078_Patient	patientDrug	Carboplatin
81110078_Patient	patientDrug	Paclitaxel
81110078_Patient	patientDrug	Pemetrexed
81110078_Patient	patientDrug	Cisplatin
81110078_Patient	patientDrug	Afatinib
81110078_Patient	patientDrug	Osimertinib
81110078_Patient	treatmentType	Intravenous_Chemotherapy
81110078_Patient	treatmentType	Molecular_Targeted_Therapy
81110078_Patient	treatmentType	Radiotherapy_To_Bone
91110078_Patient	hasGender	Male
91110078_Patient	hasAgeCategory	Young
91110078_Patient	hasStage	IVB
91110078_Patient	hasSmokingHabit	CurrentSmoker
91110078_Patient	hasBiomarker	EGFR_Positive
91110078_Patient	hasBiomarker	ALK_Negative
91110078_Patient	hasRelapse_Progression	Progression
91110078_Patient	patientDrug	Carboplatin
91110078_Patient	patientDrug	Paclitaxel
91110078_Patient	patientDrug	Pemetrexed
91110078_Patient	patientDrug	Cisplatin
91110078_Patient	patientDrug	Afatinib
91110078_Patient	patientDrug	Osimertinib
91110078_Patient	treatmentType	Intravenous_Chemotherapy
91110078_Patient	treatmentType	Molecular_Targeted_Therapy
91110078_Patient	treatmentType	Radiotherapy_To_Bone
02831180_Patient	hasGender	Female
02831180_Patient	hasAgeCategory	Young
02831180_Patient	hasStage	IVB
02831180_Patient	hasSmokingHabit	NonSmoker
02831180_Patient	hasBiomarker	EGFR_Positive
02831180_Patient	hasBiomarker	PDL1_Positive
02831180_Patient	hasBiomarker	ALK_Negative
02831180_Patient	hasBiomarker	ROS1_Negative
02831180_Patient	patientDrug	Afatinib
02831180_Patient	patientDrug	Osimertinib
02831180_Patient	treatmentType	Molecular_Targeted_Therapy
02831180_Patient	treatmentType	Radiotherapy_To_Bone
12831180_Patient	hasGender	Female
12831180_Patient	hasAgeCategory	Young
12831180_Patient	hasStage	IVB
12831180_Patient	hasSmokingHabit	NonSmoker
12831180_Patient	hasBiomarker	EGFR_Positive
12831180_Patient	hasBiomarker	PDL1_Positive
12831180_Patient	hasBiomarker	ALK_Negative
12831180_Patient	hasBiomarker	ROS1_Negative
12831180_Patient	patientDrug	Afatinib
12831180_Patient	patientDrug	Osimertinib
12831180_Patient	treatmentType	Molecular_Targeted_Therapy
12831180_Patient	treatmentType	Radiotherapy_To_Bone
22831180_Patient	hasGender	Female
22831180_Patient	hasAgeCategory	Young
22831180_Patient	hasStage	IVB
22831180_Patient	hasSmokingHabit	NonSmoker
22831180_Patient	hasBiomarker	EGFR_Positive
22831180_Patient	hasBiomarker	PDL1_Positive
22831180_Patient	hasBiomarker	ALK_Negative
22831180_Patient	hasBiomarker	ROS1_Negative
22831180_Patient	patientDrug	Afatinib
22831180_Patient	patientDrug	Osimertinib
22831180_Patient	treatmentType	Molecular_Targeted_Therapy
22831180_Patient	treatmentType	Radiotherapy_To_Bone
32831180_Patient	hasGender	Female
32831180_Patient	hasAgeCategory	Young
32831180_Patient	hasStage	IVB
32831180_Patient	hasSmokingHabit	NonSmoker
32831180_Patient	hasBiomarker	EGFR_Positive
32831180_Patient	hasBiomarker	PDL1_Positive
32831180_Patient	hasBiomarker	ALK_Negative
32831180_Patient	hasBiomarker	ROS1_Negative
32831180_Patient	patientDrug	Afatinib
32831180_Patient	patientDrug	Osimertinib
32831180_Patient	treatmentType	Molecular_Targeted_Therapy
32831180_Patient	treatmentType	Radiotherapy_To_Bone
42831180_Patient	hasGender	Female
42831180_Patient	hasAgeCategory	Young
42831180_Patient	hasStage	IVB
42831180_Patient	hasSmokingHabit	NonSmoker
42831180_Patient	hasBiomarker	EGFR_Positive
42831180_Patient	hasBiomarker	PDL1_Positive
42831180_Patient	hasBiomarker	ALK_Negative
42831180_Patient	hasBiomarker	ROS1_Negative
42831180_Patient	patientDrug	Afatinib
42831180_Patient	patientDrug	Osimertinib
42831180_Patient	treatmentType	Molecular_Targeted_Therapy
42831180_Patient	treatmentType	Radiotherapy_To_Bone
52831180_Patient	hasGender	Female
52831180_Patient	hasAgeCategory	Young
52831180_Patient	hasStage	IVB
52831180_Patient	hasSmokingHabit	NonSmoker
52831180_Patient	hasBiomarker	EGFR_Positive
52831180_Patient	hasBiomarker	PDL1_Positive
52831180_Patient	hasBiomarker	ALK_Negative
52831180_Patient	hasBiomarker	ROS1_Negative
52831180_Patient	patientDrug	Afatinib
52831180_Patient	patientDrug	Osimertinib
52831180_Patient	treatmentType	Molecular_Targeted_Therapy
52831180_Patient	treatmentType	Radiotherapy_To_Bone
62831180_Patient	hasGender	Female
62831180_Patient	hasAgeCategory	Young
62831180_Patient	hasStage	IVB
62831180_Patient	hasSmokingHabit	NonSmoker
62831180_Patient	hasBiomarker	EGFR_Positive
62831180_Patient	hasBiomarker	PDL1_Positive
62831180_Patient	hasBiomarker	ALK_Negative
62831180_Patient	hasBiomarker	ROS1_Negative
62831180_Patient	patientDrug	Afatinib
62831180_Patient	patientDrug	Osimertinib
62831180_Patient	treatmentType	Molecular_Targeted_Therapy
62831180_Patient	treatmentType	Radiotherapy_To_Bone
72831180_Patient	hasGender	Female
72831180_Patient	hasAgeCategory	Young
72831180_Patient	hasStage	IVB
72831180_Patient	hasSmokingHabit	NonSmoker
72831180_Patient	hasBiomarker	EGFR_Positive
72831180_Patient	hasBiomarker	PDL1_Positive
72831180_Patient	hasBiomarker	ALK_Negative
72831180_Patient	hasBiomarker	ROS1_Negative
72831180_Patient	patientDrug	Afatinib
72831180_Patient	patientDrug	Osimertinib
72831180_Patient	treatmentType	Molecular_Targeted_Therapy
72831180_Patient	treatmentType	Radiotherapy_To_Bone
82831180_Patient	hasGender	Female
82831180_Patient	hasAgeCategory	Young
82831180_Patient	hasStage	IVB
82831180_Patient	hasSmokingHabit	NonSmoker
82831180_Patient	hasBiomarker	EGFR_Positive
82831180_Patient	hasBiomarker	PDL1_Positive
82831180_Patient	hasBiomarker	ALK_Negative
82831180_Patient	hasBiomarker	ROS1_Negative
82831180_Patient	patientDrug	Afatinib
82831180_Patient	patientDrug	Osimertinib
82831180_Patient	treatmentType	Molecular_Targeted_Therapy
82831180_Patient	treatmentType	Radiotherapy_To_Bone
92831180_Patient	hasGender	Female
92831180_Patient	hasAgeCategory	Young
92831180_Patient	hasStage	IVB
92831180_Patient	hasSmokingHabit	NonSmoker
92831180_Patient	hasBiomarker	EGFR_Positive
92831180_Patient	hasBiomarker	PDL1_Positive
92831180_Patient	hasBiomarker	ALK_Negative
92831180_Patient	hasBiomarker	ROS1_Negative
92831180_Patient	patientDrug	Afatinib
92831180_Patient	patientDrug	Osimertinib
92831180_Patient	treatmentType	Molecular_Targeted_Therapy
92831180_Patient	treatmentType	Radiotherapy_To_Bone
0583557_Patient	hasGender	Male
0583557_Patient	hasAgeCategory	Old
0583557_Patient	hasStage	IVB
0583557_Patient	hasSmokingHabit	NonSmoker
0583557_Patient	hasBiomarker	EGFR_Positive
0583557_Patient	hasBiomarker	ALK_Negative
0583557_Patient	hasBiomarker	ROS1_Negative
0583557_Patient	hasRelapse_Progression	Progression
0583557_Patient	patientDrug	Carboplatin
0583557_Patient	patientDrug	Pemetrexed
0583557_Patient	patientDrug	Vinorelbine
0583557_Patient	patientDrug	Erlotinib
0583557_Patient	patientDrug	Gefitinib
0583557_Patient	treatmentType	Molecular_Targeted_Therapy
0583557_Patient	treatmentType	Immunotherapy
0583557_Patient	treatmentType	Radiotherapy_To_Bone
0583557_Patient	hasBiomarker	EGFR_Negative
1583557_Patient	hasGender	Male
1583557_Patient	hasAgeCategory	Old
1583557_Patient	hasStage	IVB
1583557_Patient	hasSmokingHabit	NonSmoker
1583557_Patient	hasBiomarker	EGFR_Positive
1583557_Patient	hasBiomarker	ALK_Negative
1583557_Patient	hasBiomarker	ROS1_Negative
1583557_Patient	hasRelapse_Progression	Progression
1583557_Patient	patientDrug	Carboplatin
1583557_Patient	patientDrug	Pemetrexed
1583557_Patient	patientDrug	Vinorelbine
1583557_Patient	patientDrug	Erlotinib
1583557_Patient	patientDrug	Gefitinib
1583557_Patient	treatmentType	Molecular_Targeted_Therapy
1583557_Patient	treatmentType	Immunotherapy
1583557_Patient	treatmentType	Radiotherapy_To_Bone
1583557_Patient	hasBiomarker	EGFR_Negative
2583557_Patient	hasGender	Male
2583557_Patient	hasAgeCategory	Old
2583557_Patient	hasStage	IVB
2583557_Patient	hasSmokingHabit	NonSmoker
2583557_Patient	hasBiomarker	EGFR_Positive
2583557_Patient	hasBiomarker	ALK_Negative
2583557_Patient	hasBiomarker	ROS1_Negative
2583557_Patient	hasRelapse_Progression	Progression
2583557_Patient	patientDrug	Carboplatin
2583557_Patient	patientDrug	Pemetrexed
2583557_Patient	patientDrug	Vinorelbine
2583557_Patient	patientDrug	Erlotinib
2583557_Patient	patientDrug	Gefitinib
2583557_Patient	treatmentType	Molecular_Targeted_Therapy
2583557_Patient	treatmentType	Immunotherapy
2583557_Patient	treatmentType	Radiotherapy_To_Bone
2583557_Patient	hasBiomarker	EGFR_Negative
3583557_Patient	hasGender	Male
3583557_Patient	hasAgeCategory	Old
3583557_Patient	hasStage	IVB
3583557_Patient	hasSmokingHabit	NonSmoker
3583557_Patient	hasBiomarker	EGFR_Positive
3583557_Patient	hasBiomarker	ALK_Negative
3583557_Patient	hasBiomarker	ROS1_Negative
3583557_Patient	hasRelapse_Progression	Progression
3583557_Patient	patientDrug	Carboplatin
3583557_Patient	patientDrug	Pemetrexed
3583557_Patient	patientDrug	Vinorelbine
3583557_Patient	patientDrug	Erlotinib
3583557_Patient	patientDrug	Gefitinib
3583557_Patient	treatmentType	Molecular_Targeted_Therapy
3583557_Patient	treatmentType	Immunotherapy
3583557_Patient	treatmentType	Radiotherapy_To_Bone
3583557_Patient	hasBiomarker	EGFR_Negative
4583557_Patient	hasGender	Male
4583557_Patient	hasAgeCategory	Old
4583557_Patient	hasStage	IVB
4583557_Patient	hasSmokingHabit	NonSmoker
4583557_Patient	hasBiomarker	EGFR_Positive
4583557_Patient	hasBiomarker	ALK_Negative
4583557_Patient	hasBiomarker	ROS1_Negative
4583557_Patient	hasRelapse_Progression	Progression
4583557_Patient	patientDrug	Carboplatin
4583557_Patient	patientDrug	Pemetrexed
4583557_Patient	patientDrug	Vinorelbine
4583557_Patient	patientDrug	Erlotinib
4583557_Patient	patientDrug	Gefitinib
4583557_Patient	treatmentType	Molecular_Targeted_Therapy
4583557_Patient	treatmentType	Immunotherapy
4583557_Patient	treatmentType	Radiotherapy_To_Bone
4583557_Patient	hasBiomarker	EGFR_Negative
5583557_Patient	hasGender	Male
5583557_Patient	hasAgeCategory	Old
5583557_Patient	hasStage	IVB
5583557_Patient	hasSmokingHabit	NonSmoker
5583557_Patient	hasBiomarker	EGFR_Positive
5583557_Patient	hasBiomarker	ALK_Negative
5583557_Patient	hasBiomarker	ROS1_Negative
5583557_Patient	hasRelapse_Progression	Progression
5583557_Patient	patientDrug	Carboplatin
5583557_Patient	patientDrug	Pemetrexed
5583557_Patient	patientDrug	Vinorelbine
5583557_Patient	patientDrug	Erlotinib
5583557_Patient	patientDrug	Gefitinib
5583557_Patient	treatmentType	Molecular_Targeted_Therapy
5583557_Patient	treatmentType	Immunotherapy
5583557_Patient	treatmentType	Radiotherapy_To_Bone
5583557_Patient	hasBiomarker	EGFR_Negative
6583557_Patient	hasGender	Male
6583557_Patient	hasAgeCategory	Old
6583557_Patient	hasStage	IVB
6583557_Patient	hasSmokingHabit	NonSmoker
6583557_Patient	hasBiomarker	EGFR_Positive
6583557_Patient	hasBiomarker	ALK_Negative
6583557_Patient	hasBiomarker	ROS1_Negative
6583557_Patient	hasRelapse_Progression	Progression
6583557_Patient	patientDrug	Carboplatin
6583557_Patient	patientDrug	Pemetrexed
6583557_Patient	patientDrug	Vinorelbine
6583557_Patient	patientDrug	Erlotinib
6583557_Patient	patientDrug	Gefitinib
6583557_Patient	treatmentType	Molecular_Targeted_Therapy
6583557_Patient	treatmentType	Immunotherapy
6583557_Patient	treatmentType	Radiotherapy_To_Bone
6583557_Patient	hasBiomarker	EGFR_Negative
7583557_Patient	hasGender	Male
7583557_Patient	hasAgeCategory	Old
7583557_Patient	hasStage	IVB
7583557_Patient	hasSmokingHabit	NonSmoker
7583557_Patient	hasBiomarker	EGFR_Positive
7583557_Patient	hasBiomarker	ALK_Negative
7583557_Patient	hasBiomarker	ROS1_Negative
7583557_Patient	hasRelapse_Progression	Progression
7583557_Patient	patientDrug	Carboplatin
7583557_Patient	patientDrug	Pemetrexed
7583557_Patient	patientDrug	Vinorelbine
7583557_Patient	patientDrug	Erlotinib
7583557_Patient	patientDrug	Gefitinib
7583557_Patient	treatmentType	Molecular_Targeted_Therapy
7583557_Patient	treatmentType	Immunotherapy
7583557_Patient	treatmentType	Radiotherapy_To_Bone
7583557_Patient	hasBiomarker	EGFR_Negative
8583557_Patient	hasGender	Male
8583557_Patient	hasAgeCategory	Old
8583557_Patient	hasStage	IVB
8583557_Patient	hasSmokingHabit	NonSmoker
8583557_Patient	hasBiomarker	EGFR_Positive
8583557_Patient	hasBiomarker	ALK_Negative
8583557_Patient	hasBiomarker	ROS1_Negative
8583557_Patient	hasRelapse_Progression	Progression
8583557_Patient	patientDrug	Carboplatin
8583557_Patient	patientDrug	Pemetrexed
8583557_Patient	patientDrug	Vinorelbine
8583557_Patient	patientDrug	Erlotinib
8583557_Patient	patientDrug	Gefitinib
8583557_Patient	treatmentType	Molecular_Targeted_Therapy
8583557_Patient	treatmentType	Immunotherapy
8583557_Patient	treatmentType	Radiotherapy_To_Bone
8583557_Patient	hasBiomarker	EGFR_Negative
9583557_Patient	hasGender	Male
9583557_Patient	hasAgeCategory	Old
9583557_Patient	hasStage	IVB
9583557_Patient	hasSmokingHabit	NonSmoker
9583557_Patient	hasBiomarker	EGFR_Positive
9583557_Patient	hasBiomarker	ALK_Negative
9583557_Patient	hasBiomarker	ROS1_Negative
9583557_Patient	hasRelapse_Progression	Progression
9583557_Patient	patientDrug	Carboplatin
9583557_Patient	patientDrug	Pemetrexed
9583557_Patient	patientDrug	Vinorelbine
9583557_Patient	patientDrug	Erlotinib
9583557_Patient	patientDrug	Gefitinib
9583557_Patient	treatmentType	Molecular_Targeted_Therapy
9583557_Patient	treatmentType	Immunotherapy
9583557_Patient	treatmentType	Radiotherapy_To_Bone
9583557_Patient	hasBiomarker	EGFR_Negative
01077426_Patient	hasGender	Female
01077426_Patient	hasAgeCategory	Young
01077426_Patient	hasStage	IVA
01077426_Patient	hasSmokingHabit	FormerSmoker
01077426_Patient	hasBiomarker	EGFR_Positive
01077426_Patient	hasBiomarker	PDL1_Positive
01077426_Patient	hasBiomarker	ALK_Negative
01077426_Patient	hasBiomarker	BRAF_Negative
01077426_Patient	hasBiomarker	ROS1_Negative
01077426_Patient	patientDrug	Osimertinib
01077426_Patient	treatmentType	Molecular_Targeted_Therapy
01077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
01077426_Patient	treatmentType	Radiotherapy_To_Bone
01077426_Patient	hasBiomarker	EGFR_Negative
11077426_Patient	hasGender	Female
11077426_Patient	hasAgeCategory	Young
11077426_Patient	hasStage	IVA
11077426_Patient	hasSmokingHabit	FormerSmoker
11077426_Patient	hasBiomarker	EGFR_Positive
11077426_Patient	hasBiomarker	PDL1_Positive
11077426_Patient	hasBiomarker	ALK_Negative
11077426_Patient	hasBiomarker	BRAF_Negative
11077426_Patient	hasBiomarker	ROS1_Negative
11077426_Patient	patientDrug	Osimertinib
11077426_Patient	treatmentType	Molecular_Targeted_Therapy
11077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
11077426_Patient	treatmentType	Radiotherapy_To_Bone
11077426_Patient	hasBiomarker	EGFR_Negative
21077426_Patient	hasGender	Female
21077426_Patient	hasAgeCategory	Young
21077426_Patient	hasStage	IVA
21077426_Patient	hasSmokingHabit	FormerSmoker
21077426_Patient	hasBiomarker	EGFR_Positive
21077426_Patient	hasBiomarker	PDL1_Positive
21077426_Patient	hasBiomarker	ALK_Negative
21077426_Patient	hasBiomarker	BRAF_Negative
21077426_Patient	hasBiomarker	ROS1_Negative
21077426_Patient	patientDrug	Osimertinib
21077426_Patient	treatmentType	Molecular_Targeted_Therapy
21077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
21077426_Patient	treatmentType	Radiotherapy_To_Bone
21077426_Patient	hasBiomarker	EGFR_Negative
31077426_Patient	hasGender	Female
31077426_Patient	hasAgeCategory	Young
31077426_Patient	hasStage	IVA
31077426_Patient	hasSmokingHabit	FormerSmoker
31077426_Patient	hasBiomarker	EGFR_Positive
31077426_Patient	hasBiomarker	PDL1_Positive
31077426_Patient	hasBiomarker	ALK_Negative
31077426_Patient	hasBiomarker	BRAF_Negative
31077426_Patient	hasBiomarker	ROS1_Negative
31077426_Patient	patientDrug	Osimertinib
31077426_Patient	treatmentType	Molecular_Targeted_Therapy
31077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
31077426_Patient	treatmentType	Radiotherapy_To_Bone
31077426_Patient	hasBiomarker	EGFR_Negative
41077426_Patient	hasGender	Female
41077426_Patient	hasAgeCategory	Young
41077426_Patient	hasStage	IVA
41077426_Patient	hasSmokingHabit	FormerSmoker
41077426_Patient	hasBiomarker	EGFR_Positive
41077426_Patient	hasBiomarker	PDL1_Positive
41077426_Patient	hasBiomarker	ALK_Negative
41077426_Patient	hasBiomarker	BRAF_Negative
41077426_Patient	hasBiomarker	ROS1_Negative
41077426_Patient	patientDrug	Osimertinib
41077426_Patient	treatmentType	Molecular_Targeted_Therapy
41077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
41077426_Patient	treatmentType	Radiotherapy_To_Bone
41077426_Patient	hasBiomarker	EGFR_Negative
51077426_Patient	hasGender	Female
51077426_Patient	hasAgeCategory	Young
51077426_Patient	hasStage	IVA
51077426_Patient	hasSmokingHabit	FormerSmoker
51077426_Patient	hasBiomarker	EGFR_Positive
51077426_Patient	hasBiomarker	PDL1_Positive
51077426_Patient	hasBiomarker	ALK_Negative
51077426_Patient	hasBiomarker	BRAF_Negative
51077426_Patient	hasBiomarker	ROS1_Negative
51077426_Patient	patientDrug	Osimertinib
51077426_Patient	treatmentType	Molecular_Targeted_Therapy
51077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
51077426_Patient	treatmentType	Radiotherapy_To_Bone
51077426_Patient	hasBiomarker	EGFR_Negative
61077426_Patient	hasGender	Female
61077426_Patient	hasAgeCategory	Young
61077426_Patient	hasStage	IVA
61077426_Patient	hasSmokingHabit	FormerSmoker
61077426_Patient	hasBiomarker	EGFR_Positive
61077426_Patient	hasBiomarker	PDL1_Positive
61077426_Patient	hasBiomarker	ALK_Negative
61077426_Patient	hasBiomarker	BRAF_Negative
61077426_Patient	hasBiomarker	ROS1_Negative
61077426_Patient	patientDrug	Osimertinib
61077426_Patient	treatmentType	Molecular_Targeted_Therapy
61077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
61077426_Patient	treatmentType	Radiotherapy_To_Bone
61077426_Patient	hasBiomarker	EGFR_Negative
71077426_Patient	hasGender	Female
71077426_Patient	hasAgeCategory	Young
71077426_Patient	hasStage	IVA
71077426_Patient	hasSmokingHabit	FormerSmoker
71077426_Patient	hasBiomarker	EGFR_Positive
71077426_Patient	hasBiomarker	PDL1_Positive
71077426_Patient	hasBiomarker	ALK_Negative
71077426_Patient	hasBiomarker	BRAF_Negative
71077426_Patient	hasBiomarker	ROS1_Negative
71077426_Patient	patientDrug	Osimertinib
71077426_Patient	treatmentType	Molecular_Targeted_Therapy
71077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
71077426_Patient	treatmentType	Radiotherapy_To_Bone
71077426_Patient	hasBiomarker	EGFR_Negative
81077426_Patient	hasGender	Female
81077426_Patient	hasAgeCategory	Young
81077426_Patient	hasStage	IVA
81077426_Patient	hasSmokingHabit	FormerSmoker
81077426_Patient	hasBiomarker	EGFR_Positive
81077426_Patient	hasBiomarker	PDL1_Positive
81077426_Patient	hasBiomarker	ALK_Negative
81077426_Patient	hasBiomarker	BRAF_Negative
81077426_Patient	hasBiomarker	ROS1_Negative
81077426_Patient	patientDrug	Osimertinib
81077426_Patient	treatmentType	Molecular_Targeted_Therapy
81077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
81077426_Patient	treatmentType	Radiotherapy_To_Bone
81077426_Patient	hasBiomarker	EGFR_Negative
91077426_Patient	hasGender	Female
91077426_Patient	hasAgeCategory	Young
91077426_Patient	hasStage	IVA
91077426_Patient	hasSmokingHabit	FormerSmoker
91077426_Patient	hasBiomarker	EGFR_Positive
91077426_Patient	hasBiomarker	PDL1_Positive
91077426_Patient	hasBiomarker	ALK_Negative
91077426_Patient	hasBiomarker	BRAF_Negative
91077426_Patient	hasBiomarker	ROS1_Negative
91077426_Patient	patientDrug	Osimertinib
91077426_Patient	treatmentType	Molecular_Targeted_Therapy
91077426_Patient	treatmentType	Whole_Brain_Radiation_Therapy
91077426_Patient	treatmentType	Radiotherapy_To_Bone
91077426_Patient	hasBiomarker	EGFR_Negative
